EurekaMag Full Text Articles Chapter 55,729

Cauley, J.A.; Parimi, N.; Ensrud, K.E.; Bauer, D.C.; Cawthon, P.M.; Cummings, S.R.; Hoffman, A.R.; Shikany, J.M.; Barrett-Connor, E.; Orwoll, E. 2010: Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 25(3): 545-553

Konstari, S.; Kaila-Kangas, L.; Jääskeläinen, T.; Heliövaara, M.; Rissanen, H.; Marniemi, J.; Knekt, P.; Arokoski, J.; Karppinen, J. 2014: Serum 25-hydroxyvitamin D and the risk of knee and hip osteoarthritis leading to hospitalization: a cohort study of 5274 Finns. Rheumatology 53(10): 1778-1782

Tanaka, S.; Kuroda, T.; Yamazaki, Y.; Shiraki, Y.; Yoshimura, N.; Shiraki, M. 2014: Serum 25-hydroxyvitamin D below 25 ng/mL is a risk factor for long bone fracture comparable to bone mineral density in Japanese postmenopausal women. Journal of Bone and Mineral Metabolism 32(5): 514-523

Llewellyn, D.J.; Langa, K.M.; Lang, I.A. 2009: Serum 25-hydroxyvitamin D concentration and cognitive impairment. Journal of Geriatric Psychiatry and Neurology 22(3): 188-195

Dumitrescu, G.; Mihai, C.; Dranga, M.; Prelipcean, C.C. 2014: Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World Journal of Gastroenterology 20(9): 2392-2396

Ceglia, L.; Chiu, G.R.; Harris, S.S.; Araujo, A.B. 2011: Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clinical Endocrinology 74(3): 370-376

de Boer, I.H.; Levin, G.; Robinson-Cohen, C.; Biggs, M.L.; Hoofnagle, A.N.; Siscovick, D.S.; Kestenbaum, B. 2012: Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Annals of Internal Medicine 156(9): 627-634

Schafer, A.L.; Napoli, N.; Lui, L.; Schwartz, A.V.; Black, D.M. 2014: Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women. Diabetic Medicine: a Journal of the British Diabetic Association 31(5): 564-569

Atwa, M.A.; Balata, M.G.; Hussein, A.M.; Abdelrahman, N.I.; Elminshawy, H.H. 2013: Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Medical Journal 34(8): 806-813

Deleskog, A.; Piksasova, O.; Silveira, A.; Gertow, K.; Baldassarre, D.; Veglia, F.; Sennblad, B.; Strawbridge, R.J.; Larsson, M.; Leander, K.; Gigante, B.; Kauhanen, J.; Rauramaa, R.; Smit, A.J.; Mannarino, E.; Giral, P.; Gustafsson, S.; Östenson, C.-G.ör.; Humphries, S.E.; Tremoli, E.; de Faire, U.; Öhrvik, J.; Hamsten, A. 2013: Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology 33(11): 2633-2638

Boxer, R.S.; Kenny, A.M.; Cheruvu, V.K.; Vest, M.; Fiutem, J.J.; Piña, I.I. 2010: Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. American Heart Journal 160(5): 893-899

Liu, J.-x.; Xiang, J.; Bu, R.-f.; Wu, W.-j.; Shen, H.; Wang, X.-j. 2012: Serum 25-hydroxyvitamin D concentration is negatively related to carotid artery intima-media thickness in type 2 diabetic patients. Zhonghua Xin Xue Guan Bing Za Zhi 40(2): 115-119

Heere, C.; Skeaff, C.M.; Waqatakirewa, L.; Vatucawaqa, P.; Khan, A.N.; Green, T.J. 2010: Serum 25-hydroxyvitamin D concentration of Indigenous-Fijian and Fijian-Indian women. Asia Pacific Journal of Clinical Nutrition 19(1): 43-48

Deleskog, A.; Piksasova, O.; Silveira, A.; Samnegård, A.; Tornvall, P.; Eriksson, P.; Gustafsson, S.; Ostenson, C.-G.ör.; Ohrvik, J.; Hamsten, A. 2012: Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years. Atherosclerosis 223(1): 223-229

Polak, M.A.; Houghton, L.A.; Reeder, A.I.; Harper, M.J.; Conner, T.S. 2014: Serum 25-hydroxyvitamin D concentrations and depressive symptoms among young adult men and women. Nutrients 6(11): 4720-4730

McCullough, M.L.; Stevens, V.L.; Patel, R.; Jacobs, E.J.; Bain, E.B.; Horst, R.L.; Gapstur, S.M.; Thun, M.J.; Calle, E.E. 2009: Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Research: Bcr 11(4): R64

Schenk, J.M.; Till, C.A.; Tangen, C.M.; Goodman, P.J.; Song, X.; Torkko, K.C.; Kristal, A.R.; Peters, U.; Neuhouser, M.L. 2014: Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(8): 1484-1493

Ryoo, E.; Kumar, R.; Kita, H.; Juhn, Y.J. 2013: Serum 25-hydroxyvitamin D concentrations and waning pneumococcal antibody titers among individuals with atopy. Allergy and Asthma Proceedings 34(4): 370-377

Park, Y.; Kim, M. 2011: Serum 25-hydroxyvitamin D concentrations are associated with erythrocyte levels of n-3 PUFA but not risk of CVD. British Journal of Nutrition 106(10): 1529-1534

Ganji, V.; Zhang, X.; Shaikh, N.; Tangpricha, V. 2011: Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. American journal of clinical nutrition 94(1): 225-233

Gozdzik, A.; Barta, J.L.; Weir, A.; Cole, D.E.C.; Vieth, R.; Whiting, S.J.; Parra, E.J. 2010: Serum 25-hydroxyvitamin D concentrations fluctuate seasonally in young adults of diverse ancestry living in Toronto. Journal of Nutrition 140(12): 2213-2220

Waters, W.R.; Nonnecke, B.J.; Gibbs, S.E.J.; Yabsley, M.J.; Schmitt, S.M.; Cosgrove, M.K.; Palmer, M.V.; Thacker, T.C.; Olsen, S.C.; Horst, R.L.; Reinhardt, T.A. 2009: Serum 25-hydroxyvitamin D concentrations in captive and free-ranging, white-tailed deer (Odocoileus virginianus). International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 79(3): 180-187

Selting, K.A.; Sharp, C.R.; Ringold, R.; Thamm, D.H.; Backus, R. 2016: Serum 25-hydroxyvitamin D concentrations in dogs - correlation with health and cancer risk. Veterinary and Comparative Oncology 14(3): 295-305

Yildizhan, R.; Kurdoglu, M.; Adali, E.; Kolusari, A.; Yildizhan, B.; Sahin, H.G.; Kamaci, M. 2009: Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of Gynecology and Obstetrics 280(4): 559-563

Xu, X.; Fu, W.-W.; Wu, W.-Y. 2012: Serum 25-hydroxyvitamin D deficiency in Chinese patients with vitiligo: a case-control study. Plos one 7(12): E52778

Kaptein, E.M.; Yi, S.S.; Endres, D.B.; Kaptein, J.S.; Chan, L.S. 2014: Serum 25-hydroxyvitamin D deficiency; a risk factor for chronic kidney disease in ambulatory indigent patients. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20(3): 236-243

Massart, C.; Souberbielle, J.-C. 2009: Serum 25-hydroxyvitamin D immunoassays: recommendations for correct clinical interpretation. Clinical Chemistry 55(6): 1247-1248

Miettinen, M.E.; Kinnunen, L.; Harjutsalo, V.; Reinert-Hartwall, L.; Lamberg-Allardt, C.; Tuomilehto, J.; Säilä, H. 2013: Serum 25-hydroxyvitamin D in juvenile idiopathic arthritis patients in Finland. Clinical and Experimental Rheumatology 31(6): 988

Lagunova, Z.; Porojnicu, A.C.; Vieth, R.; Lindberg, F.A.; Hexeberg, S.; Moan, J. 2011: Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. Journal of Nutrition 141(1): 112-117

Heaney, R.P. 2011: Serum 25-hydroxyvitamin D is a reliable indicator of vitamin D status. American Journal of Clinical Nutrition 94(2): 619

Lee, J.; Zhao, H.; Fenta, Y.; Kita, H.; Kumar, R.; Juhn, Y.J. 2011: Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma. Allergy and Asthma Proceedings 32(6): 445-452

Maki, K.C.; Rubin, M.R.; Wong, L.G.; McManus, J.F.; Jensen, C.D.; Marshall, J.W.; Lawless, A. 2009: Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. Journal of Clinical Lipidology 3(4): 289-296

Del Gobbo, L.C.; Song, Y.; Dannenbaum, D.A.; Dewailly, E.; Egeland, G.M. 2011: Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. Journal of Nutrition 141(2): 290-295

Saadi, H.F.; Nicholls, M.G.; Frampton, C.M.; Benedict, S.; Yasin, J. 2009: Serum 25-hydroxyvitamin D is not related to cardiac natriuretic peptide in nulliparous and lactating women. Bmc Endocrine Disorders 9: 4

Stewart, J.W.; Alekel, D.L.; Ritland, L.M.; Van Loan, M.; Gertz, E.; Genschel, U. 2009: Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 16(6): 1093-1101

Srivastava, T.; Dai, H.; Haney, C.J.; Alon, U.S. 2011: Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 26(2): 437-438

Seker, T.; Gür, M.; Yüksel Kalkan, G.ül.; Kuloğlu, O.; Yıldız Koyunsever, N.; Yıldıray Şahin, D.ş; Türkoğlu, C.; Akyol, S.; Elbasan, Z.; Harbalıoğlu, H.; Caylı, M. 2014: Serum 25-hydroxyvitamin D level and extent and complexity of coronary artery disease. Journal of Clinical Laboratory Analysis 28(1): 52-58

Ohta, H.; Uemura, Y.; Nakamura, T.; Fukunaga, M.; Ohashi, Y.; Hosoi, T.; Mori, S.; Sugimoto, T.; Itoi, E.; Orimo, H.; Shiraki, M.; Tanaka, S.; Morimoto, S.; Itabashi, A.; Yamashita, T.; Gorai, I.; Kishimoto, H.; Mizunuma, H.; Endo, N.; Nishizawa, Y. 2014: Serum 25-hydroxyvitamin D level as an independent determinant of quality of life in osteoporosis with a high risk for fracture. Clinical Therapeutics 36(2): 225-235

Kuloğlu, O.; Gür, M.; Şeker, T.; Kalkan, Gülhan.Yüksel.; Şahin, Dş.Yıldıray.; Tanboğa, I.Halil.; Koyunsever, N.Yıldız.; Harbaloğlu, H.; Türkoğlu, C.; Akyol, S.; Elbasan, Z.; Acele, Ağan.; Caylı, M. 2013: Serum 25-hydroxyvitamin D level is associated with arterial stiffness, left ventricle hypertrophy, and inflammation in newly diagnosed hypertension. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 61(6): 989-994

Growdon, A.S.; Camargo, C.A.; Clark, S.; Hannon, M.; Mansbach, J.M. 2012: Serum 25-hydroxyvitamin D levels among Boston trainee doctors in winter. Nutrients 4(3): 197-207

Mansbach, J.M.; Ginde, A.A.; Camargo, C.A. 2009: Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D?. Pediatrics 124(5): 1404-1410

Zhao, G.; Ford, E.S.; Li, C.; Croft, J.B. 2012: Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. Journal of Hypertension 30(2): 284-289

Mai, X.-M.; Langhammer, A.; Camargo, C.A.; Chen, Y. 2012: Serum 25-hydroxyvitamin D levels and incident asthma in adults: the HUNT Study. American Journal of Epidemiology 176(12): 1169-1176

Larose, T.L.; Langhammer, A.; Chen, Y.; Camargo, C.A.; Romundstad, P.ål.; Mai, X.-M. 2015: Serum 25-hydroxyvitamin D levels and lung function in adults with asthma: the HUNT Study. European Respiratory Journal 45(4): 1019-1026

Boonchaya-anant, P.; Holick, M.F.; Apovian, C.M. 2014: Serum 25-hydroxyvitamin D levels and metabolic health status in extremely obese individuals. Obesity 22(12): 2539-2543

Ensrud, K.E.; Taylor, B.C.; Paudel, M.L.; Cauley, J.A.; Cawthon, P.M.; Cummings, S.R.; Fink, H.A.; Barrett-Connor, E.; Zmuda, J.M.; Shikany, J.M.; Orwoll, E.S. 2009: Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. Journal of Clinical Endocrinology and Metabolism 94(8): 2773-2780

Mai, X-M.; Chen, Y.; Camargo, C.A.; Langhammer, A. 2014: Serum 25-hydroxyvitamin D levels and self-reported allergic rhinitis in Norwegian adults - The HUNT Study. Allergy 69(4): 488-493

Maalmi, H.; Ordóñez-Mena, J.é M.; Schöttker, B.; Brenner, H. 2014: Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. European Journal of Cancer 50(8): 1510-1521

Oosterwerff, M.M.; Eekhoff, E.M.W.; Heymans, M.W.; Lips, P.; van Schoor, N.M. 2011: Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clinical Endocrinology 75(5): 608-613

Thomas, X.; Chelghoum, Y.; Fanari, N.; Cannas, G. 2011: Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies. Hematology 16(5): 278-283

Yavuz, B.; Sen, O.; Deveci, O.S.; Akin, K.O.; Dal, K.; Ata, N.; Ertugrul, D.T. 2012: Serum 25-hydroxyvitamin D levels are correlated with mitral valve calcification score in patients with rheumatic mitral stenosis. Journal of Heart Valve Disease 21(5): 570-575

Hutchinson, M.S.; Figenschau, Y.; Njølstad, I.; Schirmer, H.; Jorde, R. 2011: Serum 25-hydroxyvitamin D levels are inversely associated with glycated haemoglobin (HbA(1c)). the Tromsø Study. Scandinavian Journal of Clinical and Laboratory Investigation 71(5): 399-406

Bellia, A.; Garcovich, C.; D'Adamo, M.; Lombardo, M.; Tesauro, M.; Donadel, G.; Gentileschi, P.; Lauro, D.; Federici, M.; Lauro, R.; Sbraccia, P. 2013: Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Internal and Emergency Medicine 8(1): 33-40

Wang, L.-F.; Lee, C.-H.; Chien, C.-Y.; Chen, J.Y.-F.; Chiang, F.-Y.; Tai, C.-F. 2013: Serum 25-hydroxyvitamin D levels are lower in chronic rhinosinusitis with nasal polyposis and are correlated with disease severity in Taiwanese patients. American Journal of Rhinology and Allergy 27(6): E162-E165

Pinto, J.M.; Schneider, J.; Perez, R.; DeTineo, M.; Baroody, F.M.; Naclerio, R.M. 2008: Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. Journal of allergy and clinical immunology 122(2): 415-417

Shin, D.-Y.; Kim, S.; Park, S.; Koh, J.S.; Kim, C.H.; Baek, H.; Yang, S.H.; Na, I.I. 2014: Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma. Endocrine-Related Cancer 21(5): 715-721

Menon, J.; Maranda, L.; Nwosu, B.U. 2012: Serum 25-hydroxyvitamin D levels do not correlate with asthma severity in a case-controlled study of children and adolescents. Journal of Pediatric Endocrinology and Metabolism: Jpem 25(7-8): 673-679

Gong, Z.-L.; Luo, C.-M.; Wang, L.; Shen, L.; Wei, F.; Tong, R.-J.; Liu, Y. 2014: Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders. Neuroreport 25(1): 23-27

Cutillas-Marco, E.; Morales-Suárez-Varela, M.; Marquina-Vila, A.; Grant, W. 2010: Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 19(7): 810-814

Salehin, D.; Haugk, C.; Thill, M.; Cordes, T.; Hornung, D.; Abu-Hechle, A.; Hemmerlein, B.; Friedrich, M. 2012: Serum 25-hydroxyvitamin D levels in patients with vulvar cancer. Anticancer Research 32(1): 265-270

Öhlund, I.; Silfverdal, S.-A.; Hernell, O.; Lind, T.ör. 2013: Serum 25-hydroxyvitamin D levels in preschool-age children in northern Sweden are inadequate after summer and diminish further during winter. Journal of Pediatric Gastroenterology and Nutrition 56(5): 551-555

Yao, T.-C.; Tu, Y.-L.; Chang, S.-W.; Tsai, H.-J.; Gu, P.-W.; Ning, H.-C.; Hua, M.-C.; Liao, S.-L.; Tsai, M.-H.; Chiu, C.-Y.; Lai, S.-H.; Yeh, K.-W.; Huang, J.-L.; Huang, J.-L.; Yao, T.-C.; Lee, W.-I.; Ou, L.-S.; Chen, L.-C.; Yeh, K.-W.; Tu, Y.-L.; Lai, S.-H.; Hua, M.-C.; Tsai, M.-H.; Liao, S.-L. 2014: Serum 25-hydroxyvitamin D levels in relation to lung function and exhaled nitric oxide in children. Journal of Pediatrics 165(6): 1098-1103.E1

Hutchinson, M.S.; Figenschau, Y.; Almås, B.ør.; Njølstad, I.; Jorde, R. 2011: Serum 25-hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes - the Tromsø OGTT-study. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 81(5): 317-327

Glendenning, P.; Chew, G.T.; Seymour, H.M.; Gillett, M.J.; Goldswain, P.R.; Inderjeeth, C.A.; Vasikaran, S.D.; Taranto, M.; Musk, A.A.; Fraser, W.D. 2009: Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 45(5): 870-875

Bertoldo, F.; Pancheri, S.; Zenari, S.; Boldini, S.; Giovanazzi, B.; Zanatta, M.; Valenti, M.T.; Dalle Carbonare, L.; Lo Cascio, V. 2010: Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 25(3): 447-454

Liu, Y.; Zhang, B.-S. 2014: Serum 25-hydroxyvitamin D predicts severity in Parkinson's disease patients. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 35(1): 67-71

Tu, W.-J.; Zhao, S.-J.; Xu, D.-J.; Chen, H. 2014: Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clinical Science 126(5): 339-346

Havens, P.L.; Mulligan, K.; Hazra, R.; Flynn, P.; Rutledge, B.; Van Loan, M.D.; Lujan-Zilbermann, J.; Kapogiannis, B.G.; Wilson, C.M.; Stephensen, C.B. 2012: Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. Journal of Clinical Endocrinology and Metabolism 97(11): 4004-4013

Gambichler, T.; Bindsteiner, M.; Höxtermann, S.; Kreuter, A. 2013: Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma. British Journal of Dermatology 168(3): 625-628

Fourtounas, C.; Vlachojannis, J.G. 2009: Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients. American Journal of Clinical Nutrition 89(1): 436; Author Reply 436-8

Chan, J.; Jaceldo-Siegl, K.; Fraser, G.E. 2009: Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2. American Journal of Clinical Nutrition 89(5): 1686s-1692s

Chan, R.; Chan, C.C.D.; Woo, J.; Ohlsson, C.; Mellström, D.; Kwok, T.; Leung, P.C. 2011: Serum 25-hydroxyvitamin D, bone mineral density, and non-vertebral fracture risk in community-dwelling older men: results from Mr. Os, Hong Kong. Archives of Osteoporosis 6: 21-30

Dalmar, A.; Raff, H.; Chauhan, S.P.; Singh, M.; Siddiqui, D.S. 2015: Serum 25-hydroxyvitamin D, calcium, and calcium-regulating hormones in preeclamptics and controls during first day postpartum. Endocrine 48(1): 287-292

Khaw, K.-T.; Luben, R.; Wareham, N. 2014: Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. American Journal of Clinical Nutrition 100(5): 1361-1370

Cawthon, P.M.; Parimi, N.; Barrett-Connor, E.; Laughlin, G.A.; Ensrud, K.E.; Hoffman, A.R.; Shikany, J.M.; Cauley, J.A.; Lane, N.E.; Bauer, D.C.; Orwoll, E.S.; Cummings, S.R. 2010: Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. Journal of Clinical Endocrinology and Metabolism 95(10): 4625-4634

Li, L-Hua.; Yin, X-Yan.; Yao, C-Yong.; Zhu, X-Chuang.; Wu, X-Hua. 2013: Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese. Endocrine 44(2): 465-472

Shardell, M.; D'Adamo, C.; Alley, D.E.; Miller, R.R.; Hicks, G.E.; Milaneschi, Y.; Semba, R.D.; Cherubini, A.; Bandinelli, S.; Ferrucci, L. 2012: Serum 25-hydroxyvitamin D, transitions between frailty states, and mortality in older adults: the Invecchiare in Chianti Study. Journal of the American Geriatrics Society 60(2): 256-264

Weinstein, S.J.; Purdue, M.P.; Smith-Warner, S.A.; Mondul, A.M.; Black, A.; Ahn, J.; Huang, W.-Y.; Horst, R.L.; Kopp, W.; Rager, H.; Ziegler, R.G.; Albanes, D. 2015: Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. International Journal of Cancer 136(6): E654-E664

Tolppanen, A.-M.; Sayers, A.; Fraser, W.D.; Lewis, G.; Zammit, S.; McGrath, J.; Lawlor, D.A. 2012: Serum 25-hydroxyvitamin D3 and D2 and non-clinical psychotic experiences in childhood. Plos one 7(7): E41575

Moghaddasi, M.; Mamarabadi, M.; Aghaii, M. 2013: Serum 25-hydroxyvitamin D3 concentration in Iranian patients with Parkinson's disease. Iranian Journal of Neurology 12(2): 56-59

Lym, Y.L.; Joh, H.-K. 2009: Serum 25-hydroxyvitamin D3 is related to fish intake and exercise in Korean adult men. Asia Pacific Journal of Clinical Nutrition 18(3): 372-376

Atsukawa, M.; Tsubota, A.; Shimada, N.; Kondo, C.; Itokawa, N.; Nakagawa, A.; Hashimoto, S.; Fukuda, T.; Matsushita, Y.; Narahara, Y.; Iwakiri, K.; Nakatsuka, K.; Kawamoto, C.; Sakamoto, C. 2014: Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load. Hepatology Research: the Official Journal of the Japan Society of Hepatology 44(13): 1277-1285

Ogbah, Z.; Visa, L.; Badenas, C.; Ríos, J.é; Puig-Butille, J.A.; Bonifaci, N.; Guino, E.; Augé, J.M.; Kolm, I.; Carrera, C.; Pujana, M.Án.; Malvehy, J.; Puig, S. 2013: Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona. Bmc Medical Genetics 14: 26

Newton-Bishop, J.A.; Beswick, S.; Randerson-Moor, J.; Chang, Y-Mei.; Affleck, P.; Elliott, F.; Chan, M.; Leake, S.; Karpavicius, B.; Haynes, S.; Kukalizch, K.; Whitaker, L.; Jackson, S.; Gerry, E.; Nolan, C.; Bertram, C.; Marsden, J.; Elder, D.E.; Barrett, J.H.; Bishop, D.Timothy. 2009: Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(32): 5439-5444

Ordóñez-Mena, J.é M.; Schöttker, B.; Haug, U.; Müller, H.; Köhrle, J.; Schomburg, L.; Holleczek, B.; Brenner, H. 2013: Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 22(5): 905-916

Sabetta, J.R.; DePetrillo, P.; Cipriani, R.J.; Smardin, J.; Burns, L.A.; Landry, M.L. 2010: Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. Plos one 5(6): E11088

Toffanello, E.D.; Sergi, G.; Veronese, N.; Perissinotto, E.; Zambon, S.; Coin, A.; Sartori, L.; Musacchio, E.; Corti, M.-C.; Baggio, G.; Crepaldi, G.; Manzato, E. 2014: Serum 25-hydroxyvitamin d and the onset of late-life depressive mood in older men and women: the Pro.V.A. study. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 69(12): 1554-1561

Knekt, P.; Sääksjärvi, K.; Järvinen, R.; Marniemi, J.; Männistö, S.; Kanerva, N.; Heliövaara, M. 2014: Serum 25-hydroxyvitamin d concentration and risk of dementia. Epidemiology 25(6): 799-804

Nanri, A.; Foo, L.H.; Nakamura, K.; Hori, A.; Poudel-Tandukar, K.; Matsushita, Y.; Mizoue, T. 2011: Serum 25-hydroxyvitamin d concentrations and season-specific correlates in Japanese adults. Journal of Epidemiology 21(5): 346-353

Chaudhuri, J.R.; Mridula, K.R.; Alladi, S.; Anamika, A.; Umamahesh, M.; Balaraju, B.; Swath, A.; Bandaru, V.S. 2014: Serum 25-hydroxyvitamin d deficiency in ischemic stroke and subtypes in Indian patients. Journal of Stroke 16(1): 44-50

Science, M.; Maguire, J.L.; Russell, M.L.; Smieja, M.; Walter, S.D.; Loeb, M. 2014: Serum 25-hydroxyvitamin d level and influenza vaccine immunogenicity in children and adolescents. Plos one 9(1): E83553

Poudel-Tandukar, K.; Poudel, K.C.; Jimba, M.; Kobayashi, J.; Johnson, C.A.; Palmer, P.H. 2013: Serum 25-hydroxyvitamin d levels and C-reactive protein in persons with human immunodeficiency virus infection. Aids Research and Human Retroviruses 29(3): 528-534

McKenzie, R.; Scragg, R.; Liley, B.; Johnston, P.; Wishart, J.; Stewart, A.; Prematunga, R. 2012: Serum 25-hydroxyvitamin-D responses to multiple UV exposures from solaria: inferences for exposure to sunlight. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 11(7): 1174-1185

Folsom, A.R.; Roetker, N.S.; Rosamond, W.D.; Heckbert, S.R.; Basu, S.; Cushman, M.; Lutsey, P.L. 2014: Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study. Journal of Thrombosis and Haemostasis: Jth 12(9): 1455-1460

Liu, J.; Tan, H.; Jeynes, B. 2011: Serum 25OH vitamin D level, femur length, and risk of type 2 diabetes among adults. Applied Physiology Nutrition and Metabolism 36(2): 264-270

Chen, J.; Zhang, X.; Cao, R.; Lu, X.; Zhao, S.; Fekete, A.; Huang, Q.; Schmitt-Kopplin, P.; Wang, Y.; Xu, Z.; Wan, X.; Wu, X.; Zhao, N.; Xu, C.; Xu, G. 2011: Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. Journal of Proteome Research 10(5): 2625-2632

Zheng, J.; Bao, W.Q.; Sheng, W.Q.; Guo, L.; Zhang, H.L.; Wu, L.H.; Wu, X.Z. 2009: Serum 3'-sulfo-Lea indication of gastric cancer metastasis. Clinica Chimica Acta; International Journal of Clinical Chemistry 405(1-2): 119-126

Kikuchi, K.; Wakamatsu, K.; Tada, Y.; Komine, M.; Ito, S.; Tamaki, K. 2008: Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy. Clinical and Experimental Dermatology 33(6): 750-753

Freudenberg, F.; Gothe, F.; Beigel, F.; Rust, C.; Koletzko, S. 2013: Serum 7-alpha-hydroxy-4-cholesten-3-one as a marker for bile acid loss in children. Journal of Pediatrics 163(5): 1367-71.E1

Makila-Mabe, B.G.; Kikandau, K.J.; Sombo, T.ér.ès.M.; Okitundu, D.L.; Mwanza, J.-C.; Boivin, M.J.; Ngoyi, M.D.; Muyembe, J.-J.T.; Banea, J.-P.; Boss, G.R.; Tshala-Katumbay, D.é 2014: Serum 8,12-iso-iPF2α-Vi isoprostane marker of oxidative damage and cognition deficits in children with konzo. Plos one 9(9): E107191

Ece, H.; Mehmet, E.; Cigir, B.A.; Yavuz, D.; Muammer, K.; Cumhur, G.; Mustafa, H.; Sevki, C.; Fusun, S.ıl.ı; Gokhan, O.A. 2013: Serum 8-OHdG and HIF-1α levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?. Contemporary Oncology 17(1): 51-57

Bathia, D.P.; Carless, D.R.; Viswanathan, K.; Hall, A.S.; Barth, J.H. 2009: Serum 99th centile values for two heart-type fatty acid binding protein assays. Annals of Clinical Biochemistry 46(Part 6): 464-467

Zhou, M.; Bao, Y.; Lu, J.; Zhou, J.; Jia, W. 2011: Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone. Plos one 6(10): E27032

Dokrunova, A.A.; Sokolova, O.S. 2012: Serum A1-antitrypsin levels in prostate pathology. Urologiia 5: 77-80

Haberka, M.; Mizia-Stec, K.; Gasior, Z.; Mizia, M.; Janowska, J.; Holecki, M.ł; Zahorska-Markiewicz, B. 2009: Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X. Upsala Journal of Medical Sciences 114(4): 221-227

Suh, J.-B.; Kim, S.M.; Cho, G.-J.; Choi, K.M. 2014: Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 49(8): 979-985

Subwongcharoen, S.; Leelawat, K.; Treepongkaruna, S.-a.; Narong, S. 2011: Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses. Journal of the Medical Association of Thailand 94(Suppl 2): S46-S51

Chung, K.; Nishiyama, N.; Yamano, S.; Komatsu, H.; Hanada, S.; Wei, M.; Wanibuchi, H.; Suehiro, S.; Kakehashi, A. 2011: Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma. Cancer Biomarkers: Section a of Disease Markers 10(2): 101-107

Cao, Y.-T.; Li, J.-H.; Wang, Y.-T.; Fu, Y.-W.; Xu, J. 2014: Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer. Tumori 100(2): 214-218

Balasubramanian, S.; Kaarthigeyan, K.; Srinivas, S.; Rajeswari, R. 2010: Serum ALT: LDH ratio in typhoid fever and acute viral hepatitis. Indian Pediatrics 47(4): 339-341

Matuszczak, E.; Hermanowicz, A.; Debek, W. 2012: Serum AMH concentration as a marker evaluating gonadal function in boys operated on for unilateral cryptorchidism between 1st and 4th year of life-why patients with inguinal hernia served as controls. Endocrine 41(3): 544-545

Matuszczak, E.; Hermanowicz, A.; Komarowska, M.; Debek, W. 2013: Serum AMH in Physiology and Pathology of Male Gonads. International Journal of Endocrinology 2013: 128907

Peigné, M.ël.; Decanter, C. 2014: Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review. Reproductive Biology and Endocrinology: Rb&e 12: 26

Lamazou, F.; Genro, V.; Fuchs, F.; Grynberg, M.; Gallot, V.; Achour-Frydman, N.; Fanchin, R.; Frydman, R. 2011: Serum AMH level is not a predictive value for IVF in modified natural cycle: analysis of 342 cycles. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 40(3): 205-210

Tuten, A.; Sahmay, S.; Oncul, M.; Acikgoz, A.S.; Imamoglu, M.; Gurleyen, H.C.; Senturk, M.L. 2014: Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions. European Journal of Obstetrics Gynecology and Reproductive Biology 177: 121-125

Yarde, F.; Maas, A.H.E.M.; Franx, A.; Eijkemans, M.J.C.; Drost, J.T.; van Rijn, B.B.; van Eyck, J.; van der Schouw, Y.T.; Broekmans, F.J.M. 2014: Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian aging. Journal of Clinical Endocrinology and Metabolism 99(2): 579-586

Georgopoulos, N.A.; Saltamavros, A.D.; Decavalas, G.; Piouka, A.; Katsikis, I.; Panidis, D. 2010: Serum AMH, FSH, and LH levels in PCOS. Fertility and Sterility 93(3): E13; Author Reply E14

Endo, M.; Yamamoto, Y.; Nakano, M.; Masuda, T.; Odagiri, H.; Horiguchi, H.; Miyata, K.; Kadomatsu, T.; Motokawa, I.; Okada, S.; Iwase, H.; Oike, Y. 2014: Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis. International Journal of Biological Markers 29(3): E239-E245

Dai, N.; Cao, X.-J.; Li, M.-X.; Qing, Y.; Liao, L.; Lu, X.-F.; Zhang, S.-H.; Li, Z.; Yang, Y.-X.; Wang, D. 2013: Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer. Plos one 8(3): E58001

Wang, Y.; Zhang, M.; Yan, L.; Ding, S.; Xie, X. 2012: Serum APPL1 level is elevated in newly diagnosed cases of type 2 diabetes mellitus. Nan Fang Yi Ke da Xue Xue Bao 32(9): 1373-1376

Wang, F.; Chen, L.; Ding, W.; Wang, G.; Wu, Y.; Wang, J.; Luo, L.; Cong, H.; Wang, Y.; Ju, S.; Shao, J.; Wang, H. 2011: Serum APRIL, a potential tumor marker in pancreatic cancer. Clinical Chemistry and Laboratory Medicine 49(10): 1715-1719

Abdullah, L.; Luis, C.; Paris, D.; Mouzon, B.; Ait-Ghezala, G.; Keegan, A.P.; Wang, D.; Crawford, F.; Mullan, M. 2009: Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort. Molecular Medicine 15(11-12): 432-437

Ware, A.G.; Seegers, W.H. 1948: Serum Ac-globulin; role in blood coagulation; partial purification; properties; and quantitative determination. American Journal of Physiology 152(3): 567-576

Crook, M.; Williams, A.; Tutt, P. 1992: Serum Acid phosphatase in essential thrombocythaemia. Platelets 3(3): 171-172

Refaat, B.; El-Shemi, A.Galal.; Ashshi, A.Mohamed.; Alzanbagi, A. 2014: Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report. Gastroenterology research and practice 2014: 628683

Demir, G.ül.; Borman, P.ın.; Ayhan, F.; Ozgün, T.; Kaygısız, F.; Yilmez, G. 2014: Serum Adenosine Deaminase Level is High but not Related with Disease Activity Parameters in Patients with Rheumatoid Arthritis. Open Rheumatology Journal 8: 24-28

Sood, A.; Dominic, E.; Qualls, C.; Steffes, M.W.; Thyagarajan, B.; Smith, L.J.; Lewis, C.E.; Jacobs, D.R. 2011: Serum Adiponectin is Associated with Adverse Outcomes of Asthma in Men but not in Women. Frontiers in Pharmacology 2: 55

Ripoll, C.; Bari, K.; Garcia-Tsao, G. 2015: Serum Albumin can Identify Patients with Compensated Cirrhosis with a Good Prognosis. Journal of Clinical Gastroenterology 49(7): 613-619

Saif, M.W.; Alexander, D.; Wicox, C.M. 2005: Serum Alkaline Phosphatase Level as a Prognostic Tool in Colorectal Cancer: a Study of 105 patients. Journal of Applied Research 5(1): 88-95

Tang, Y.-W. 2005: Serum Amino Acids (Glutamine, Glutamate, Methionine, and Arginine) Flux after Cutaneous Thermal and Smoke Inhalation injuries in rats. Annals of Burns and Fire Disasters 18(4): 211-216

Boyd, T.F.; Perez, J.L.; Byrne, J.J. 1961: Serum Amylase Levels in Experimental Intestinal Obstruction: Does Small Bowel Necrosis Cause a Rise in Serum Amylase?. Annals of Surgery 154(1): 85-89

Robati, R.M.; Ayatollahi, A.; Toossi, P.; Younespour, S. 2014: Serum Angiotensin converting enzyme in pemphigus vulgaris. Indian Journal of Dermatology 59(4): 348-351

Liu, X.; Hu, Q.; Liu, S.; Tallo, L.J.; Sadzewicz, L.; Schettine, C.A.; Nikiforov, M.; Klyushnenkova, E.N.; Ionov, Y. 2013: Serum Antibody Repertoire Profiling Using in Silico Antigen Screen. Plos one 8(6): E67181

Marton, K.; Flajšman, M.; Radišek, S.; Košmelj, K.; Jakše, J.; Javornik, B.; Berne, S. 2018: Comprehensive analysis of Verticillium nonalfalfae in silico secretome uncovers putative effector proteins expressed during hop invasion. Plos one 13(6): E0198971

Rivière, S.éb.; Denis, B.; Bougnoux, M.-E.; Lanternier, F.; Lecuit, M.; Lortholary, O. 2012: Serum Aspergillus galactomannan for the management of disseminated histoplasmosis in AIDS. American Journal of Tropical Medicine and Hygiene 87(2): 303-305

Johansson, M.; Relton, C.; Ueland, P.M.; Vollset, S.E.; Midttun, Øi.; Nygård, O.; Slimani, N.; Boffetta, P.; Jenab, M.; Clavel-Chapelon, F.ço.; Boutron-Ruault, M.-C.; Fagherazzi, G.; Kaaks, R.; Rohrmann, S.; Boeing, H.; Weikert, C.; Bueno-de-Mesquita, H.B.; Ros, M.M.; van Gils, C.H.; Peeters, P.H.M.; Agudo, A.; Barricarte, A.; Navarro, C.; Rodríguez, L.; Sánchez, M.-J.é; Larrañaga, N.; Khaw, K.-T.; Wareham, N.; Allen, N.E.; Crowe, F.; Gallo, V.; Norat, T.; Krogh, V.; Masala, G.; Panico, S.; Sacerdote, C.; Tumino, R.; Trichopoulou, A.; Lagiou, P.; Trichopoulos, D.; Rasmuson, T.; Hallmans, G.ör.; Riboli, E.; Vineis, P.; Brennan, P. 2010: Serum B vitamin levels and risk of lung cancer. JAMA 303(23): 2377-2385

Xin, G.; Chen, M.; Su, Y.; Xu, L.-X.; Zhao, M.-H.; Li, K.-S. 2014: Serum B-cell activating factor in myeloperoxiase-antineutrophil cytoplasmic antibodies-associated vasculitis. American Journal of the Medical Sciences 348(1): 25-29

Jeong, Y.-H.; Kim, W.-J.; Park, D.-W.; Choi, B.-R.; Lee, S.-W.; Kim, Y.-H.; Lee, C.W.; Hong, M.-K.; Kim, J.-J.; Park, S.-W.; Park, S.-J. 2010: Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction. International Journal of Cardiology 141(2): 175-181

Elkhatib, I.; Cao, W.; Rao, S.; Fryer, J.; Buchman, A.L. 2010: Serum B12 concentration is elevated in patients receiving chronic parenteral nutrition, but is not a marker of intestinal failure-associated liver disease. Journal of Clinical Gastroenterology 44(8): 571-574

Rosenberg, P.; Hagen, K. 2011: Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection. Journal of Viral Hepatitis 18(2): 129-134

Shi, H.; Ji, M.; Wu, J.; Zhou, Q.; Li, X.; Li, Z.; Zheng, X.; Xu, B.; Zhao, W.; Wu, C.; Jiang, J. 2014: Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer. World Journal of Surgical Oncology 12: 188

Migita, K.; Ilyassova, B.; Kovzel, E.F.; Nersesov, A.; Abiru, S.; Maeda, Y.; Komori, A.; Ito, M.; Yano, K.; Yatsuhashi, H.; Shimoda, S.; Ishibashi, H.; Nakamura, M. 2010: Serum BAFF and APRIL levels in patients with PBC. Clinical Immunology 134(2): 217-225

Xin, G.; Cui, Z.; Su, Y.; Xu, L-Xia.; Zhao, M-Hui.; Li, K-Sheng. 2013: Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease. Nephrology 18(3): 209-214

Kim, J.Y.; Yang, Y.; Moon, J.-S.; Lee, E.Y.; So, S.H.; Lee, H.-S.; Park, K.D.; Choi, Y.-C. 2008: Serum BAFF expression in patients with myasthenia gravis. Journal of Neuroimmunology 199(1-2): 151-154

Xin, G.; Shi, W.; Xu, L.-X.; Su, Y.; Yan, L.-J.; Li, K.-S. 2013: Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. Journal of Nephrology 26(4): 683-690

Hamzaoui, K.; Houman, H.; Ben Dhifallah, I.; Kamoun, M.; Hamzaoui, A. 2008: Serum BAFF levels and skin mRNA expression in patients with Behçet's disease. Clinical and Experimental Rheumatology 26(4 Suppl 50: S64-S71

Kim, S.Jin.; Lee, S.Jin.; Choi, I.Young.; Park, Y.; Choi, C.Won.; Kim, I.Sun.; Yu, W.; Hwang, H.Sang.; Kim, B.Soo. 2008: Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy. European Journal of Haematology 81(3): 177-184

Pongratz, G.; Straub, R.H.; Schölmerich, J.; Fleck, M.; Härle, P. 2010: Serum BAFF strongly correlates with PsA activity in male patients only--is there a role for sex hormones?. Clinical and Experimental Rheumatology 28(6): 813-819

Molendijk, M.L.; Haffmans, J.P.M.; Bus, B.A.A.; Spinhoven, P.; Penninx, B.W.J.H.; Prickaerts, J.; Oude Voshaar, R.C.; Elzinga, B.M. 2012: Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight. Plos one 7(11): E48046

Wolkowitz, O.M.; Wolf, J.; Shelly, W.; Rosser, R.; Burke, H.M.; Lerner, G.K.; Reus, V.I.; Nelson, J.C.; Epel, E.S.; Mellon, S.H. 2011: Serum BDNF levels before treatment predict SSRi response in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35(7): 1623-1630

Park, Y.-M.; Lee, B.-H.; Um, T.H.; Kim, S. 2014: Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study. Plos one 9(3): E91061

Lee, H.-T.; Shiao, Y.-M.; Wu, T.-H.; Chen, W.-S.; Hsu, Y.-H.; Tsai, S.-F.; Tsai, C.-Y. 2010: Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. Journal of Rheumatology 37(1): 45-52

Ansell, S.M.; Novak, A.J.; Ziesmer, S.; Price-Troska, T.; LaPlant, B.; Dillon, S.R.; Witzig, T.E. 2009: Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphoma. American Journal of Hematology 84(2): 71-73

Fei, Z.-H.; Yao, C.-Y.; Yang, X.-L.; Huang, X.-E.; Ma, S.-L. 2013: Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients. Asian Pacific Journal of Cancer Prevention: Apjcp 14(9): 5293-5299

Son, J.-W.; Jang, E.-H.; Kim, M.-K.; Baek, K.-H.; Song, K.-H.; Yoon, K.-H.; Cha, B.-Y.; Son, H.-Y.; Lee, K.-W.; Jo, H.; Kwon, H.-S. 2011: Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes. Biomarkers in Medicine 5(6): 827-835

Bavbek, N.ük.; Akay, H.; Altay, M.; Uz, E.; Turgut, F.; Uyar, M.E.; Karanfil, A.; Selcoki, Y.; Akcay, A.; Duranay, M. 2007: Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(6): 663-668

Blangy, H.; Sadoul, N.; Dousset, B.; Radauceanu, A.; Fay, R.; Aliot, E.; Zannad, F. 2007: Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 9(9): 724-729

Spencer, C.; Fatemi, S.; Singer, P.; Nicoloff, J.; Lopresti, J. 2010: Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. Thyroid: Official Journal of the American Thyroid Association 20(6): 587-595

Tarantino, G.; Scopacasa, F.; Colao, A.; Capone, D.; Tarantino, M.; Grimaldi, E.; Savastano, S. 2011: Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. World Journal of Gastroenterology 17(48): 5280-5288

Akın, A.; Alehan, D.; Aykan, H.H.; Özkutlu, S.üh.; Özer, S.; Karagöz, T. 2015: Serum Bcl-2 values in children with pulmonary hypertension. Pediatric Cardiology 36(3): 579-583

Madureira Silva, M.V.; Moscoso-Solorzano, G.T.; Nishida, S.K.; Mastroianni-Kirsztajn, G. 2012: Serum Beta 2-microglobulin/cystatin C index: a useful biomarker in lupus nephritis?. Nephron Extra 2(1): 169-176

Kontara, L.; Briana, D.D.; Baka, S.; Boutsikou, M.; Marmarinos, A.; Gourgiotis, D.; Malamitsi-Puchner, A. 2008: Serum Beta-2-microglobulin levels in intrauterine growth-restricted and normal pregnancies. Fetal Diagnosis and Therapy 24(3): 220-224

Lin, C.-L.; Liu, C.-H.; Wang, C.-C.; Liang, C.-C.; Su, T.-H.; Liu, C.-J.; Kao, J.-H. 2015: Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. Journal of Clinical Gastroenterology 49(8): 705-713

Jevtović, S.ša.; Karlović, D.; Mihaljević-Peleš, A.; Šerić, V.; Vrkić, N.; Jakšić, N. 2011: Serum Brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression. Psychiatria Danubina 23(4): 363-369

Zhang, Q.-b.; Jiang, L.-f.; Kong, L.-y.; Lu, Y.-J. 2014: Serum Brain-derived neurotrophic factor levels in Chinese children with autism spectrum disorders: a pilot study. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 37: 65-68

Li, J.; Zhao, Y.-D.; Zeng, J.-W.; Chen, X.-Y.; Wang, R.-D.; Cheng, S.-Y. 2014: Serum Brain-derived neurotrophic factor levels in post-stroke depression. Journal of Affective Disorders 168: 373-379

Chowta, M.N.; Adhikari, P.M.; Chowta, N.K.; Shenoy, A.K.; D'Souza, S. 2010: Serum C peptide level and renal function in diabetes mellitus. Indian Journal of Nephrology 20(1): 25-28

Kerkhof, H.J.M.; Bierma-Zeinstra, S.M.A.; Castano-Betancourt, M.C.; de Maat, M.P.; Hofman, A.; Pols, H.A.P.; Rivadeneira, F.; Witteman, J.C.; Uitterlinden, A.é G.; van Meurs, J.B.J. 2010: Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index. Annals of the Rheumatic Diseases 69(11): 1976-1982

Pochintesta, L.; Mangiacavalli, S.; Cocito, F.; Pompa, A.; Albertini, R.; Pascutto, C.; Ferretti, V.V.; Cazzola, M.; Corso, A. 2014: Serum C terminal telopeptide maintains its correlation with bone disease in patients with myeloma even under treatment with bisphosphonates. Leukemia and Lymphoma 55(6): 1397-1398

Kraus, V.B.; Jordan, J.M. 2007: Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?. Biomarker Insights 1: 77-80

Jones, J.D.; Hamilton, B.J.; Challener, G.J.; de Brum-Fernandes, A.J.; Cossette, P.; Liang, P.; Masetto, A.; Ménard, H.A.; Carrier, N.; Boyle, D.L.; Rosengren, S.; Boire, G.; Rigby, W.F.C. 2014: Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels. Arthritis Research and Therapy 16(2): R103

Maciejewska-Jeske, M.; Szczesna, A.; Męczekalski, B. 2010: Serum C-peptide concentration in overweight and obese women with polycystic ovary syndrome. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 29(170): 93-99

Min, J.-Y.; Min, K.-B. 2013: Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals. European Journal of Epidemiology 28(9): 771-774

Li, X.-Y.; Xu, M.; Wang, J.-G.; Wang, X.-J.; Huang, Y.; Cheng, Q.; Huang, H.-E.; Li, R.; Xiang, J.; Tan, J.-R.; Dai, M.; Ning, G. 2009: Serum C-reactive protein (CRP) and microalbuminuria in relation to fasting and 2-h postload plasma glucose in a Chinese population. Clinical Endocrinology 70(5): 691-697

Crouzet, J.; Faucher, J.-F.; Toubin, M.; Hoen, B.; Estavoyer, J.-M. 2011: Serum C-reactive protein (CRP) and procalcitonin (PCT) levels and kinetics in patients with leptospirosis. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 30(2): 299-302

Li, Y.-J.; Li, Z.-M.; Xia, Y.; Huang, J.-J.; Huang, H.-Q.; Xia, Z.-J.; Lin, T.-Y.; Li, S.; Cai, X.-Y.; Wu-Xiao, Z.-J.; Jiang, W.-Q. 2013: Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type. Plos one 8(5): E64158

Koukourakis, M.I.; Kambouromiti, G.; Pitsiava, D.; Tsousou, P.; Tsiarkatsi, M.; Kartalis, G. 2009: Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 32(3): 169-175

Xu, L.; Zhao, Q.; Huang, S.; Li, S.; Wang, J.; Li, Q. 2015: Serum C-reactive protein acted as a prognostic biomarker for overall survival in metastatic prostate cancer patients. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(2): 669-673

Bovet, P.; Rossi, I. 2012: Serum C-reactive protein and carotid intima-media thickness. International Journal of Cardiology 157(1): 143-144

Choi, Y-Hee.; McKeown, R.E.; Mayer-Davis, E.J.; Liese, A.D.; Song, K-Bae.; Merchant, A.T. 2014: Serum C-reactive protein and immunoglobulin G antibodies to periodontal pathogens may be effect modifiers of periodontitis and hyperglycemia. Journal of Periodontology 85(9): 1172-1181

Kaur, S.; Singh, N.P.; Jain, A.K.; Thakur, A. 2012: Serum C-reactive protein and leptin for assessment of nutritional status in patients on maintenance hemodialysis. Indian Journal of Nephrology 22(6): 419-423

Alexandrova, M.L.; Danovska, M.P. 2011: Serum C-reactive protein and lipid hydroperoxides in predicting short-term clinical outcome after spontaneous intracerebral hemorrhage. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 18(2): 247-252

Kawada, T. 2013: Serum C-reactive protein and metabolic components. Endocrine 44(3): 819

Battistelli, S.; Fortina, M.; Carta, S.; Guerranti, R.; Nobile, F.; Ferrata, P. 2014: Serum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty. Biomed Research International 2014: 565080

Tulek, B.; Koylu, H.; Kanat, F.; Arslan, U.; Ozer, F. 2013: Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients. Contemporary Oncology 17(1): 68-72

Jiang, S.; Bao, Y.; Hou, X.; Fang, Q.; Wang, C.; Pan, J.; Zuo, Y.; Zhong, W.; Xiang, K.; Jia, W. 2009: Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population. American Journal of Cardiology 103(12): 1727-1731

Xu, M.; Zhu, M.; Du, Y.; Yan, B.; Wang, Q.; Wang, C.; Zhao, J. 2013: Serum C-reactive protein and risk of lung cancer: a case-control study. Medical Oncology 30(1): 319

Douglas, J.B.; Silverman, D.T.; Weinstein, S.J.; Graubard, B.I.; Pollak, M.N.; Tao, Y.; Virtamo, J.; Albanes, D.; Stolzenberg-Solomon, R.Z. 2011: Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 20(2): 359-369

Tsuchikura, S.; Shoji, T.; Shimomura, N.; Kakiya, R.; Emoto, M.; Koyama, H.; Ishimura, E.; Inaba, M.; Nishizawa, Y. 2010: Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate. Bmc Nephrology 11: 7

Chen, S.-B.; Lee, Y.-C.; Ser, K.-H.; Chen, J.-C.; Chen, S.C.; Hsieh, H.-F.; Lee, W.-J. 2009: Serum C-reactive protein and white blood cell count in morbidly obese surgical patients. Obesity Surgery 19(4): 461-466

Liu, A.; Bui, T.; Van Nguyen, H.; Ong, B.; Shen, Q.; Kamalasena, D. 2010: Serum C-reactive protein as a biomarker for early detection of bacterial infection in the older patient. Age and Ageing 39(5): 559-565

Viitanen, S.J.; Laurila, H.P.; Lilja-Maula, L.I.; Melamies, M.A.; Rantala, M.; Rajamäki, M.M. 2014: Serum C-reactive protein as a diagnostic biomarker in dogs with bacterial respiratory diseases. Journal of Veterinary Internal Medicine 28(1): 84-91

Wu, L.; Han, T.; Fan, X.; Pan, W.; Wang, C.; Zhong, H.; Ai, X.; Zhang, W.; Xu, X.; Ye, Z.; Terai, T.; Sato, N.; Watanabe, S.; Das, U.N. 2012: Serum C-reactive protein as a possible marker to predict delayed hemorrhage after colonoscopic polypectomy. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 18(8): Cr480-Cr485

Khandavilli, S.D.; Ceallaigh, P.O.; Lloyd, C.J.; Whitaker, R. 2009: Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncology 45(10): 912-914

Bielsa, S.; Valencia, H.; Ruiz-González, A.ín.; Esquerda, A.; Porcel, J.é M. 2014: Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions. Lung 192(4): 577-581

Hefler, L.A.; Concin, N.; Hofstetter, G.; Marth, C.; Mustea, A.; Sehouli, J.; Zeillinger, R.; Leipold, H.; Lass, H.; Grimm, C.; Tempfer, C.B.; Reinthaller, A. 2008: Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(3): 710-714

Kompoti, M.; Drimis, S.; Papadaki, A.; Kotsomytis, K.; Poulopoulou, C.; Gianneli, D.; Voutsinas, D. 2008: Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. European Journal of Internal Medicine 19(4): 261-265

Yang, N.; Zhao, K.; Li, X.; Zhao, R.; Aslam, M.Z.; Yu, L.; Chen, L. 2018: Comprehensive analysis of wintersweet flower reveals key structural genes involved in flavonoid biosynthetic pathway. Gene 676: 279-289

Zaciragić, A.; Huskić, J.; Hadzović-Dzuvo, A.; Valjevac, A.; Avdagić, N.; Mulabegović, N. 2007: Serum C-reactive protein concentration and measures of adiposity in patients with type 2 diabetes mellitus. Bosnian Journal of Basic Medical Sciences 7(4): 322-327

Pine, J.K.; Fusai, K.G.; Young, R.; Sharma, D.; Davidson, B.R.; Menon, K.V.; Rahman, S.H. 2009: Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 35(6): 605-610

Orati, J.A.; Almeida, P.; Santos, V.; Ciorla, G.; Lobo, S.M. 2013: Serum C-reactive protein concentrations in early abdominal and pulmonary sepsis. Revista Brasileira de Terapia Intensiva 25(1): 6-11

Niu, K.; Hozawa, A.; Guo, H.; Kuriyama, S.; Ebihara, S.; Yang, G.; Ohmori-Matsuda, K.; Nakaya, N.; Takahashi, H.; Fujita, K.; Wen, S.; Arai, H.; Tsuji, I.; Nagatomi, R. 2008: Serum C-reactive protein even at very low (<1.0 mg/l) concentration is associated with physical performance in a community-based elderly population aged 70 years and over. Gerontology 54(5): 260-267

Hefler-Frischmuth, K.; Hefler, L.A.; Heinze, G.; Paseka, V.; Grimm, C.; Tempfer, C.B. 2009: Serum C-reactive protein in the differential diagnosis of ovarian masses. European Journal of Obstetrics Gynecology and Reproductive Biology 147(1): 65-68

An, H.J.; Jang, J.W.; Bae, S.H.; Choi, J.Y.; Yoon, S.K.; Lee, M.A.; You, Y.K.; Kim, D.G.; Jung, E.S. 2012: Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 18(12): 1406-1414

Wersching, H.; Duning, T.; Lohmann, H.; Mohammadi, S.; Stehling, C.; Fobker, M.; Conty, M.; Minnerup, J.; Ringelstein, E.B.; Berger, K.; Deppe, M.; Knecht, S. 2010: Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 74(13): 1022-1029

Sabanayagam, C.; Shankar, A.; Lim, S.C.; Lee, J.; Tai, E.S.; Wong, T.Y. 2011: Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 54(4): 767-775

Roudbary, S.A.; Saadat, F.; Forghanparast, K.; Sohrabnejad, R. 2011: Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Medica Iranica 49(3): 149-152

Cheng, Y.; Dang, A.; Lv, N.; Gao, Q.; Chen, B.; Liu, G. 2016: Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis. Clinical Rheumatology 35(3): 673-678

Morizane, S.; Iwamoto, H.; Yao, A.; Isoyama, T.; Sejima, T.; Takenaka, A. 2012: Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin - preliminary results. Central European Journal of Urology 65(2): 62-66

Koeda, Y.; Nakamura, M.; Tanaka, F.; Onoda, T.; Itai, K.; Tanno, K.; Ohsawa, M.; Makita, S.; Ishibashi, Y.; Koyama, T.; Yoshida, Y.; Omama, S-ichi.; Ogasawara, K.; Ogawa, A.; Kuribayashi, T.; Okayama, A. 2011: Serum C-reactive protein levels and death and cardiovascular events in mild to moderate chronic kidney disease. International Heart Journal 52(3): 180-184

Liu, J.; Wu, Y.-F.; Ding, Y.; Ge, S.; Rao, L.; Tang, H. 2009: Serum C-reactive protein levels and lipid profiles concentrations in moderate to severe periodontitis and coronary heart disease: a comparative study. Zhonghua Kou Qiang Yi Xue Za Zhi 44(3): 150-154

Liao, C.-H.; Chung, S.-D.; Kuo, H.-C. 2011: Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment. Urology 78(6): 1373-1378

Makita, S.; Nakamura, M.; Satoh, K.; Tanaka, F.; Onoda, T.; Kawamura, K.; Ohsawa, M.; Tanno, K.; Itai, K.; Sakata, K.; Okayama, A.; Terayama, Y.; Yoshida, Y.; Ogawa, A. 2009: Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis 204(1): 234-238

Hoge, M.; Chun, Y.-H.P.; Jones, A.A. 2012: Serum C-reactive protein levels cannot be used to accurately assess the extent or severity of periodontal disease. Texas Dental Journal 129(2): 150

Oh, J.Y.; Lee, J.-A.; Lee, H.; Oh, J.-Y.; Sung, Y.-A.; Chung, H. 2009: Serum C-reactive protein levels in normal-weight polycystic ovary syndrome. Korean Journal of Internal Medicine 24(4): 350-355

Romero, F.áv.R.; Bertolini, E.d.F.; Figueiredo, E.G.; Teixeira, M.J. 2012: Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage. Arquivos de Neuro-Psiquiatria 70(3): 202-205

Lawn, S.D.; Kerkhoff, A.D. 2013: Serum C-reactive protein measurement for ruling out HIV-associated tuberculosis. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 17(2): 283-284

Perez Valdivieso, J.R.; Bes-Rastrollo, M.; Monedero, P.; Olaondo, L.L.; de Irala, J.; Lavilla, F.J. 2008: Serum C-reactive protein on the prognosis of oncology patients with acute renal failure: an observational cohort study. Archives of Medical Research 39(3): 326-331

Eggers, H.; Seidel, C.; Schrader, A.J.; Lehmann, R.; Wegener, G.; Kuczyk, M.A.; Steffens, S. 2013: Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder. Medical Oncology 30(4): 705

López-Carrizosa, Mía.Concepción.; Samper-Ots, P.María.; Pérez, A.Rodríguez. 2010: Serum C-telopeptide levels predict the incidence of skeletal-related events in cancer patients with secondary bone metastases. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 12(8): 568-573

Kishida, K.; Kishida, N.; Arima, M.; Nakatsuji, H.; Kobayashi, H.; Funahashi, T.; Shimomura, I. 2013: Serum C1q- binding adiponectin in maintenance hemodialysis patients. Bmc Nephrology 14: 50

Ray, D.; Subramanyam, S.; Krishna, S.H.; Ramanathan, V.D. 2010: Serum C3d levels in tropical pulmonary eosinophilia. Indian Journal of Medical Research 131: 555-558

Yasuda, M.; Suenaga, Y.; Nishimukai, H.; Nobunaga, M. 2002: Serum C4 levels in patients with systemic lupus erythematosus in remission. Modern Rheumatology 12(3): 213-218

Hoshino, M.; Kawashima, H.; Ogose, A.; Kudo, N.; Ariizumi, T.; Hotta, T.; Umezu, H.; Hatano, H.; Morita, T.; Nishio, J.; Iwasaki, H.; Endo, N. 2010: Serum CA 125 expression as a tumor marker for diagnosis and monitoring the clinical course of epithelioid sarcoma. Journal of Cancer Research and Clinical Oncology 136(3): 457-464

Ricci, A.; Mariotta, S.; Bronzetti, E.; Bruno, P.; Vismara, L.; De Dominicis, C.; Laganà, B.; Paone, G.; Mura, M.; Rogliani, P.; Mastrangeldo, M.; Sciacchitano, S.; Saltini, C. 2009: Serum CA 15-3 is increased in pulmonary fibrosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 26(1): 54-63

Lee, K.J.; Yi, S.W.; Chung, M.J.; Park, S.W.; Song, S.Y.; Chung, J.B.; Park, J.Y. 2013: Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. Yonsei Medical Journal 54(3): 643-649

Ballehaninna, U.K.; Chamberlain, R.S. 2011: Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian Journal of Surgical Oncology 2(2): 88-100

Katz, M.H.G.; Varadhachary, G.R.; Fleming, J.B.; Wolff, R.A.; Lee, J.E.; Pisters, P.W.T.; Vauthey, J.-N.; Abdalla, E.K.; Sun, C.C.; Wang, H.; Crane, C.H.; Lee, J.H.; Tamm, E.P.; Abbruzzese, J.L.; Evans, D.B. 2010: Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Annals of Surgical Oncology 17(7): 1794-1801

Boone, B.A.; Steve, J.; Zenati, M.S.; Hogg, M.E.; Singhi, A.D.; Bartlett, D.L.; Zureikat, A.H.; Bahary, N.; Zeh, H.J. 2014: Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma. Annals of Surgical Oncology 21(13): 4351-4358

Hermsen, B.B.J.; von Mensdorff-Pouilly, S.; Berkhof, J.; van Diest, P.J.; Gille, J.J.P.; Menko, F.H.; Blankenstein, M.A.; Kenemans, P.; Verheijen, R.é H.M. 2007: Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(11): 1383-1389

Rahimi-Rad, M.Hossein.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension. Pneumologia 63(3): 164-166

Sahin, F.üs.; Yildiz, P. 2012: Serum CA-125: biomarker of pulmonary tuberculosis activity and evaluation of response to treatment. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 35(4): E223-E228

Fang, S.-C.; Zhang, H.-T.; Wang, C.-Y.; Zhang, Y.-M. 2014: Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis. Clinica Chimica Acta; International Journal of Clinical Chemistry 433: 123-127

Wiernik, P.H. 2008: Serum CA125 and PSA concentrations in patients with lymphoma. Clinical Advances in Hematology and Oncology: H&o 6(7): 527-531

Gadducci, A.; Sartori, E.; Zola, P.; Landoni, F.; Maggino, T.; Palai, N.; Fanucchi, A.; Katsaros, D. 1996: Serum CA125 assay in the early diagnosis of recurrent epithelial ovarian cancer. Oncology Reports 3(2): 301-303

Wang, S.; Lang, J.-H.; Leng, J.-H.; Zhu, L.; Fan, Q.-B.; Li, X.-C. 2013: Serum CA125 changes in one case with malignant transformation from benign endometriosis to Müllerian adenosarcoma. Chinese Medical Journal 126(17): 3397-3398

Joo, N.-S.; Kim, K.-N.; Kim, K.S. 2011: Serum CA125 concentration has inverse correlation with metabolic syndrome. Journal of Korean Medical Science 26(10): 1328-1332

Yang, Z.; Liang, Y.; Li, C.; Zhong, R. 2012: Serum CA125 elevation is independently associated with serositis in SLE patients. Clinical and Experimental Rheumatology 30(1): 93-98

Kobayashi, H.; Ooi, H.; Yamada, Y.; Sakata, M.; Kawaguchi, R.; Kanayama, S.; Sumimoto, K.; Terao, T. 2007: Serum CA125 level before the development of ovarian cancer. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 99(2): 95-99

Zeng, Y.-C.; Wu, R.; Wang, S.-L.; Chi, F.; Xing, R.; Cai, W.-S.; Fan, G.-L.; Fan, Y.-C.; Zhong, W.-Z.; Wu, L.-N.; Chen, X.-D.; Chen, H.-H.; Xiao, Y.-P. 2014: Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy. Medical Oncology 31(7): 48

Huang, G.S.; Chiu, L.G.; Gebb, J.S.; Gunter, M.J.; Sukumvanich, P.; Goldberg, G.L.; Einstein, M.H. 2007: Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecologic Oncology 107(3): 513-517

Takahashi, H.; Ohigashi, H.; Ishikawa, O.; Eguchi, H.; Gotoh, K.; Yamada, T.; Nakaizumi, A.; Uehara, H.; Tomita, Y.; Nishiyama, K.; Yano, M. 2010: Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival. Annals of Surgery 251(3): 461-469

Cho, H.-Y.; Kyung, M.S. 2014: Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 20: 1334-1339

Wong, D.; Ko, A.H.; Hwang, J.; Venook, A.P.; Bergsland, E.K.; Tempero, M.A. 2008: Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy. Pancreas 37(3): 269-274

O'Brien, D.P.; Sandanayake, N.S.; Jenkinson, C.; Gentry-Maharaj, A.; Apostolidou, S.; Fourkala, E.-O.; Camuzeaux, S.; Blyuss, O.; Gunu, R.; Dawnay, A.; Zaikin, A.; Smith, R.C.; Jacobs, I.J.; Menon, U.; Costello, E.; Pereira, S.P.; Timms, J.F. 2015: Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 21(3): 622-631

Yu, H.; Li, R.; Zhang, L.; Chen, H.; Bao, Y.; Jia, W. 2012: Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients. Experimental Diabetes Research 2012: 745189

Park, H.-D.; Kang, E.-S.; Kim, J.-W.; Lee, K.-T.; Lee, K.H.; Park, Y.S.; Park, J.-O.; Lee, J.; Heo, J.S.; Choi, S.H.; Choi, D.W.; Kim, S.; Lee, J.K.; Lee, S.-Y. 2012: Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. Proteomics 12(23-24): 3590-3597

Kelly, P.J.; Archbold, P.; Price, J.H.; Cardwell, C.; McCluggage, W.G. 2010: Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype. Journal of Clinical Pathology 63(2): 169-173

Prasse, A.; Probst, C.; Bargagli, E.; Zissel, G.; Toews, G.B.; Flaherty, K.R.; Olschewski, M.; Rottoli, P.; Müller-Quernheim, J. 2009: Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 179(8): 717-723

Gambichler, T.; Yilmaz, E.; Höxtermann, S.; Kolios, A.; Moritz, R.; Bechara, F.G.; Kreuter, A. 2011: Serum CCL13 levels in patients with systemic sclerosis and controls. British Journal of Dermatology 165(1): 216-218

Schupp, J.; Becker, M.; Günther, J.; Müller-Quernheim, J.; Riemekasten, G.; Prasse, A. 2014: Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis. European Respiratory Journal 43(5): 1530-1532

Ding, L.; Li, B.; Zhao, Y.; Fu, Y.-F.; Hu, E.-L.; Hu, Q.-G.; Ni, Y.-H.; Hou, Y.-Y. 2014: Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(10): 10539-10546

Lu, X.; Qian, C.-N.; Mu, Y.-G.; Li, N.-W.; Li, S.; Zhang, H.-B.; Li, S.-W.; Wang, F.-L.; Guo, X.; Xiang, Y.-Q. 2011: Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma. European Journal of Cancer 47(3): 339-346

Yanaba, K.; Yoshizaki, A.; Muroi, E.; Ogawa, F.; Asano, Y.; Kadono, T.; Sato, S. 2011: Serum CCL23 levels are increased in patients with systemic sclerosis. Archives of Dermatological Research 303(1): 29-34

Sasaki, T.; Kuniyasu, H.; Luo, Y.; Fujiwara, R.; Kitayoshi, M.; Tanabe, E.; Kato, D.; Shinya, S.; Fujii, K.; Ohmori, H.; Yamashita, Y. 2014: Serum CD10 is associated with liver metastasis in colorectal cancer. Journal of Surgical Research 192(2): 390-394

Jones, K.; Vari, F.; Keane, C.; Crooks, P.; Nourse, J.P.; Seymour, L.A.; Gottlieb, D.; Ritchie, D.; Gill, D.; Gandhi, M.K. 2013: Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(3): 731-742

De Chiara, L.; Rodríguez-Piñeiro, A.M.; Rodríguez-Berrocal, F.J.; Cordero, O.J.; Martínez-Ares, D.; Páez de la Cadena, M.ía. 2010: Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas. Bmc Cancer 10: 333

Lan, J.-H.; Wu, R.-H.; Lv, Z.-C. 2009: Serum CD4+ and CD8+ levels and the CD4+/CD8+ ratio in children with febrile convulsion. Zhongguo Dang Dai Er Ke Za Zhi 11(6): 492-493

Loeffler-Ragg, J.; Germing, U.; Sperr, W.R.; Herrmann, H.; Zwierzina, H.; Valent, P.; Ulmer, H.; Stauder, R. 2011: Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromes. Critical Reviews in Oncology/Hematology 78(2): 150-161

Qin, H.-F.; Qu, L.-L.; Liu, H.; Wang, S.-S.; Gao, H.-J. 2013: Serum CEA level change and its significance before and after Gefitinib therapy on patients with advanced non-small cell lung cancer. Asian Pacific Journal of Cancer Prevention: Apjcp 14(7): 4205-4208

Sivan, S.; Suzan, F.; Rona, O.; Tamar, H.; Vivian, B.; Tamar, P.; Jacob, S.; Gal, M.; Michal, L. 2012: Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients. Clinical and Developmental Immunology 2012: 290536

Happonen, K.E.; Saxne, T.; Geborek, P.; Andersson, M.; Bengtsson, A.A.; Hesselstrand, R.; Heinegård, D.; Blom, A.M. 2012: Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment. Arthritis Research and Therapy 14(1): R15

Ognjanovic, S.; Yamamoto, J.; Saltzman, B.; Franke, A.; Ognjanovic, M.; Yokochi, L.; Vogt, T.; Decker, R.; Le Marchand, L.ïc. 2010: Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes and Control: Ccc 21(7): 1131-1138

Zhang, Y.-H.; Guo, X.-H.; Zhang, Q.-M.; Yan, G.-T.; Wang, T.-L. 2015: Serum CRP and urinary trypsin inhibitor implicate postoperative cognitive dysfunction especially in elderly patients. International Journal of Neuroscience 125(7): 501-506

Luo, Y.; Wang, Z.; Li, J.; Xu, Y. 2012: Serum CRP concentrations and severity of ischemic stroke subtypes. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 39(1): 69-73

Okuda, C.; Koyama, H.; Tsutsumi, Z.; Yamamoto, A.; Kurajoh, M.; Moriwaki, Y.; Yamamoto, T. 2011: Serum CRP in patients with gout and effects of benzbromarone. International Journal of Clinical Pharmacology and Therapeutics 49(3): 191-197

Schwartz, H.C. 2008: Serum CTX testing. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons 66(6): 1319-20; author reply 1320

Assael, L.A. 2007: Serum CTX to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk?. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 65(12): 2395-2396

Cakir, M.; Levendoglu, F.; Kiyici, A.; Coskun, Y. 2011: Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases. Autoimmunity 44(6): 496-503

Rotondi, M.; Minelli, R.; Magri, F.; Leporati, P.; Romagnani, P.; Baroni, M.Cristina.; Delsignore, R.; Serio, M.; Chiovato, L. 2007: Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis. European Journal of Endocrinology 156(4): 409-414

Wutte, N.; Berghold, A.; Krainberger, I.; Aberer, E. 2011: Serum CXCL13 chemokine is not a marker for active Lyme borreliosis. Acta Dermato-Venereologica 91(6): 724-725

Zhao, L.; Wu, F.; Jin, L.; Lu, T.; Yang, L.; Pan, X.; Shao, C.; Li, X.; Lin, Z. 2014: Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus. Plos one 9(1): E87786

Yanaba, K.; Muroi, E.; Yoshizaki, A.; Hara, T.; Ogawa, F.; Shimizu, K.; Yozaki, M.; Hasegawa, M.; Fujimoto, M.; Takehara, K.; Sato, S. 2009: Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis. Journal of Rheumatology 36(9): 1917-1923

Hsin, L.-J.; Kao, H.-K.; Chen, I.-H.; Tsang, N.-M.; Hsu, C.-L.; Liu, S.-C.; Chang, Y.-S.; Chang, K.-P. 2013: Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma. Plos one 8(11): E80052

Zhu, W.-Q.; Yu, J.-M.; Sun, X.-D.; Xie, P.; Kong, L. 2010: Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 15(7): 602-607

Lee, D.S.; Kim, S.J.; Kang, J.H.; Hong, S.H.; Jeon, E.K.; Kim, Y.K.; Yoo, I.R.; Park, J.G.; Jang, H.S.; Lee, H.C.; Kim, Y.S. 2014: Serum Carcinoembryonic Antigen Levels and the Risk of Whole-body Metastatic Potential in Advanced Non-small Cell Lung Cancer. Journal of Cancer 5(8): 663-669

Lalor, S.M.; Gunn-Moore, D.A.; Cash, R.; Foot, A.; Reed, N.; Mellanby, R.J. 2014: Serum Cardiac Troponin i concentrations in cats with anaemia - a preliminary, single-centre observational study. Journal of Small Animal Practice 55(6): 320-322

Behringer, M.; Montag, J.; Kilian, Y.; McCourt, M.; Liphardt, A.-M.; Mester, J. 2014: Serum Cartilage Oligomeric Matrix Protein: is there a Repeated Bout Effect?. Orthopedic Reviews 6(3): 5543

Petersen, W.; Jobling, J.W.; Eggstein, A.A. 1916: Serum Changes and the Cause of Death in Experimental Pancreatitis : Studies on Ferment Action. Xxx. Journal of Experimental Medicine 23(4): 491-498

Jobling, J.W.; Petersen, W.; Eggstein, A.A. 1915: Serum Changes following Kaolin Injections : Studies on Ferment Action. Xxv. Journal of Experimental Medicine 22(5): 590-596

Petersen, W.; Jobling, J.W.; Eggstein, A.A. 1916: Serum Changes following Thyroparathyroidectomy : Studies on Ferment Action. Xxxi. Journal of Experimental Medicine 23(4): 499-505

Pomerantz, H.Z. 1960: Serum Cholesterol Levels in Atherosclerosis. Canadian Medical Association Journal 82(9): 497-498

Anonymous 1950: Serum Cholesterol and Atheroma. British Medical Journal 1(4645): 109-110

Dey, M.; Arora, D.; Narayan, N.; Kumar, R. 2013: Serum Cholesterol and Ceruloplasmin Levels in Second Trimester can Predict Development of Pre-eclampsia. North American Journal of Medical Sciences 5(1): 41-46

Holmes, B.E. 1941: Serum Cholesterol and Irradiation Sickness. British Medical Journal 1(4182): 314

Weston, P.G. 1914: Serum Cholesterol and the Wassermann Reaction. Journal of Medical Research 30(3): 377-381

Wiswedel, I.; Peter, D.; Gardemann, A.; Carluccio, F.; Hampl, H.; Siems, W. 2008: Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia. Biomarker Insights 3: 419-428

Schulte, S.; Schiffer, T.; Sperlich, B.; Kleinöder, H.; Holmberg, H.Christer. 2011: Serum Concentrations of S100B are not Affected by Cycling to Exhaustion With or Without Vibration. Journal of Human Kinetics 30: 59-63

Jumaan, R.'a.M. 2008: Serum Copper, Zinc and Copper/Zinc Ratio and their Relationship to Age and Growth Status in Yemeni Adolescent Girls. Sultan Qaboos University Medical Journal 8(3): 291-299

Tavakoli, N.; Bidari, A.; Shams Vahdati, S. 2012: Serum Cortisol Levels as a Predictor of Neurologic Survival in Successfully Resuscitated Victims of Cardiopulmonary Arrest. Journal of Cardiovascular and Thoracic Research 4(4): 107-111

Išić, T.; Savin, S.; Cvejić, D.; Marečko, I.; Tatić, S.; Havelka, M.; Paunović, I. 2010: Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors. Journal of Cancer Research and Clinical Oncology 136(12): 1805-1812

Delaney, M.P.; Stevens, P.E.; Witham, H.J.; Judge, C.; Eaglestone, G.L.; Carter, J.L.; Bassett, P.; Lamb, E.J. 2016: Serum Cystatin C Does not Predict Mortality or Treatment Failure in Peritoneal Dialysis: a Prospective Study. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 36(1): 94-100

Del Ben, M.; Polimeni, L.; Baratta, F.; Bartimoccia, S.; Carnevale, R.; Loffredo, L.; Pignatelli, P.; Violi, F.; Angelico, F. 2014: Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver. International Journal of Hepatology 2014: 784985

Akkurt, Z.M.; Bozkurt, M.; Uçmak, D.; Yüksel, H.; Uçak, H.; Sula, B.; Gürsel Özkurt, Z.; Yildiz, M.; Akdeniz, D.; Arica, M. 2015: Serum Cytokine Levels in Behçet's Disease. Journal of Clinical Laboratory Analysis 29(4): 317-320

Chiu, C.-C.; Li, Y.-N.; Lin, L.-J.; Hsiao, C.-T.; Hsiao, K.-Y.; Chen, I.-C. 2012: Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 19(6): 810-813

Tellioglu, G.; Agcaoglu, O.; Siperstein, A.; Berber, E. 2012: Serum D-dimer as a prognostic marker in patients undergoing radiofrequency ablation of colorectal liver metastasis. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 25(5): 295-300

Wang, Z.F.; Su, F.; Lin, X.J.; Dai, B.; Kong, L.F.; Zhao, H.W.; Kang, J. 2011: Serum D-dimer changes and prognostic implication in 2009 novel influenza A(H1N1). Thrombosis Research 127(3): 198-201

Kong, H.; Ding, Z.; Zhu, X.-C.; Gao, X.-Y.; Sun, S.-B.; Wu, J.; Zhao, G.; Wang, C.-Y.; Hou, X.-H. 2007: Serum D-dimer changes and prognostic implication in acute pancreatitis. Zhonghua Nei Ke Za Zhi 46(12): 1011-1013

Sexton, D.J.; Clarkson, M.R.; Mazur, M.J.; Plant, W.D.; Eustace, J.A. 2012: Serum D-dimer concentrations in nephrotic syndrome track with albuminuria, not estimated glomerular filtration rate. American Journal of Nephrology 36(6): 554-560

Marill, K.A. 2008: Serum D-dimer is a sensitive test for the detection of acute aortic dissection: a pooled meta-analysis. Journal of Emergency Medicine 34(4): 367-376

Jee, D.; Zako, M.; La, T.Y. 2015: Serum D-dimer levels to evaluate the risk for arterial thromboembolism after intravitreal injection of bevacizumab and ranibizumab. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 31(1): 32-36

Kanazawa, I.; Yamaguchi, T.; Yamamoto, M.; Yamauchi, M.; Kurioka, S.; Yano, S.; Sugimoto, T. 2008: Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus. Endocrine Journal 55(4): 667-675

He, X.Y.; Liu, B.Y.; Yao, W.Y.; Zhao, X.J.; Zheng, Z.; Li, J.F.; Yu, B.Q.; Yuan, Y.Z. 2011: Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer. Journal of Digestive Diseases 12(2): 131-137

Yamane, T.; Murao, S.; Kozuka, M.; Shimizu, M.; Suzuki, J.; Kubo, C.; Yamaguchi, A.; Musashi, M.; Minegishi, Y.; Momose, I.; Matsushita, M.; Shirahata, A.; Furukawa, N.; Kobayashi, R.; Umezawa, A.; Sakamoto, M.; Moriya, K.; Saito, M.; Makita, A.; Ohkubo, I.; Ariga, H. 2014: Serum DJ-1 level is positively associated with improvements in some aspects of metabolic syndrome in Japanese women through lifestyle intervention. Nutrition Research 34(10): 851-855

Bande, M.F.; Santiago, M.; Blanco, M.J.; Mera, P.; Capeans, C.; Rodríguez-Alvarez, M.X.; Pardo, M.; Piñeiro, A. 2012: Serum DJ-1/PARK 7 is a potential biomarker of choroidal nevi transformation. Investigative Ophthalmology and Visual Science 53(1): 62-67

Lavon, I.; Refael, M.; Zelikovitch, B.; Shalom, E.; Siegal, T. 2010: Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades. Neuro-Oncology 12(2): 173-180

Hauser, S.; Kogej, M.; Fechner, G.; VON Pezold, J.; Vorreuther, R.; Lümmen, G.; Müller, S.C.; Ellinger, J.ör. 2013: Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study. Anticancer Research 33(3): 779-784

Hauser, S.; Zahalka, T.; Fechner, G.; Müller, S.C.; Ellinger, J.ör. 2013: Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study. Anticancer Research 33(10): 4651-4656

Avraham, A.; Uhlmann, R.; Shperber, A.; Birnbaum, M.; Sandbank, J.; Sella, A.; Sukumar, S.; Evron, E. 2012: Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. International Journal of Cancer 131(7): E1166-E1172

Beck, J.; Urnovitz, H.B.; Saresella, M.; Caputo, D.; Clerici, M.; Mitchell, W.M.; Schütz, E. 2010: Serum DNA motifs predict disease and clinical status in multiple sclerosis. Journal of Molecular Diagnostics: Jmd 12(3): 312-319

Skiljevic, D.; Jeremic, I.; Nikolic, M.; Andrejevic, S.; Sefik-Bukilica, M.; Stojimirovic, B.; Bonaci-Nikolic, B. 2013: Serum DNase i activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement. Clinical Chemistry and Laboratory Medicine 51(5): 1083-1091

Erić-Nikolić, A.; Matić, I.Z.; Dorđević, M.; Milovanović, Z.; Marković, I.; Džodić, R.; Inić, M.či.; Srdić-Rajić, T.; Jevrić, M.; Gavrilović, D.ši.; Cordero, O.J.; Juranić, Z.D. 2011: Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors. Immunobiology 216(8): 942-946

Schmitt, L.S. 1911: Serum Diagnosis of Syphilis. California State Journal of Medicine 9(1): 9-13

Van Lierop, A.H.; Moester, M.J.C.; Hamdy, N.A.T.; Papapoulos, S.E. 2014: Serum Dickkopf 1 levels in sclerostin deficiency. Journal of Clinical Endocrinology and Metabolism 99(2): E252-E256

Zhou, S.-j.; Zhuo, S.-r.; Yang, X.-q.; Qin, C.-x.; Wang, Z.-l. 2014: Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer. Diagnostic Pathology 9: 161

Voskaridou, E.; Christoulas, D.; Xirakia, C.; Varvagiannis, K.; Boutsikas, G.; Bilalis, A.; Kastritis, E.; Papatheodorou, A.; Terpos, E. 2009: Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. Haematologica 94(5): 725-728

Yan, L.-J.; Thangthaeng, N.; Sumien, N.; Forster, M.J. 2013: Serum Dihydrolipoamide Dehydrogenase Is a Labile Enzyme. Journal of Biochemical and Pharmacological Research 1(1): 30-42

Rolleston, H. 1918: Serum Disease after Intrathecal Injections of Serum: (Abstract). Proceedings of the Royal Society of Medicine 11(Med Sect): 1

Aeberli, D.; Schett, G.; Eser, P.; Seitz, M.; Villiger, P.M. 2011: Serum Dkk-1 levels of DISH patients are not different from healthy controls. Joint Bone Spine 78(4): 422-423

Rao, G.S.N.; Gurumurthy, P.; Gururajan, P.; Saibabu, R.; Cherian, K.M. 2011: Serum E-selectin levels in Indian children and adolescents: relation to clinical and biochemical parameters. Pediatrics International: Official Journal of the Japan Pediatric Society 53(1): 40-45

Cheng, K.-J.; Wang, S.-Q.; Xu, Y.-Y.; Liu, H.-Y. 2009: Serum ECP levels in patients with allergic rhinitis and chronic rhinosinusitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44(12): 1001-1005

Kose, M.; Emet, S.; Akpinar, T.S.; Kocaaga, M.; Cakmak, R.; Akarsu, M.; Yuruyen, G.; Arman, Y.; Tukek, T. 2015: Serum Endocan Level and the Severity of Coronary Artery Disease: a Pilot Study. Angiology 66(8): 727-731

Su, Y.-H.; Shu, K.-H.; Hu, C.-P.; Cheng, C.-H.; Wu, M.-J.; Yu, T.-M.; Chuang, Y.-W.; Huang, S.-T.; Chen, C.-H. 2014: Serum Endocan correlated with stage of chronic kidney disease and deterioration in renal transplant recipients. Transplantation Proceedings 46(2): 323-327

Chan, P.W.K.; Samsinah, H.H.; Arpin, H.Z.; Mustafa, A.M.; de Bruyne, J.A. 2002: Serum Eosinophilic Cationic Protein (ECP) in Asthmatic Malaysian Children. Medical Journal of Malaysia 57(2): 201-204

Gebauer, F.; Struck, L.; Tachezy, M.; Vashist, Y.; Wicklein, D.; Schumacher, U.; Izbicki, J.R.; Bockhorn, M. 2014: Serum EpCAM expression in pancreatic cancer. Anticancer Research 34(9): 4741-4746

Berth, M.; Vanheule, G.; Depuydt, C.; Benoy, I. 2011: Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(2): 184-185

Cheng, X.; Zhu, B.; Jiang, F.; Fan, H. 2011: Serum FGF-21 levels in type 2 diabetic patients. Endocrine Research 36(4): 142-148

Kukla, M.ł; Berdowska, A.; Stygar, D.; Gabriel, A.; Mazur, W.ło.; Łogiewa-Bazger, B.; Sobala-Szczygieł, B.; Bułdak, R.ł J.; Rokitka, M.; Zajęcki, W.; Kępa, L.; Sawczyn, T.; Zwirska-Korczala, K. 2012: Serum FGF21 and RBP4 levels in patients with chronic hepatitis C. Scandinavian Journal of Gastroenterology 47(8-9): 1037-1047

Lee, Y.; Lim, S.; Hong, E.-S.; Kim, J.H.; Moon, M.K.; Chun, E.J.; Choi, S.I.; Kim, Y.-B.; Park, Y.J.; Park, K.S.; Jang, H.C.; Choi, S.H. 2014: Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Clinical Endocrinology 80(1): 57-64

Hero, M.; Dunkel, L.; Vaaralahti, K.; Raivio, T. 2011: Serum FGF21 in boys with idiopathic short stature: relationship to lipid profile, onset of puberty and growth. Clinical Endocrinology 75(1): 141-142

Mutanen, A.; Heikkilä, P.äi.; Lohi, J.; Raivio, T.; Jalanko, H.; Pakarinen, M.P. 2014: Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure. Journal of Hepatology 60(1): 183-190

Domingo, P.; Gallego-Escuredo, Jé.M.; Domingo, J.C.; Gutiérrez, M.del.Mar.; Mateo, M.G.; Fernández, I.; Vidal, F.; Giralt, M.; Villarroya, F. 2010: Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients. Aids 24(17): 2629-2637

Koene, S.; de Laat, P.; van Tienoven, D.èn.H.; Vriens, D.; Brandt, A.é M.; Sweep, F.C.G.J.; Rodenburg, R.J.T.; Donders, A.R.T.; Janssen, M.C.H.; Smeitink, J.A.M. 2014: Serum FGF21 levels in adult m.3243A>G carriers: clinical implications. Neurology 83(2): 125-133

Ärnlöv, J.; Carlsson, A.C.; Sundström, J.; Ingelsson, E.; Larsson, A.; Lind, L.; Larsson, T.E. 2013: Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology. Clinical Journal of the American Society of Nephrology: Cjasn 8(5): 781-786

Vitthala, S.; Bouaziz, J.; Tozer, A.; Zosmer, A.; Al-Shawaf, T. 2012: Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles. International Journal of Endocrinology 2012: 540681

Aso, K.; Koto, S.; Higuchi, A.; Ariyasu, D.; Izawa, M.; Miyamoto Igaki, J.; Hasegawa, Y. 2010: Serum FSH level below 10 mIU/mL at twelve years old is an index of spontaneous and cyclical menstruation in Turner syndrome. Endocrine journal 57(10): 909-913

Dignam, W.J. 1973: Serum FSH-LH Determinations in Gynecologic Practice. California Medicine 119(1): 64

Ristić, T.; Djordjević, V.B.; Deljanin-Ilić, M.; Cosić, V.; Kundalić, S. 2010: Serum Fas/FasL levels in dependence on clinical presentations of coronary disease and their relationship with risk factors. Vojnosanitetski Pregled 67(7): 537-542

Jobling, J.W.; Petersen, W.; Eggstein, A.A. 1915: Serum Ferments and Antiferment after Feeding : Studies on Ferment Action. Xxi. Journal of Experimental Medicine 22(2): 129-140

Jobling, J.W.; Petersen, W.; Eggstein, A.A. 1915: Serum Ferments and Antiferment during Trypsin Shock : Studies on Ferment Action. Xxii. Journal of Experimental Medicine 22(2): 141-153

Lee, J.-Y.; Park, J.-M.; Hong, J.-A.; Lee, D.-C.; Im, J.-A.; Lee, J.-W. 2012: Serum Ferritin Is Differentially Associated with Anti-oxidative Status and Insulin Resistance in Healthy Obese and Non-obese Women. Korean Journal of Family Medicine 33(4): 205-210

Argani, H.; Ghorbanihaghjo, A.; Panahi, G.; Rashtchizadeh, N.; Safa, J.; Meimand, S.M. 2012: Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients. Clinical Biochemistry 45(10-11): 775-779

Enli, Y.; Fenkci, S.M.; Fenkci, V.; Oztekin, O. 2013: Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 29(12): 1036-1039

Bussen, S.; Bussen, D. 2012: Serum Folate and Cobalamin Levels in Women Using Combined Contraceptive Vaginal Ring. Geburtshilfe und Frauenheilkunde 72(2): 149-153

Han, X.; He, J.; Wang, A.; Dong, M. 2014: Serum Follistatin-like-3 was elevated in second trimester of pregnant women who subsequently developed preeclampsia. Hypertension in Pregnancy 33(3): 277-282

Ebana, H.; Nakamura, K.-I.; Nozawa, Y.; Seki, R.; Mita, M. 2014: Serum Free Light Chain only Myeloma with Cytoplasmic IgM. Case Reports in Hematology 2014: 676913

Schou, A.J.; Wolthers, O.D. 2011: Serum Fructosamine, Total Cholesterol, and High-Density Lipoprotein in Children with Asthma during Glucocorticoid Treatment. Isrn Allergy 2011: 295124

Kamada, Y.; Akita, M.; Takeda, Y.; Yamada, S.; Fujii, H.; Sawai, Y.; Doi, Y.; Asazawa, H.; Nakayama, K.; Mizutani, K.; Fujii, H.; Yakushijin, T.; Miyazaki, M.; Ezaki, H.; Hiramatsu, N.; Yoshida, Y.; Kiso, S.; Imai, Y.; Kawada, N.; Takehara, T.; Miyoshi, E. 2013: Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis. Plos one 8(6): E66328

Storoni, M.; Verbeek, M.M.; Illes, Z.; Marignier, R.; Teunissen, C.E.; Grabowska, M.; Confavreux, C.; Plant, G.T.; Petzold, A. 2012: Serum GFAP levels in optic neuropathies. Journal of the Neurological Sciences 317(1-2): 117-122

Gohel, M.G.; Chacko, A.N. 2013: Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: An evidence linking oxidative stress, inflammation and glycemic control. Journal of Diabetes and Metabolic Disorders 12(1): 56

Hou, S-Cong.; Xiao, M-Bing.; Ni, R-Zhou.; Ni, W-Kai.; Jiang, F.; Li, X-Yan.; Lu, C-Hua.; Chen, B-You. 2013: Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma. Oncology Letters 6(4): 1152-1158

Wei, H.-S.; Kang, Y.-F.; Hao, X.-H.; Liu, J.; Li, H.-M.; Liu, A.-X.; Ren, H.; Huang, Y.-B.; Li, B.-A. 2013: Serum GP73 were increased in patients with fatty liver disease. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 27(4): 244-246

Wei, H.; Li, B.; Zhang, R.; Hao, X.; Huang, Y.; Qiao, Y.; Hou, J.; Li, X.; Li, X. 2013: Serum GP73, a marker for evaluating progression in patients with chronic HBV infections. Plos one 8(2): E53862

Gang, L.; Wei-Hua, L.; Rong, A.; Jian-Hong, Y.; Zi-Hua, Z.; Zhong-Zhi, T. 2015: Serum Gamma-glutamyltransferase Levels Predict the Progression of Coronary Artery Calcification in Adults with Type 2 Diabetes Mellitus. Angiology 66(7): 667-674

Jin, H.; Yu, J.; Wang, W.; Chen, C.; Chen, X.; Deng, W.; Xiong, X.; Sun, H. 2012: Serum Gc-globulin levels are reduced in patients with severe acute pancreatitis. European Journal of Gastroenterology and Hepatology 24(5): 501-505

Gunes, F.; Asik, M.; Temiz, A.; Vural, A.; Sen, H.; Binnetoglu, E.; Bozkurt, N.; Tekeli, Z.; Erbag, G.; Ukinc, K.; Akbal, E. 2014: Serum H-FABP levels in patients with hypothyroidism. Wiener Klinische Wochenschrift 126(21-22): 727-733

Lü, W.; Yang, H.-H.; Fan, Y.-M.; Li, T.; Zhang, L.-F.; Mui, C.; Fan, H.-W.; Zhou, B.-T.; Liu, Z.-Y.; Ng, H.; Liu, X.-Q. 2013: Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients. Chinese Medical Journal 126(12): 2333-2336

Zheng, Q.; Jiang, J.-j.; Chen, J.; Zhu, Y.-y.; Liu, Y.-r.; Chen, Y.-t. 2011: Serum HBV DNA level at week 24 as a proper predictor for the effect of 2-year lamivudine treatment. Chinese Medical Journal 124(8): 1257-1260

Kurosaki, M.; Tsuchiya, K.; Nakanishi, H.; Itakura, J.; Izumi, N. 2013: Serum HBV RNA as a possible marker of HBV replication in the liver during nucleot(s)ide analogue therapy. Journal of Gastroenterology 48(6): 777-778

Choi, J.S.; Han, K.J.; Lee, S.; Chun, S.W.; Kim, D.J.; Kim, H.C.; Kim, H.M. 2015: Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome in Korean adult men. Journal of Epidemiology 25(1): 74-79

Wang, X.-Y.; Zhang, X.-X.; Yao, X.; Jiang, J.-H.; Xie, Y.-H.; Yuan, Z.-H.; Wen, Y.-M. 2010: Serum HBeAg sero-conversion correlated with decrease of HBsAg and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine. Vaccine 28(51): 8169-8174

Chen, J.; Wang, Z.; Guo, Y.; Peng, J.; Sun, J.; Ahmed, C.S.; Zhou, Y.; Hou, J. 2009: Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-alpha-2a. Antiviral Research 81(1): 88-91

Zoutendijk, R.; Hansen, B.E.; van Vuuren, A.J.; Boucher, C.A.B.; Janssen, H.L.A. 2011: Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss. Journal of Infectious Diseases 204(3): 415-418

Lai, J.; Sun, H.-x.; Jie, Y.-S.; Zhang, K.; Ke, W.-m. 2014: Serum HBsAg level and its clinical significance in lamivudine treatment for patients with HBeAg-negative acute-on-chronic liver failure. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 22: 78-82

Song, E.Y.; Shin, Y.; Roh, E.Y.; Sue, S.; Park, M.H.; Kim, B.H.; Kim, W.; Yoon, J.-H.; Lee, Y.-J.; Park, S.J.; Jung, E.U.; Lee, J.-H.; Myung, S.J.; Kim, Y.-J.; Lee, H.-S. 2011: Serum HBsAg levels during peginterferon α-2a treatment with or without thymosin α-1 in HBeAg-positive chronic hepatitis B patients. Journal of Medical Virology 83(1): 88-94

Ramachandran, J.; Ismail, A.M.; Chawla, G.; Fletcher, G.J.; Goel, A.; Eapen, C.E.; Abraham, P. 2014: Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 33(2): 131-135

Chan, H.L.-Y.; Wong, V.W.-S.; Chim, A.M.-L.; Chan, H.-Y.; Wong, G.L.-H.; Sung, J.J.-Y. 2010: Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B. Alimentary Pharmacology and Therapeutics 32(11-12): 1323-1331

Huang, H.-C.; Chuang, C.-S.; Hsieh, Y.-Y.; Chang, T.-S.; Wei, K.-L.; Shen, C.-H.; Wu, C.-S.; Tung, S.-Y. 2011: Serum HCV RNA level is not associated with insulin resistance and metabolic syndrome in chronic hepatitis C patients with genotype 1 or 2 infection. Chang Gung Medical Journal 34(5): 487-495

Tsochatzis, E.; Manolakopoulos, S.; Papatheodoridis, G.V.; Hadziyannis, E.; Triantos, C.; Zisimopoulos, K.; Goulis, I.; Tzourmakliotis, D.; Akriviadis, E.; Manesis, E.K.; Archimandritis, A.J. 2009: Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study. Alimentary Pharmacology and Therapeutics 30(9): 947-954

Łucejko, M.; Grzeszczuk, A.; Jaroszewicz, J.; Flisiak, R. 2013: Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 35(206): 72-76

Al-Khurri, L.E.; Al-Khafaji, K.R.; Al-Salihi, S.A.; Alwaysi, S.A.A.; Al-Akayshi, R.J. 2009: Serum HCV-RNA levels in patients with chronic hepatitis C: Correlation with histological features. Arab Journal of Gastroenterology: the Official Publication of the Pan-Arab Association of Gastroenterology 10(1): 10-13

Trkanjec, Z.; Béné, R.; Martinić-Popović, I.; Jurasić, J.M.; Lisak, M.; Serić, V.; Demarin, V. 2009: Serum HDL, LDL and total cholesterol in patients with late-life onset of Alzheimer's disease versus vascular dementia. Acta Clinica Croatica 48(3): 259-263

Guo, E.; Chen, L.; Xie, Q.; Chen, J.; Tang, Z.; Wu, Y. 2007: Serum HDL-C as a potential biomarker for nodal stages in gastric cancer. Annals of Surgical Oncology 14(9): 2528-2534

Hosseini, M.; Navidi, I.; Yousefifard, M.; Heshmat, R.; Koohpayehzadeh, J.; Asgari, F.; Etemad, K.; Rafei, A.; Gouya, M.Mehdi. 2014: Serum HDL-C level of Iranian adults: results from sixth national Surveillance of Risk Factors of Non-Communicable Disease. Journal of Diabetes and Metabolic Disorders 13: 67

Nessa, A.; Latif, S.A.; Uddin, M.M.; Hussain, M.A. 2007: Serum HDL-cholesterol in women using low dose oral contraceptives. Mymensingh Medical Journal: Mmj 16(2 Suppl): S3-S6

Hynninen, J.; Auranen, A.; Dean, K.; Lavonius, M.; Carpen, O.; Perheentupa, A.; Seppänen, M.; Grénman, S. 2011: Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 21(9): 1573-1578

Vallius, T.; Hynninen, J.; Auranen, A.; Carpén, O.; Matomäki, J.; Oksa, S.; Virtanen, J.; Grénman, S. 2014: Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(12): 12389-12395

Brennan, D.J.; Hackethal, A.; Metcalf, A.M.; Coward, J.; Ferguson, K.; Oehler, M.K.; Quinn, M.A.; Janda, M.; Leung, Y.; Freemantle, M.; Webb, P.M.; Spurdle, A.B.; Obermair, A.; Webb, P.M.; Young, J.; McQuire, L.; Baron-Hay, S.; Bell, D.; Bonaventura, A.; Brand, A.; Braye, S.; Carter, J.; Chan, F.; Dalrymple, C.; Ferrier, A.; Gard, G.; Hacker, N.; Hogg, R.; Houghton, R.; Marsden, D.; McIlroy, K.; Otton, G.; Pather, S.; Proietto, A.; Robertson, G.; Scurry, J.; Sharma, R.; Wain, G.; Wong, F.; Armes, J.; Crandon, A.; Cummings, M.; Land, R.; Nicklin, J.; Perrin, L.; Obermair, A.; Ward, B.; Davy, M.; Dodd, T.; Miller, J.; Oehler, M.; Paramasivum, S.; Pierides, J.; Whitehead, F.; Blomfield, P.; Challis, D.; Neesham, D.; Pyman, J.; Quinn, M.; Rome, 2014: Serum HE4 as a prognostic marker in endometrial cancer--a population based study. Gynecologic Oncology 132(1): 159-165

Zheng, H.; Gao, Y. 2012: Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 22(6): 1000-1005

Hallamaa, M.; Suvitie, P.; Huhtinen, K.; Matomäki, J.; Poutanen, M.; Perheentupa, A. 2012: Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women. Gynecologic Oncology 125(3): 667-672

Manganaro, L.; Michienzi, S.; Vinci, V.; Falzarano, R.; Saldari, M.; Granato, T.; Viggiani, V.; Frati, L.; Anastasi, E. 2013: Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer. Oncology Reports 30(5): 2481-2487

Chudecka-Głaz, A.M.; Cymbaluk-Płoska, A.A.; Menkiszak, J.L.; Sompolska-Rzechuła, A.M.; Tołoczko-Grabarek, A.I.; Rzepka-Górska, I.A. 2014: Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. Journal of Ovarian Research 7: 62

Dai, S.-Q.; An, X.; Wang, F.; Shao, Q.; Chen, Y.-C.; Kong, Y.-N.; Chen, C.; Li, C.; Luo, H.-Y.; Liang, Y.; Wang, F.-H.; Xu, R.-H.; Li, Y.-H. 2013: Serum HER 2 extracellular domain level is correlated with tissue HER 2 status in metastatic gastric or gastro-oesophageal junction adenocarcinoma. Plos one 8(5): E63458

Fernández-Real, J.é M.; Menendez, J.A.; Frühbeck, G.; Moreno-Navarrete, J.é M.ía.; Vazquez-Martín, A.; Ricart, W. 2010: Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. Nutrition and Metabolism 7: 14

Sørensen, P.D.; Jakobsen, E.H.; Langkjer, S.T.; Bokmand, S.; Østergaard, B.; Olsen, D.A.; Madsen, J.S.; Brandslund, I. 2009: Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting. Clinical Chemistry and Laboratory Medicine 47(9): 1117-1123

Kan, N.; Yoshikawa, S. 2009: Serum HER-2 determination using a centauer HER-2/neu kit (CLIA method) in metastatic breast cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 779-783

Petersen, E.R.B.; Sørensen, P.D.; Jakobsen, E.H.; Madsen, J.S.; Brandslund, I. 2013: Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer. Clinical Chemistry and Laboratory Medicine 51(7): 1483-1492

Sørensen, P.D.; Madsen, J.S.; Brandslund, I. 2011: Serum HER-2/ECD analysis in monitoring breast cancer patients. Clinical Chemistry and Laboratory Medicine 50(1): 175-176

Ali, S.M.; Carney, W.P.; Esteva, F.J.; Fornier, M.; Harris, L.; Köstler, W.J.; Lotz, J.-P.; Luftner, D.; Pichon, M.-F.; Lipton, A.; Brault, D.; Burstein, H.; Gligorov, J.; Leitzel, K.; Neumann, R.; Price, C.P.; Thiel, R.P.; Wheler, J. 2008: Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer. Cancer 113(6): 1294-1301

Zhou, J.; Liu, Y.; Wang, T.; Zhang, H.; Du, M.; Zhang, S.; Wu, S.; Song, S.; Liu, B.; Zhang, H.; Jiang, Z. 2014: Serum HER2 ECD level and its clinical significance in advanced breast cancer patients with different molecular subtypes. Zhonghua Yi Xue Za Zhi 94(18): 1384-1387

Baskić, D.; Ristić, P.; Pavlović, S.; Arsenijević, N. 2004: Serum HER2 and CA 15-3 in breast cancer patients. Journal of BUON: Official Journal of the Balkan Union of Oncology 9(3): 289-294

Kong, S.-Y.; Lee, D.H.; Lee, E.S.; Park, S.; Lee, K.S.; Ro, J. 2006: Serum HER2 as a response indicator to various chemotherapeutic agents in tissue HER2 positive metastatic breast cancer. Cancer Research and Treatment 38(1): 35-39

Peng, Z.; Liu, Y.; Li, Y.; Zhang, X.; Zhou, J.; Lu, M.; Li, Q.; Shen, L. 2014: Serum HER2 extracellular domain as a potential alternative for tissue HER2 status in metastatic gastric cancer patients. Biomarkers in Medicine 8(5): 663-670

Domingo-Domenech, J.; Fernandez, P.L.; Filella, X.; Martinez-Fernandez, A.; Molina, R.; Fernandez, E.; Alcaraz, A.; Codony, J.; Gascon, P.; Mellado, B. 2008: Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel. Annals of Oncology: Official Journal of the European Society for Medical Oncology 19(2): 269-275

Tan, L.-D.; Xu, Y.-Y.; Yu, Y.; Li, X.-Q.; Chen, Y.; Feng, Y.-M. 2011: Serum HER2 level measured by dot blot: a valid and inexpensive assay for monitoring breast cancer progression. Plos one 6(4): E18764

Sasaki, T.; Fuse, N.; Kuwata, T.; Nomura, S.; Kaneko, K.; Doi, T.; Yoshino, T.; Asano, H.; Ochiai, A.; Komatsu, Y.; Sakamoto, N.; Ohtsu, A. 2015: Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients. Japanese Journal of Clinical Oncology 45(1): 43-48

Di Gioia, D.; Dresse, M.; Mayr, D.; Nagel, D.; Heinemann, V.; Kahlert, S.; Stieber, P. 2014: Serum HER2 supports HER2-testing in tissue at the time of primary diagnosis of breast cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry 430: 86-91

Leyland-Jones, B.; Smith, B.R. 2011: Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls. LANCET. Oncology 12(3): 286-295

Badzek, S.; Kelovic, V.L.; Plestina, S.; Humar, I.; Veir, Z.; Mihaljevic, Z. 2011: Serum HER2/ECD value in stage i and Ii early breast cancer: need of a lower cut-off?. Wiener Klinische Wochenschrift 123(23-24): 726-731

Jia, Z.-z.; Jiang, G.-m.; Feng, Y.-l. 2011: Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer. Chinese Medical Sciences Journal 26(3): 158-162

Arathoon, E.G.; Mejía, C.R.; Y Martín, R.M.; Hernández, J.E.; Turner, G.J.; Kitchen, L.W. 1994: Serum HIV-1 p24 levels and body weight measurements before and after 4 weeks of diethylcarbamazine treatment given to HIV-1 seropositive persons. International Journal of Antimicrobial Agents 3(4): 275-278

Oztekin, O.; Fenkci, S.M.; Fenkci, V.; Enli, Y.; Cabus, U. 2015: Serum HLA-G levels in women with polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(3): 243-246

Tabata, C.; Kanemura, S.; Tabata, R.; Masachika, E.; Shibata, E.; Otsuki, T.-I.; Nishizaki, T.; Nakano, T. 2013: Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma. Journal of Clinical Gastroenterology 47(8): 684-688

Wibisono, D.; Csernok, E.; Lamprecht, P.; Holle, J.U.; Gross, W.L.; Moosig, F. 2010: Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitis. Annals of the Rheumatic Diseases 69(10): 1888-1889

Miyazaki, T.; Kirino, Y.; Takeno, M.; Hama, M.; Ushihama, A.; Watanabe, R.; Takase, K.; Tachibana, T.; Matsumoto, K.; Tanaka, M.; Yamaji, S.; Ideguchi, H.; Tomita, N.; Fujita, H.; Ohno, S.; Ueda, A.; Ishigatsubo, Y. 2010: Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions. International Journal of Hematology 91(2): 229-237

Marquez, E.; Sadowski, E.; Reese, S.; Vidyasagar, A.; Artz, N.; Fain, S.; Jacobson, L.; Swain, W.; Djamali, A. 2012: Serum HSP27 is associated with medullary perfusion in kidney allografts. Journal of Nephrology 25(6): 1075-1080

Dutta, S.K.; Girotra, M.; Singla, M.; Dutta, A.; Otis Stephen, F.; Nair, P.P.; Merchant, N.B. 2012: Serum HSP70: a novel biomarker for early detection of pancreatic cancer. Pancreas 41(4): 530-534

Okonko, I.O.; Cookey, T.I.; Okerentugba, P.O.; Frank-Peterside, N. 2015: Serum HSV-1 and -2 IgM in pregnant women in Port Harcourt, Nigeria. Journal of Immunoassay and Immunochemistry 36(4): 343-358

Tada, D.G.; Khandelwal, N. 2012: Serum HSV-1 and 2 IgM in Sexually Transmitted Diseases - more for Screening Less for Diagnosis: An Evaluation of Clinical Manifestation. Journal of Global Infectious Diseases 4(3): S1-S4

Mwangi, D.W.; Mukuria, J.C.; Noguchi, A. 1998: Serum Hanganutziu and Deicher (HD) antibody and total sialic acid levels in hepatoma patients. African Journal of Health Sciences 5(1-2): 108-112

Gao, H.; Meng, J.; Xu, M.; Zhang, S.; Ghose, B.; Liu, J.; Yao, P.; Yan, H.; Wang, D.; Liu, L. 2013: Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population. Plos one 8(6): E67727

Shiota, S.; Matsunari, O.; Watada, M.; Yamaoka, Y. 2010: Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiology 5(12): 1885-1893

Zhao, Z.; Li, Y.; Liu, S.; Fu, W. 2014: Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(12): 12217-12224

Shiota, S.; Murakami, K.; Okimoto, T.; Kodama, M.; Yamaoka, Y. 2014: Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. Journal of Gastroenterology and Hepatology 29(1): 67-73

Lee, J.W.; Park, H.J.; Park, N.C. 2013: Serum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients with Erectile Dysfunction and Diabetes. Korean Journal of Urology 54(12): 858-864

Song, J.H.; Park, M.H.; Han, C.; Jo, S.A.; Ahn, K. 2010: Serum Homocysteine and Folate Levels are Associated with Late-life Dementia in a Korean Population. Osong Public Health and Research Perspectives 1(1): 17-22

Ray, L.; Khemka, V.K.; Behera, P.; Bandyopadhyay, K.; Pal, S.; Pal, K.; Basu, D.; Chakrabarti, S. 2013: Serum Homocysteine, Dehydroepiandrosterone Sulphate and Lipoprotein (a) in Alzheimer's Disease and Vascular Dementia. Aging and Disease 4(2): 57-64

Kabaca, C.; Dolgun, Z.Nihal.; Telci, Aşegül.; Karateke, Aş. 2014: Serum Human Epididymis Protein 4 (HE4) in the Differential Diagnosis of Peritoneal Tuberculosis: A Report of Two Cases. Balkan Medical Journal 31(3): 270-271

Wu, Q.; Yang, Q.; Sun, H.; Li, M.; Zhang, Y.; La Cava, A. 2013: Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients. Autoimmunity 46(1): 40-43

Courtland, H.-W.; Elis, S.; Wu, Y.; Sun, H.; Rosen, C.J.; Jepsen, K.J.; Yakar, S. 2011: Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner. Plos one 6(3): E14762

Yüksel, B.; Özbek, M.Nuri.; Mungan, N.Önenli.; Darendeliler, F.; Budan, B.; Bideci, A.; Çetinkaya, Eün.; Berberoğlu, M.; Evliyaoğlu, O.; Yeşilkaya, E.; Arslanoğlu, İlknur.; Darcan, Şükran.; Bundak, R.; Ercan, O. 2011: Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age. Journal of clinical research in pediatric endocrinology 3(2): 84-88

Teas, J.; Irhimeh, M.R.; Druker, S.; Hurley, T.G.; Hébert, J.R.; Savarese, T.M.; Kurzer, M.S. 2011: Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women. Nutrition and cancer 63(5): 743-748

Zgaljardic, D.J.; Guttikonda, S.; Grady, J.J.; Gilkison, C.R.; Mossberg, K.A.; High, W.M.; Masel, B.E.; Urban, R.J. 2011: Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing. Clinical Endocrinology 74(3): 365-369

Yakar, S.; Canalis, E.; Sun, H.; Mejia, W.; Kawashima, Y.; Nasser, P.; Courtland, H.-W.; Williams, V.; Bouxsein, M.; Rosen, C.; Jepsen, K.J. 2009: Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 24(8): 1481-1492

Subbarayan, S.K.; Fleseriu, M.; Gordon, M.B.; Brzana, J.A.; Kennedy, L.; Faiman, C.; Hatipoglu, B.A.; Prayson, R.A.; Delashaw, J.B.; Weil, R.J.; Hamrahian, A.H. 2012: Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 18(6): 817-825

Jain, S.; Jain, S.; Deoskar, A.; Prasad, V.S.S. 2013: Serum IGF-1 levels as a clinical tool for optimizing orthodontic treatment timing. Progress in Orthodontics 14: 46

Aksu, I.; Baykara, B.; Kiray, M.; Gurpinar, T.; Sisman, A.R.; Ekerbicer, N.; Tas, A.; Gokdemir-Yazar, O.; Uysal, N. 2013: Serum IGF-1 levels correlate negatively to liver damage in diabetic rats. Biotechnic and Histochemistry: Official Publication of the Biological Stain Commission 88(3-4): 194-201

Rehem, R.N.A.M.A.; El-Shikh, W.M.H.M. 2011: Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma. Hepato-Gastroenterology 58: 107-108

Dinleyici, E.C.; Kilic, Z.; Buyukkaragoz, B.; Ucar, B.; Alatas, O.; Aydogdu, S.D.; Dogruel, N. 2007: Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Neuro Endocrinology Letters 28(3): 279-283

Chaler, E.A.; Meazza, C.; Guercio, G.; Maceiras, M.; Rivarola, M.A.; Laarej, K.; Pagani, S.; Areny, G.; Albertini, R.; Llinares, V.; Belgorosky, A.; Bozzola, M. 2009: Serum IGF-I and IGFBP-3 reference values from a chemiluminescent assay in normal children and adolescents of hispanic and italian origin: presence of sexual dimorphism in IGF-I values. Journal of Pediatric Endocrinology and Metabolism: Jpem 22(12): 1127-1135

Zebrowska, A.; Gąsior, Z.; Langfort, J.óz. 2009: Serum IGF-i and hormonal responses to incremental exercise in athletes with and without left ventricular hypertrophy. Journal of Sports Science and Medicine 8(1): 67-76

Åberg, D.; Jood, K.; Blomstrand, C.; Jern, C.; Nilsson, M.; Isgaard, J.ör.; Aberg, N.D. 2011: Serum IGF-i levels correlate to improvement of functional outcome after ischemic stroke. Journal of Clinical Endocrinology and Metabolism 96(7): E1055-E1064

Brooke, A.M.; Drake, W.M. 2007: Serum IGF-i levels in the diagnosis and monitoring of acromegaly. Pituitary 10(2): 173-179

Granada, M.L.; Ulied, A.; Casanueva, F.F.; Pico, A.; Lucas, T.; Torres, E.; Sanmartí, A. 2008: Serum IGF-i measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Clinical Endocrinology 68(6): 942-950

Douglas, J.B.; Silverman, D.T.; Pollak, M.N.; Tao, Y.; Soliman, A.S.; Stolzenberg-Solomon, R.Z. 2010: Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 19(9): 2298-2306

Gallego, R.; Codony-Servat, J.; García-Albéniz, X.; Carcereny, E.; Longarón, R.; Oliveras, A.; Tosca, M.ón.; Augé, J.M.; Gascón, P.; Maurel, J. 2009: Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer. Endocrine-Related Cancer 16(1): 311-317

Matheny, R.W.; Matheny, W.; Merritt, E.; Zannikos, S.V.; Farrar, R.P.; Adamo, M.L. 2009: Serum IGF-I-deficiency does not prevent compensatory skeletal muscle hypertrophy in resistance exercise. Experimental Biology and Medicine 234(2): 164-170

Aleem, E.; Elshayeb, A.; Elhabachi, N.; Mansour, A.R.; Gowily, A.; Hela, A. 2012: Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncology Letters 3(3): 704-712

Kendrick, Z.W.; Firpo, M.A.; Repko, R.C.; Scaife, C.L.; Adler, D.G.; Boucher, K.M.; Mulvihill, S.J. 2014: Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 16(7): 670-676

Bien, E.; Krawczyk, M.; Izycka-Swieszewska, E.; Trzonkowski, P.; Kazanowska, B.; Adamkiewicz-Drozynska, E.; Balcerska, A. 2013: Serum IL-10 and IL-12 levels reflect the response to chemotherapy but are influenced by G-CSF therapy and sepsis in children with soft tissue sarcomas. Postepy Higieny i Medycyny Doswiadczalnej 67: 517-528

Zaringhalam, J.; Hormozi, A.; Tekieh, E.; Razavi, J.; Khanmohammad, R.; Golabi, S. 2014: Serum IL-10 involved in morphine tolerance development during adjuvant-induced arthritis. Journal of Physiology and Biochemistry 70(2): 497-507

Suárez-Álvarez, K.; Solís-Lozano, L.; Leon-Cabrera, S.; González-Chávez, A.; Gómez-Hernández, G.; Quiñones-Álvarez, M.S.; Serralde-Zúñiga, A.E.; Hernández-Ruiz, J.; Ramírez-Velásquez, J.; Galindo-González, F.J.; Zavala-Castillo, J.C.; De León-Nava, M.A.; Robles-Díaz, G.; Escobedo, G. 2013: Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters. Mediators of Inflammation 2013: 967067

Wan, Q.-H.; Wang, J.-L.; He, L.-F.; Liu, H.; Zhang, X. 2006: Serum IL-12 level in mice infected with Trichinella spiralis. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 24(6): 475-476

Nogueira, E.; Hamour, S.; Sawant, D.; Henderson, S.; Mansfield, N.; Chavele, K.-M.; Pusey, C.D.; Salama, A.D. 2010: Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(7): 2209-2217

Pan, H-F.; Zhang, N.; Ye, D-Q.; Li, X-P. 2010: Serum IL-17 level in systemic lupus erythematosus patients. Journal of Internal Medicine 267(4): 438; Author Reply 439

Ciprandi, G.; Fenoglio, D.; De Amici, M.; Quaglini, S.; Negrini, S.; Filaci, G. 2008: Serum IL-17 levels in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology 122(3): 650

Wendling, D.; Cedoz, J.-P.; Racadot, E.; Dumoulin, G. 2007: Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 74(3): 304-305

Roohi, A.; Tabrizi, M.; Abbasi, F.; Ataie-Jafari, A.; Nikbin, B.; Larijani, B.; Qorbani, M.; Meysamie, A.; Asgarian-Omran, H.; Nikmanesh, B.; Bajouri, A.; Shafiey, N.; Maleki, A. 2014: Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls. Biomed Research International 2014: 718946

Ohman, L.; Dahlén, R.; Isaksson, S.; Sjöling, A.; Wick, M.-J.; Sjövall, H.; Van Oudenhove, L.; Simrén, M.; Strid, H. 2013: Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease. Inflammatory Bowel Diseases 19(11): 2433-2439

Bushnell, S.E.; Zhao, Z.; Stebbins, C.C.; Cadavid, D.; Buko, A.M.; Whalley, E.T.; Davis, J.A.; Versage, E.M.; Richert, J.R.; Axtell, R.C.; Steinman, L.; Medori, R. 2012: Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS. Neurology 79(6): 531-537

Akbarzadeh, M.; Eftekhari, M.H.; Dabbaghmanesh, M.H.; Hasanzadeh, J.; Bakhshayeshkaram, M. 2013: Serum IL-18 and hsCRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes. Iranian Journal of Immunology: Iji 10(3): 167-176

Takahara, T.; Shimizu, M.; Nakagishi, Y.; Kinjo, N.; Yachie, A. 2015: Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease. Rheumatology International 35(1): 81-84

Shi, B.; Ni, Z.; Cao, L.; Zhou, M.; Mou, S.; Wang, Q.; Zhang, M.; Fang, W.; Yan, Y.; Qian, J. 2012: Serum IL-18 is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA nephropathy. Mediators of Inflammation 2012: 728417

Leng, J.-H.; Yao, H.-P.; Shen, J.-Y.; Wang, K.-Y.; Wang, Z.-W.; Zhuo, G.-C. 2011: Serum IL-18 levels in mice with collagen-induced arthritis treated by recombinant adenovirus containing mIL-18BP and mIL-4 fusion gene. Zhejiang da Xue Xue Bao. Yi Xue Ban 40(2): 195-199

Eklund, K.K.; Leirisalo-Repo, M.; Ranta, P.; Mäki, T.; Kautiainen, H.; Hannonen, P.; Korpela, M.; Hakala, M.; Järvinen, P.; Möttönen, T. 2007: Serum IL-1beta levels are associated with the presence of erosions in recent onset rheumatoid arthritis. Clinical and Experimental Rheumatology 25(5): 684-689

Kurt, A.N.C.; Aygun, A.D.; Godekmerdan, A.; Kurt, A.; Dogan, Y.; Yilmaz, E. 2007: Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediators of Inflammation 2007: 31397

Chen, H.-M.; Liu, H.-L.; Yang, Y.-C.; Cheng, X.-L.; Wang, Y.-F.; Xing, F.-F.; Zhao, Y.-R. 2014: Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure. Experimental and Therapeutic Medicine 7(4): 1013-1019

Lo, Y.-H.; Torii, K.; Saito, C.; Furuhashi, T.; Maeda, A.; Morita, A. 2010: Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy. Journal of Dermatological Science 58(3): 225-227

Ciprandi, G.; Cuppari, C.; Salpietro, A.; Tosca, M.; Grasso, L.; Rigoli, L.; La Rosa, M.; Marseglia, G.L.; Miraglia Del Giudice, M.; Salpietro, C. 2012: Serum IL-23 in asthmatic children. Journal of Biological Regulators and Homeostatic Agents 26(1 Suppl): S53-S61

Ciprandi, G.; Cuppari, C.; Salpietro, A.M.; Tosca, M.A.; Rigoli, L.; Grasso, L.; La Rosa, M.; Marseglia, G.L.; Del Giudice, M.M.; Salpietro, C. 2012: Serum IL-23 strongly and inversely correlates with FEV1 in asthmatic children. International Archives of Allergy and Immunology 159(2): 183-186

Ciprandi, G.; Cuppari, C.; Salpietro, C. 2012: Serum IL-23: a surrogate biomarker for asthma?. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 42(9): 1416-7; author reply 1418

Hartmann, K.; Wagner, N.; Rabenhorst, A.; Pflanz, L.; Leja, S.; Förster, A.; Gehring, M.; Kapp, A.; Raap, U. 2013: Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients. Journal of Allergy and Clinical Immunology 132(1): 232-235

Ohmatsu, H.; Sugaya, M.; Suga, H.; Morimura, S.; Miyagaki, T.; Kai, H.; Kagami, S.; Fujita, H.; Asano, Y.; Tada, Y.; Kadono, T.; Sato, S. 2012: Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma. Acta Dermato-Venereologica 92(3): 282-283

Hu, L.-A.; Fu, Y.; Zhang, D.-N.; Zhang, J. 2013: Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer. Asian Pacific Journal of Cancer Prevention: Apjcp 14(4): 2563-2566

Koca, S.S.; Kara, M.; Deniz, F.; Ozgen, M.; Demir, C.F.; Ilhan, N.; Isik, A. 2015: Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease. Rheumatology International 35(3): 471-477

Hamzaoui, K.; Kaabachi, W.; Fazaa, B.; Zakraoui, L.; Mili-Boussen, I.; Haj-Sassi, F. 2013: Serum IL-33 levels and skin mRNA expression in Behçet's disease. Clinical and Experimental Rheumatology 31(3 Suppl 77: 6-14

Wang, J.; Cai, Y.; Ji, H.; Feng, J.; Ayana, D.A.; Niu, J.; Jiang, Y. 2012: Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 32(6): 248-253

Wang, J.; Zhao, P.; Guo, H.; Sun, X.; Jiang, Z.; Xu, L.; Feng, J.; Niu, J.; Jiang, Y. 2012: Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators of Inflammation 2012: 819636

Yanaba, K.; Yoshizaki, A.; Asano, Y.; Kadono, T.; Sato, S. 2011: Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clinical Rheumatology 30(6): 825-830

Ciprandi, G.; De Amici, M.; Murdaca, G.; Colombo, B.M.; Quaglini, S.; Marseglia, G.; Di Gioacchino, M. 2008: Serum IL-4 as a marker of immunological response to sublingual immunotherapy. Journal of Biological Regulators and Homeostatic Agents 22(2): 117-123

Sarangi, A.; Mohapatra, P.C.; Dalai, R.K.; Sarangi, A.K. 2014: Serum IL-4, IL-12 and TNF-alpha in malaria: a comparative study associating cytokine responses with severity of disease from the Coastal Districts of Odisha. Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology 38(2): 143-147

De Saint-Hubert, M.; Jamart, J.; Morrhaye, G.; Martens, H.J.; Geenen, V.; Duy Vo, T.K.; Toussaint, O.; Swine, C. 2011: Serum IL-6 and IGF-1 improve clinical prediction of functional decline after hospitalization in older patients. Aging Clinical and Experimental Research 23(2): 106-111

El-Faramawy, A.A.M.; El-Shazly, L.B.E.; Abbass, A.A.; Ismail, H.A.B. 2011: Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 32(1): 50-55

Paradkar, P.H.; Agashe, S.V.; Joshi, J.V.; Jagtap, S.S.; Affandi, M.Z.; Vaidya, R.A. 2010: Serum IL-6 and micrometry of pap smears in women with cervical low-grade intraepithelial lesions. Asian Pacific Journal of Cancer Prevention: Apjcp 11(4): 989-992

Demir, B.; Guven, S.; Guven, E.Seda.Guvendag.; Atamer, Y.; Gul, T. 2009: Serum IL-6 level may have role in the pathophysiology of unexplained infertility. American Journal of Reproductive Immunology 62(4): 261-267

Nakagawa, H.; Maeda, S.; Yoshida, H.; Tateishi, R.; Masuzaki, R.; Ohki, T.; Hayakawa, Y.; Kinoshita, H.; Yamakado, M.; Kato, N.; Shiina, S.; Omata, M. 2009: Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. International Journal of Cancer 125(10): 2264-2269

Lai, S.; Fishman, E.K.; Lai, H.; Pannu, H.; Detrick, B. 2009: Serum IL-6 levels are associated with significant coronary stenosis in cardiovascularly asymptomatic inner-city black adults in the US. Inflammation Research: Official Journal of the European Histamine Research Society . 58(1): 15-21

Duletić-Nacinović, A.; Stifter, S.; Marijić, B.; Lucin, K.; Valković, T.; Petranović, D.; Jonjić, N. 2008: Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma. Tumori 94(4): 511-517

Açikalin, A.ça.; Gökel, Y.ük. 2011: Serum IL-6, TNFα levels in snakebite cases occurring in Southern Turkey. Emergency Medicine Journal: Emj 28(3): 208-211

Hung, K.-C.; Wu, C.-C.; Chen, H.-S.; Ma, W.-Y.; Tseng, C.-F.; Yang, L.-K.; Hsieh, H.-L.; Lu, K.-C. 2011: Serum IL-6, albumin and co-morbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 26(2): 658-664

Hergenroeder, G.W.; Moore, A.N.; McCoy, J.Philip.; Samsel, L.; Ward, N.H.; Clifton, G.L.; Dash, P.K. 2010: Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. Journal of Neuroinflammation 7: 19

Lehto, S.M.; Huotari, A.; Niskanen, L.; Herzig, K.-H.; Tolmunen, T.; Viinamäki, H.; Koivumaa-Honkanen, H.; Honkalampi, K.; Sinikallio, S.; Ruotsalainen, H.; Hintikka, J. 2010: Serum IL-7 and G-CSF in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34(6): 846-851

Rhodes, J.; Sharkey, J.; Andrews, P. 2009: Serum IL-8 and MCP-1 concentration do not identify patients with enlarging contusions after traumatic brain injury. Journal of Trauma 66(6): 1591-1597; Discussion 1598

Ciprandi, G. 2012: Serum IL-9 and lung function. Journal of Allergy and Clinical Immunology 130(3): 819; Author Reply 820

Ciprandi, G.; De Amici, M.; Marseglia, G.L. 2011: Serum IL-9 levels and sublingual immunotherapy: preliminary report. Journal of biological regulators and homeostatic agents 25(2): 295-297

Ciprandi, G.; De Amici, M.; Castellazzi, A.M.; Tosca, M.A.; Marseglia, G. 2011: Serum IL-9 levels depend on allergen exposure: preliminary study. International Archives of Allergy and Immunology 154(3): 246-248

Ciprandi, G.; De Amici, M.; Legoratto, S.; Giunta, V.; Vignini, M.; Borroni, G. 2012: Serum IL-9 levels in patients with spontaneous urticaria: a preliminary study. Journal of Investigational Allergology and Clinical Immunology 22(3): 232-234

Alhamarneh, O.; Agada, F.; Madden, L.; Stafford, N.; Greenman, J. 2011: Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head and Neck 33(3): 415-423

Green, V.L.; Irune, E.; Prasai, A.; Alhamarneh, O.; Greenman, J.; Stafford, N.D. 2012: Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients. International Journal of Oncology 40(3): 833-839

You, C.R.; Park, S.-H.; Jeong, S.W.; Woo, H.Y.; Bae, S.H.; Choi, J.Y.; Sung, Y.C.; Yoon, S.K. 2011: Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV. Gut and Liver 5(4): 506-512

Quint, J.K.; Donaldson, G.C.; Goldring, J.J.P.; Baghai-Ravary, R.; Hurst, J.R.; Wedzicha, J.A. 2010: Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. Chest 137(4): 812-822

Li, Y.-N.; Guo, J.-P.; He, J.; Liu, X.; Yin, F.-R.; Ding, Y.; Yao, H.-H.; Kang, A.-J.; Li, Z.-G. 2011: Serum IgA against type 3 muscarinic acetylcholine receptor is a novel marker in diagnosis of Sjögren's syndrome. Chinese Medical Journal 124(16): 2490-2495

Skare, T.L.; Mantovani, A.P.F.ça.; Monclaro, M.P. 2010: Serum IgA deficiency in systemic lupus erythematosus. Acta Reumatologica Portuguesa 35(2): 273-274

Kato, A.; Imai, Y.; Aoki, K.; Tabata, S.; Matsushita, A.; Hashimoto, H.; Takahashi, T.; Ishikawa, T. 2014: Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. Annals of Hematology 93(7): 1185-1191

Cho, S.B.; Zheng, Z.; Ahn, K.J.; Choi, M.J.; Cho, S.; Kim, D.-Y.; Lee, H.S.; Bang, D. 2013: Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2/B1 in patients with Behçet disease. British Journal of Dermatology 168(5): 977-983

Hendrikx, L.H.; Öztürk, K.; de Rond, L.G.H.; de Greeff, S.C.; Sanders, E.A.M.; Berbers, G.A.M.; Buisman, A.-M. 2011: Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics. Plos one 6(11): E27681

Le Loët, X.; Brazier, M.; Mejjad, O.; Boumier, P.; Daragon, A.; Gayet, A.; Pouplin, S.; Tron, F.ço.; Zarnitsky, C.; Vittecoq, O.; Menard, J.-F.ço.; Fardellone, P. 2010: Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort. Arthritis Care and Research 62(12): 1739-1747

McAllister, S.C.; Shedd, D.; Mueller, N.E.; Chang, E.T.; Miller, G.; Bhaduri-McIntosh, S. 2014: Serum IgA to Epstein-Barr virus early antigen-diffuse identifies Hodgkin's lymphoma. Journal of Medical Virology 86(9): 1621-1628

Ye, Z.-c.; Wang, C.; Tang, Y.; Liu, X.; Peng, H.; Zhang, H.; Lou, T.-q. 2009: Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 32(1): E20-E27

Meng, Y.-N.; Rao, H.-P.; Chen, Y.-P.; Duan, X.-J. 2008: Serum IgE and eosinophil cationic protein levels in children with cough variant asthma. Zhongguo Dang Dai Er Ke Za Zhi 10(3): 399-400

Soufras, G.D.; Kounis, G.N.; Kounis, N.G. 2013: Serum IgE antibody concentrations and the risk of Kounis syndrome. International Journal of Cardiology 168(2): 1705-1706

Ciprandi, G.; DeAmici, M. 2014: Serum IgE assessment in prescribing allergen immunotherapy. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 112(2): 184

Greer, A.M.; Wu, N.; Putnam, A.L.; Woodruff, P.G.; Wolters, P.; Kinet, J.-P.; Shin, J.-S. 2014: Serum IgE clearance is facilitated by human FcεRi internalization. Journal of Clinical Investigation 124(3): 1187-1198

Alesina, R.; De Amici, M.; Ciprandi, G. 2014: Serum IgE discriminates allergy from sensitisation better than skin testing. Allergologia et Immunopathologia 42(2): 171-173

Erwin, E.A.; James, H.R.; Gutekunst, H.M.; Russo, J.M.; Kelleher, K.J.; Platts-Mills, T.A.E. 2010: Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 104(6): 496-502

Dottorini, T.; Sole, G.; Nunziangeli, L.; Baldracchini, F.; Senin, N.; Mazzoleni, G.; Proietti, C.; Balaci, L.; Crisanti, A. 2011: Serum IgE reactivity profiling in an asthma affected cohort. Plos one 6(8): E22319

Lucendo, A.J.; Arias, A.; Tenías, J.M.; Rodriguez-Sanchez, J.; Gomez-Torrijos, E.; Feo-Brito, F.; Molina-Infante, J. 2014: Serum IgE-targeted elimination diets for treating eosinophilic esophagitis: things are not what they seem. Allergy 69(11): 1567-1568

Ramoner, R.; Rahm, A.; Falkensammer, C.E.; Leonhartsberger, N.; Thurnher, M. 2010: Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma. Cancer Immunology Immunotherapy: Cii 59(8): 1141-1147

Masdeu, J.C.; González-Pinto, A.; Matute, C.; Ruiz De Azúa, S.; Palomino, A.; De Leon, J.; Berman, K.F.; Dalmau, J. 2012: Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. American Journal of Psychiatry 169(10): 1120-1121

Halvorsen, E.H.; Haavardsholm, E.A.; Pollmann, S.; Boonen, A.; van der Heijde, D.; Kvien, T.K.; Molberg, Ø 2009: Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Annals of the Rheumatic Diseases 68(2): 249-252

Van Doorn, P.A.; Kuitwaard, K.; Jacobs, B.C. 2011: Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP. Journal of the Peripheral Nervous System: Jpns 16(Suppl 1): 38-40

Terao, C.; Ohmura, K.; Yamamoto, K.; Yukawa, N.; Kawabata, D.; Nojima, T.; Fujii, T.; Mimori, T. 2012: Serum IgG levels demonstrate seasonal change in connective tissue diseases: a large-scale, 4-year analysis in Japanese. Modern Rheumatology 22(3): 426-430

Zéphir, H.; Lefranc, D.; Dubucquoi, S.; de Seze, J.; Boron, L.; Prin, L.; Vermersch, P. 2009: Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis. Multiple Sclerosis 15(5): 593-600

Orouji, S.; Hodgins, D.C.; Lo, R.Y.C.; Shewen, P.E. 2012: Serum IgG response in calves to the putative pneumonic virulence factor Gs60 of Mannheimia haemolytica A1. Canadian Journal of Veterinary Research 76(4): 292-300

Ajjampur, S.S.R.; Sarkar, R.; Allison, G.; Banda, K.; Kane, A.; Muliyil, J.; Naumova, E.; Ward, H.; Kang, G. 2011: Serum IgG response to Cryptosporidium immunodominant antigen gp15 and polymorphic antigen gp40 in children with cryptosporidiosis in South India. Clinical and Vaccine Immunology: Cvi 18(4): 633-639

Du, C.; Wingard, J.R.; Cheng, S.; Nguyen, M.H.; Clancy, C.J. 2012: Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(12): 1927-1934

Sarkar, R.; Ajjampur, S.S.R.; Muliyil, J.; Ward, H.; Naumova, E.N.; Kang, G. 2012: Serum IgG responses and seroconversion patterns to Cryptosporidium gp15 among children in a birth cohort in south India. Clinical and Vaccine Immunology: Cvi 19(6): 849-854

Pedersen, G.K.; Höschler, K.; Øie Solbak, S.M.; Bredholt, G.; Pathirana, R.D.; Afsar, A.; Breakwell, L.; Nøstbakken, J.K.; Raae, A.J.; Brokstad, K.A.; Sjursen, H.; Zambon, M.; Cox, R.J. 2014: Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. Vaccine 32(35): 4550-4557

Tabata, T.; Kamisawa, T.; Takuma, K.; Anjiki, H.; Egawa, N.; Kurata, M.; Honda, G.; Tsuruta, K.; Setoguchi, K.; Obayashi, T.; Sasaki, T. 2009: Serum IgG4 concentrations and IgG4-related sclerosing disease. Clinica Chimica Acta; International Journal of Clinical Chemistry 408(1-2): 25-28

Frulloni, L.; Lunardi, C. 2011: Serum IgG4 in autoimmune pancreatitis: a marker of disease severity and recurrence?. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 43(9): 674-675

Kamisawa, T.; Imai, M.; Egawa, N.; Tsuruta, K.; Okamoto, A. 2008: Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis. European Journal of Gastroenterology and Hepatology 20(12): 1167-1170

Kamisawa, T.; Takuma, K.; Tabata, T.; Inaba, Y.; Egawa, N.; Tsuruta, K.; Hishima, T.; Sasaki, T.; Itoi, T. 2011: Serum IgG4-negative autoimmune pancreatitis. Journal of Gastroenterology 46(1): 108-116

Simell, B.; Nurkka, A.; Ekström, N.; Givon-Lavi, N.; Käyhty, H.; Dagan, R. 2012: Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine. Clinical and Vaccine Immunology: Cvi 19(10): 1618-1623

Bozkirli, E.; Bakiner, O.S.; Ersozlu Bozkirli, E.D.; Eksi Haydardedeoglu, F.; Sizmaz, S.; Torun, A.I.; Ertorer, M.E. 2015: Serum Immunoglobulin G4 levels are elevated in patients with Graves' ophthalmopathy. Clinical Endocrinology 83(6): 962-967

Sira, M.M.; Behairy, B.E.; Abd-Elaziz, A.M.; Abd Elnaby, S.A.; Eltahan, E.E. 2014: Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia. Hepatitis Research and Treatment 2014: 307942

Pijuan-Galitó, S.; Tamm, C.; Annerén, C. 2014: Serum Inter-α-inhibitor activates the Yes tyrosine kinase and YAP/TEAD transcriptional complex in mouse embryonic stem cells. Journal of Biological Chemistry 289(48): 33492-33502

Attia, E.A.S.; El Shennawy, D.; Sefin, A. 2010: Serum Interleukin-4 and Total Immunoglobulin e in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing. Dermatology Research and Practice 2010: 503587

Sugiyama, E.; Kuroda, A.; Hori, F.; Hori, T.; Taki, H.; Arai, N.; Kobayashi, M. 1995: Serum Interleukin-6 Level is a Sensitive Parameter of Disease Activity in Rheumatoid Arthritis. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 1(2): 93-98

Abdolsamadi, H.R.; Vahedi, M.; Esmaeili, F.; Nazari, S.; Abdollahzadeh, S. 2008: Serum Interleukin-6 as a Serologic Marker of Chronic Periapical Lesions: a Case-control Study. Journal of Dental Research Dental Clinics Dental Prospects 2(2): 43-47

Sasaki, Y.; Takeda, H.; Sato, T.; Orii, T.; Nishise, S.; Nagino, K.; Iwano, D.; Yaoita, T.; Yoshizawa, K.; Saito, H.; Tanaka, Y.; Kawata, S. 2012: Serum Interleukin-6, insulin, and HOMA-IR in male individuals with colorectal adenoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(2): 392-399

Anonymous 1949: Serum Jaundice. British Medical Journal 2(4630): 748-750

Nishida, S.; Fukazawa, R.; Imai, T.; Takeda, S.; Hayakawa, J.; Takeuchi, H.; Shimizu, K.; Kawakami, Y.; Takase, M. 2011: Serum KL-6 and surfactant protein D in children with 2009 pandemic H1N1 influenza infection. Pediatrics International: Official Journal of the Japan Pediatric Society 53(6): 910-914

Ohshimo, S.; Bonella, F.; Grammann, N.; Starke, K.; Cui, A.; Bauer, P.C.; Teschler, H.; Kohno, N.; Guzman, J.; Costabel, U. 2009: Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 26(1): 47-53

Doan, M.L.; Elidemir, O.; Dishop, M.K.; Zhang, H.; Smith, E.O.; Black, P.G.; Deterding, R.R.; Roberts, D.M.; Al-Salmi, Q.A.; Fan, L.L. 2009: Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Thorax 64(8): 677-681

Sakamoto, K.; Taniguchi, H.; Kondoh, Y.; Johkoh, T.; Sumikawa, H.; Kimura, T.; Nishiyama, O.; Kato, K.; Kataoka, K.; Ono, K.; Kitaichi, M.; Hasegawa, Y. 2010: Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parameters. Respiratory Medicine 104(1): 127-133

Haberman, B.; Doan, M.L.; Smith, E.O.'B.; Schecter, M.G.; Mallory, G.B.; Elidemir, O. 2010: Serum KL-6 level and the development of bronchiolitis obliterans syndrome in lung transplant recipients. Pediatric Transplantation 14(7): 903-908

Doishita, S.; Inokuma, S.; Asashima, H.; Nakachi, S.; Matsuo, Y.; Rokutanda, R.; Kobayashi, S.; Hagiwara, K.; Satoh, T.; Akiyama, O. 2011: Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases. Internal Medicine 50(23): 2889-2892

Kikuchi, N.; Ishii, Y.; Ohtsuka, M. 2007: Serum KL-6 levels and acute lung inflammation. Internal Medicine 46(6): 335; Author Reply 337

Kawasaki, Y.; Aoyagi, Y.; Abe, Y.; Go, H.; Imamura, T.; Kaneko, M.; Ito, M.; Katayose, M.; Hashimoto, K.; Hosoya, M. 2009: Serum KL-6 levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Journal of Medical Virology 81(12): 2104-2108

Miyazaki, K.; Kurishima, K.; Kagohashi, K.; Kawaguchi, M.; Ishikawa, H.; Satoh, H.; Hizawa, N. 2010: Serum KL-6 levels in lung cancer patients with or without interstitial lung disease. Journal of Clinical Laboratory Analysis 24(5): 295-299

Oyama, T.; Kohno, N.; Oyama, H.; Okuda, Y.; Namba, S.; Takasugi, K. 2002: Serum KL-6: a useful marker for early detection of methotrexate-induced interstitial pneumonia. Modern Rheumatology 12(4): 366-367

Valtonen, P.; Laitinen, T.; Lyyra-Laitinen, T.; Raitakari, O.T.; Juonala, M.; Viikari, J.S.A.; Heiskanen, N.; Vanninen, E.; Punnonen, K.; Heinonen, S. 2008: Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circulation Journal: Official Journal of the Japanese Circulation Society 72(11): 1879-1884

Simone, R.; Pesce, G.; Antola, P.; Merlo, D.F.; Bagnasco, M.; Saverino, D. 2013: Serum LAIR-2 is increased in autoimmune thyroid diseases. Plos one 8(5): E63282

Fang, H.; Liu, A.; Dirsch, O.; Sun, J.; Jin, H.; Lu, M.; Yang, D.; Dahmen, U. 2012: Serum LBP levels reflect the impaired synthetic capacity of the remnant liver after partial hepatectomy in rats. Journal of Immunological Methods 382(1-2): 68-75

Spruit, M.A.; Pennings, H.J.; Does, J.D.; Möller, G.M.; Janssen, P.P.; Wouters, E.F.M. 2008: Serum LDH and exercise capacity in COPD. Thorax 63(5): 472

Akay, O.Meltem.; Aslan, V.; Gulbas, Z. 2012: Serum LDH elevation should not be necessarily attributed to disease activity in patients with thrombotic thrombocytopenic purpura. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 47(3): 373-374

Faruqi, S.; Wilmot, R.; Wright, C.; Morice, A.H. 2012: Serum LDH in chronic cough: a potential marker of airway inflammation. Clinical Respiratory Journal 6(2): 81-87

Cicero, A.F.G.; Rosticci, M.; Baronio, C.; Morbini, M.; Parini, A.; Grandi, E.; D'Addato, S.; Borghi, C. 2014: Serum LDL cholesterol levels and new onset of arterial hypertension: an 8-year follow-up. European Journal of Clinical Investigation 44(10): 926-932

Serati, A.R.; Roozbeh, J.; Sagheb, M.M. 2007: Serum LDL levels are a major prognostic factor for arteriovenous fistula thrombosis (AVFT) in hemodialysis patients. Journal of Vascular Access 8(2): 109-114

Dong, J.; Guo, H.; Yang, R.; Li, H.; Wang, S.; Zhang, J.; Chen, W. 2011: Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC. Journal of Lipid Research 52(2): 383-388

Liu, Y.-L.; Qian, H.-X.; Qin, L.; Zhou, X.-J.; Zhang, B. 2011: Serum LDL-C and LDL-C/HDL-C ratio are positively correlated to lymph node stages in males with colorectal cancer. Hepato-Gastroenterology 58(106): 383-387

Roth, M.Y.; Lin, K.; Amory, J.K.; Matsumoto, A.M.; Anawalt, B.D.; Snyder, C.N.; Kalhorn, T.F.; Bremner, W.J.; Page, S.T. 2010: Serum LH correlates highly with intratesticular steroid levels in normal men. Journal of Andrology 31(2): 138-145

Shahbazi, S.; Khademi, S.; Shafa, M.; Joybar, R.; Hadibarhaghtalab, M.; Sahmeddini, M.A. 2013: Serum Lactate Is not Correlated with Mixed or Central Venous Oxygen Saturation for Detecting Tissue Hypo Perfusion During Coronary Artery Bypass Graft Surgery: a Prospective Observational Study. International Cardiovascular Research Journal 7(4): 130-134

Abdul Wahab, A.; Maarafiya, M.M.; Soliman, A.; Younes, N.B.M.; Chandra, P. 2013: Serum Leptin and Adiponectin Levels in Obese and Nonobese Asthmatic School Children in relation to Asthma Control. Journal of Allergy 2013: 654104

Pouralibaba, F.; Babaloo, Z.; Pakdel, F.; Aghazadeh, M. 2013: Serum Level of Interleukin 17 in Patients with Erosive and Non erosive Oral Lichen Planus. Journal of Dental Research Dental Clinics Dental Prospects 7(2): 91-94

Teke, H.Üsküdar.; Başak, M.; Teke, D.; Kanbay, M. 2014: Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive Multiple Myeloma Diseases: A Case Report. Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology 31(1): 84-87

Samsami, D.A.; Razmjoei, P.; Parsanezhad, M.E. 2014: Serum Levels of Anti-histone and Anti-double-Strand DNA Antibodies Before and After Laparoscopic Ovarian Drilling in Women with Polycystic Ovarian Syndrome. Journal of Obstetrics and Gynaecology of India 64(1): 47-52

Yoshimura, R.; Kishi, T.; Hori, H.; Katsuki, A.; Sugita-Ikenouchi, A.; Umene-Nakano, W.; Atake, K.; Iwata, N.; Nakamura, J. 2014: Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs. Psychiatry Investigation 11(1): 84-88

Pileri, D.; Accardo-Palumbo, A.; D'Amelio, L.; D'Arpa, N.; Arnone, G.; Grisaffi, C.; Amico, M.; Brancato, R.; Lombardo, C.; Conte, F. 2009: Serum Levels of Cortisol, Immunoglobulin, and C-reactive Protein in Burn Patients. Annals of Burns and Fire Disasters 22(1): 3-5

Nimura, A.; Katsumata, N.; Tanaka, T. 2004: Serum Levels of Free Insulin-Like Growth Factor (IGF)-i in Normal Children. Clinical Pediatric Endocrinology: Case Reports and Clinical Investigations: Official Journal of the Japanese Society for Pediatric Endocrinology 13(1): 71-78

Thakkar, V.; Patel, P.; Prajapati, N.; Kaur, R.; Nandave, M. 2014: Serum Levels of Glycoproteins are Elevated in Patients with Ovarian Cancer. Indian Journal of Clinical Biochemistry: Ijcb 29(3): 345-350

Arababadi, M.K.; Pourfathollah, A.A.; Jafarzadeh, A.; Hassanshahi, G. 2010: Serum Levels of IL-10 and IL-17A in Occult HBV-Infected South-East Iranian Patients. Hepatitis Monthly 10(1): 31-35

Lee, J.S.; Shin, J.H.; Lee, J.O.; Lee, K.M.; Kim, J.H.; Choi, B.-S. 2010: Serum Levels of Interleukin-8 and Tumor Necrosis Factor-alpha in Coal Workers' Pneumoconiosis: One-year Follow-up Study. Safety and Health at Work 1(1): 69-79

Soleimani Rad, S.; Abbasalizadeh, S.; Ghorbani Haghjo, A.; Sadagheyani, M.; Montaseri, A.; Soleimani Rad, J. 2013: Serum Levels of Melatonin and Oxidative Stress Markers and Correlation between them in Infertile Men. Journal of Caring Sciences 2(4): 287-294

Eerola, A.; Jokinen, E.; Boldt, T.; Mattila, I.P.; Pihkala, J.I. 2010: Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta-A Prospective Study. International Journal of Pediatrics 2010: 674575

Gatson, J.W.; Liu, M.-M.; Rivera-Chavez, F.A.; Minei, J.P.; Wolf, S.E. 2015: Serum Levels of Neurofilament-H are Elevated in Patients Suffering from Severe Burns. Journal of Burn Care and Research: Official Publication of the American Burn Association 36(5): 545-550

Bucak, Y.Y.; Tosun, M.; Simavli, H.üs.; Önder, H.I.; Erdurmuş, M. 2016: Serum Levels of Omentin in Pseudoexfoliation Syndrome. Journal of Glaucoma 25(2): 145-148

Okulu, E.; Arsan, S.; Akin, I.M.; Ates, C.; Alan, S.; Kilic, A.; Atasay, B. 2015: Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis. Journal of Clinical Laboratory Analysis 29(5): 347-352

Kim, H.-J.; Park, J.-B.; Won, H.-Y.; Chang, H. 2007: Serum Levels of TGF-beta1, TIMP-1 and TIMP-2 in Patients with Lumbar Spinal Stenosis and Disc Herniation. Asian Spine Journal 1(1): 8-11

Hassanzadeh, M.; Faridhosseini, R.; Mahini, M.; Faridhosseini, F.; Ranjbar, A. 2006: Serum Levels of TNF-, IL-6, and Selenium in Patients with Acute and Chronic Coronary Artery Disease. Iranian Journal of Immunology: Iji 3(3): 142-145

Zhu, H.J.; Wang, X.Q.; Pan, H.; Gong, F.Y.; Zhang, D.X.; Li, N.S.; Wang, L.J.; Yang, H.B. 2014: Serum Levels of the Adipokine Zinc- α 2-glycoprotein Are Decreased in Patients with Hypertension. Isrn Endocrinology 2014: 374090

Mehrabi Bahar, M.; Saeed Modaghegh, M.-H.; Soltani, E. 2010: Serum Lipid Changes after Short Term SIPC Therapy for Lower Limb Lymphedema. Indian Journal of Surgery 72(4): 305-307

Nigam, P.K. 2011: Serum Lipid Profile: Fasting or Non-fasting?. Indian Journal of Clinical Biochemistry: Ijcb 26(1): 96-97

Cimen, F.; Yildirmak, S.T.; Ergen, A.; Cakmak, M.; Dogan, S.; Yenice, N.; Sezgin, F. 2012: Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease. Indian Journal of Dermatology 57(2): 97-101

Freeman, N.K.; Lindgren, F.T.; Ewing, A.M. 1964: Serum Lipid-Lipoprotein Interrelationships between Males and Females. Ucrl-11833. Ucrl Reports . U.S. Atomic Energy Commission 36: 134-144

Sultan, S.; Cameron, S.; Ahmad, S.; Malik, I.A.; Schultze, F.C.; Hielscher, R.; Rave-Fränk, M.; Hess, C.F.; Ramadori, G.; Christiansen, H. 2013: Serum Lipocalin2 is a potential biomarker of liver irradiation damage. Liver International: Official Journal of the International Association for the Study of the Liver 33(3): 459-468

Paterson, J.C. 1957: Serum Lipoproteins and Coronary Artery Disease. Canadian Medical Association Journal 76(3): 223-224

Reddy, D.S.; Reddy, M.S. 2014: Serum Lithium Levels: Ideal time for Sample Collection! Are we Doing it Right?. Indian Journal of Psychological Medicine 36(3): 346-347

Kumari, S.J.; Jayaram, N.; Vincent, L.; Venkatesh, T. 2002: Serum Lp(a) in diabetics with and without evidence of clinical nephropathy-A preliminary study. Indian Journal of Clinical Biochemistry: Ijcb 17(1): 45-48

Pryer, R.W. 1923: Serum Lysins. American Journal of Public Health 13(6): 470-472

Meng, W.; Zhu, H.-H.; Xu, Z.-F.; Cai, S.-R.; Dong, Q.; Pan, Q.-R.; Zheng, S.; Zhang, S.-Z. 2012: Serum M2-pyruvate kinase: a promising non-invasive biomarker for colorectal cancer mass screening. World Journal of Gastrointestinal Oncology 4(6): 145-151

Aktaş, B.; Başar, O.; Yılmaz, B.ış; Ekiz, F.; Altınbaş, A.; Coban, S.; Büyükçam, F.; Albayrak, A.; Giniş, Z.; Yüksel, O.; Delibaşı, T. 2014: Serum M30 and M65 levels and effects of Ankaferd blood stopper in cerulein induced experimental acute pancreatitis model in rats. International Journal of Clinical and Experimental Medicine 7(7): 1676-1683

Oven Ustaalioglu, B.; Bilici, A.; Ercan, S.; Orcun, A.; Seker, M.; Ozkan, A.; Ustaalioglu, R.; Gumus, M. 2012: Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 14(5): 356-361

Yaman, E.; Coskun, U.; Sancak, B.; Buyukberber, S.; Ozturk, B.; Benekli, M. 2010: Serum M30 levels are associated with survival in advanced gastric carcinoma patients. International Immunopharmacology 10(7): 719-722

Yilmaz, Y.; Ulukaya, E.; Dolar, E. 2009: Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels. Hepatology 49(2): 697; Author Reply 697

Megyeri, M.ár.; Jani, P.ét.K.; Kajdácsi, E.; Dobó, J.óz.; Schwaner, E.; Major, B.áz.; Rigó, J.án.; Závodszky, P.ét.; Thiel, S.; Cervenak, L.ás.ó; Gál, P.ét. 2014: Serum MASP-1 in complex with MBL activates endothelial cells. Molecular Immunology 59(1): 39-45

Dekker, A.D.; Coppus, A.M.W.; Vermeiren, Y.; Aerts, T.; van Duijn, C.M.; Kremer, B.P.; Naudé, P.J.W.; Van Dam, D.; De Deyn, P.P. 2015: Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with down syndrome. Journal of Alzheimer's Disease: Jad 43(3): 871-891

Di Natale, P.; Di Domenico, C.; Di Napoli, D. 2010: Serum MIP-1 alpha level: a biomarker for the follow-up of lentiviral therapy in mucopolysaccharidosis IIIB mice. Journal of Inherited Metabolic Disease 33(2): 159-165

Smigielski, J.; Brocki, M.; Kuzdak, K.; Kołomecki, K. 2011: Serum MMP 2 and TIMP 2 in patients with inguinal hernias. European Journal of Clinical Investigation 41(6): 584-588

Pay, S.; Abbasov, T.; Erdem, H.; Musabak, U.; Simsek, I.; Pekel, A.; Akdogan, A.; Sengul, A.; Dinc, A. 2007: Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?. Clinical and Experimental Rheumatology 25(4 Suppl 45: S70-S75

Arends, S.; van der Veer, E.; Groen, H.; Houtman, P.M.; Jansen, T.L.T.A.; Leijsma, M.K.; Bijzet, J.; Limburg, P.C.; Kallenberg, C.G.M.; Spoorenberg, A.; Brouwer, E. 2011: Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis. Journal of Rheumatology 38(8): 1644-1650

Ban, C.R.; Twigg, S.M.; Franjic, B.; Brooks, B.A.; Celermajer, D.; Yue, D.K.; McLennan, S.V. 2010: Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Research and Clinical Practice 87(3): 335-341

Hästbacka, J.; Linko, R.; Tervahartiala, T.; Varpula, T.; Hovilehto, S.; Parviainen, I.; Vaara, S.T.; Sorsa, T.; Pettilä, V. 2014: Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality. Anesthesia and Analgesia 118(4): 790-798

Fertin, M.; Lemesle, G.; Turkieh, A.; Beseme, O.; Chwastyniak, M.; Amouyel, P.; Bauters, C.; Pinet, F. 2013: Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction. Plos one 8(8): E71280

Helmersson-Karlqvist, J.; Akerfeldt, T.ör.; Gunningberg, L.; Swenne, C.L.; Larsson, A. 2012: Serum MMP-9 and TIMP-1 concentrations and MMP-9 activity during surgery-induced inflammation in humans. Clinical Chemistry and Laboratory Medicine 50(6): 1115-1119

Hong, Z.; Lin, Y.-M.; Qin, X.; Peng, J.-L. 2012: Serum MMP-9 is elevated in children with asthma. Molecular Medicine Reports 5(2): 462-464

Motovali-Bashi, M.; Sadeghi, M.; Hemmati, S. 2010: Serum MMP-9 level associated with initiation and progression steps of breast cancer in the Iranian population. Reproductive Sciences 17(6): 585-589

Mäkitalo, L.; Rintamäki, H.; Tervahartiala, T.; Sorsa, T.; Kolho, K.-L. 2012: Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease. Scandinavian Journal of Gastroenterology 47(7): 785-794

Zagouri, F.; Sergentanis, T.N.; Kalogera, E.; Provatopoulou, X.; Chrysikos, D.; Zografos, E.; Bletsa, G.; Flessas, I.; Papadimitriou, C.A.; Zografos, G.C.; Gounaris, A. 2011: Serum MMPs and TIMPs: may be predictors of breast carcinogenesis?. Clinica Chimica Acta; International Journal of Clinical Chemistry 412(7-8): 537-540

Peehl, D.M.; Chen, Z.; Nolley, R. 2011: Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia. Prostate 71(1): 26-31

Hinton, P.S.; Rector, R.Scott.; Peppers, J.E.; Imhoff, R.D.; Hillman, L.S. 2006: Serum Markers of Inflammation and Endothelial Function are Elevated by Hormonal Contraceptive Use but not by Exercise-Associated Menstrual Disorders in Physically Active Young Women. Journal of Sports Science and Medicine 5(2): 235-242

Grochans, E.żb.; Karakiewicz, B.; Kozielec, T.; Brodowska, A.; Brodowski, J.; Starczewski, A.; Laszczyńska, M.; Noceń, I.; Grzywacz, A.; Samochowiec, A.; Chlubek, D. 2011: Serum Mg and Zn levels in postmenopausal women. Magnesium Research 24(4): 209-214

Han, M.G.; Park, J.-S.; Lee, C.S.; Jeong, Y.E.; Ryou, J.S.; Cho, J.E.; Ju, Y.R.; Lee, K.-K. 2011: Serum MicroRNA Expression Profiling in Mice Infected with Rabies Virus. Osong Public Health and Research Perspectives 2(3): 186-191

Wei, X.; Chen, D.; Lv, T.; Li, G.; Qu, S. 2016: Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis. Molecular Neurobiology 53(1): 163-170

Anyabolu, H.C.; Adejuyigbe, E.A.; Adeodu, O.O. 2014: Serum Micronutrient Status of Haart-Naïve, HIV Infected Children in South Western Nigeria: a Case Controlled Study. Aids Research and Treatment 2014: 351043

Chang, H.L.; Pahlavan, N.; Halpern, E.F.; MacLaughlin, D.T. 2009: Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology. Gynecologic Oncology 114(1): 57-60

McCoy, A.C.; Kliethermes, B.; Zhang, K.; Qin, W.; Sticca, R.; Bouton, M.; Sauter, E.R. 2011: Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer. Bmc Research Notes 4: 152

Ueeda, M.; Doumei, T.; Takaya, Y.; Shinohata, R.; Katayama, Y.; Ohnishi, N.; Takaishi, A.; Miyoshi, T.; Hirohata, S.; Kusachi, S. 2008: Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction. Circulation Journal: Official Journal of the Japanese Circulation Society 72(11): 1836-1843

Fukui, M.; Shimakawa, S.; Nomura, S.; Ohba, C.; Kashiwagi, M.; Miyamoto, R.; Tanabe, T.; Azumagawa, K.; Tamai, H. 2015: Serum N-Terminal Pro-B-Type Natriuretic Peptide (NTproBNP) Levels Are Elevated During the Acute Phase of Acute Encephalopathy-Associated Virus Infection. Journal of Child Neurology 30(7): 823-827

Leeming, D.J.; Koizumi, M.; Qvist, P.; Barkholt, V.; Zhang, C.; Henriksen, K.; Byrjalsen, I.; Karsdal, M.A. 2011: Serum N-Terminal Propeptide of Collagen Type i is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to other Bone Related Markers. Biomarkers in Cancer 3: 15-23

Jovanović, V.B.; Dimitrijević-Srecković, V.S.; Mandić, L.M. 2008: Serum N-acetyl-beta-D-glucosaminidase profiles in type 1 diabetes secondary complications: causes of changes and significance of determination. Journal of Clinical Laboratory Analysis 22(4): 307-313

Simone, I.L.; Ruggieri, M.; Tortelli, R.; Ceci, E.; D'Errico, E.; Leo, A.; Zoccolella, S.; Mastrapasqua, M.; Capozzo, R.; Livrea, P.; Logroscino, G. 2011: Serum N-acetylaspartate level in amyotrophic lateral sclerosis. Archives of Neurology 68(10): 1308-1312

Hatakeyama, S.; Amano, M.; Tobisawa, Y.; Yoneyama, T.; Tsuchiya, N.; Habuchi, T.; Nishimura, S.-I.; Ohyama, C. 2014: Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis. Journal of Urology 191(3): 805-813

Xia, B.; Zhang, W.; Li, X.; Jiang, R.; Harper, T.; Liu, R.; Cummings, R.D.; He, M. 2013: Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation. Analytical Biochemistry 442(2): 178-185

Vanhooren, V.; Dewaele, S.; Libert, C.; Engelborghs, S.; De Deyn, P.P.; Toussaint, O.; Debacq-Chainiaux, F.; Poulain, M.; Glupczynski, Y.; Franceschi, C.; Jaspers, K.; van der Pluijm, I.; Hoeijmakers, J.; Chen, C.C. 2010: Serum N-glycan profile shift during human ageing. Experimental Gerontology 45(10): 738-743

Hatakeyama, S.; Amano, M.; Tobisawa, Y.; Yoneyama, T.; Tsushima, M.; Hirose, K.; Yoneyama, T.; Hashimoto, Y.; Koie, T.; Saitoh, H.; Yamaya, K.; Funyu, T.; Nishimura, S.-I.; Ohyama, C. 2013: Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis. Thescientificworldjournal 2013: 268407

Fang, M.; Dewaele, S.; Zhao, Y.-P.; Stärkel, P.; Vanhooren, V.; Chen, Y.-M.; Ji, X.; Luo, M.; Sun, B.-M.; Horsmans, Y.; Dell, A.; Haslam, S.M.; Grassi, P.; Libert, C.; Gao, C.-F.; Chen, C.C. 2010: Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat. Molecular Cancer 9: 215

Qu, Y.; Gao, C.-F.; Zhou, K.; Zhao, Y.-P.; Xu, M.-Y.; Lu, L.-G. 2012: Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis B. Annals of Hepatology 11(2): 202-212

Lumachi, F.; Marino, F.; Fanti, G.; Chiara, G.B.; Basso, S.M.M. 2011: Serum N-telopeptide of type i collagen and bone alkaline phosphatase and their relationship in patients with non-small cell lung carcinoma and bone metastases. Preliminary results. Anticancer Research 31(11): 3879-3881

Kilickesmez, K.Orta.; Ozkan, A.Arat.; Abaci, O.; Camlıca, H.; Kocas, C.; Kaya, A.; Baskurt, M.; Yiğit, Z.; Kucukoğlu, S. 2011: Serum N-terminal brain natriuretic peptide indicates exercise induced augmentation of pulmonary artery pressure in patients with mitral stenosis. Echocardiography 28(1): 8-14

Kim, M.-K.; Chung, W.-Y.; Cho, Y.-S.; Choi, S.-I.; Chae, I.-H.; Choi, D.-J.; Park, Y.-B. 2011: Serum N-terminal pro-B-type natriuretic peptide levels at the time of hospital admission predict of microvascular obstructions after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Journal of Interventional Cardiology 24(1): 34-41

Zhang, X.-H.; Dong, Y.; Chen, Y.-D.; Zhou, P.; Wang, J.-D.; Wen, F.-Q. 2013: Serum N-terminal pro-brain natriuretic peptide level is a significant prognostic factor in patients with severe sepsis among Southwest Chinese population. European Review for Medical and Pharmacological Sciences 17(4): 517-521

Carlo-Stella, N.; Belloli, L.; Biondi, M.L.; Marasini, B. 2009: Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?. Clinical Rheumatology 28(2): 241-242

Ozmen, B.; Ozmen, D.; Parildar, Z.; Mutaf, Işil.; Bayindir, O. 2007: Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism. Endocrine Research 32(1-2): 1-8

Görmüş, U.; Ozmen, D.; Ozmen, B.; Parildar, Z.; Ozdoğan, O.; Mutaf, I.; Bayindir, O. 2010: Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction. Diabetes Research and Clinical Practice 87(1): 51-56

Bai, M.; Yang, J.; Li, Y. 2009: Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation. Clinical Cardiology 32(12): E1-E5

Youssef, D.M.; Esh, A.M.; Helmy Hassan, E.; Ahmed, T.M. 2013: Serum NGAL in Critically Ill Children in ICU from a Single Center in Egypt. Isrn Nephrology 2013: 140905

Leelawat, K.; Narong, S.; Wannaprasert, J.; Leelawat, S. 2011: Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases. International Journal of Hepatology 2011: 873548

Pinheiro, K.A.T.; Pinheiro, R.T.; Coelho, F.áb.M.d.C.; da Silva, R.A.; Quevedo, L.Áv.; Schwanz, C.C.; Wiener, C.D.; Manfro, G.G.; Giovenardi, M.ár.; Lucion, A.B.; de Souza, D.O.; Portela, L.V.; Oses, J.P. 2014: Serum NGF, BDNF and IL-6 levels in postpartum mothers as predictors of infant development: the influence of affective disorders. Plos one 9(4): E94581

Pignatelli, P.; Pastori, D.; Carnevale, R.; Farcomeni, A.; Cangemi, R.; Nocella, C.; Bartimoccia, S.; Vicario, T.; Saliola, M.; Lip, G.Y.H.; Violi, F. 2015: Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation. Thrombosis and Haemostasis 113(3): 617-624

Meng, D.; Wu, T.; Rao, U.; North, C.S.; Xiao, H.; Javors, M.A.; Adinoff, B. 2011: Serum NPY and BNDF response to a behavioral stressor in alcohol-dependent and healthy control participants. Psychopharmacology 218(1): 59-67

Mady, C.; Fernandes, F.áb.; Arteaga, E.; Ramires, F.J.é A.; Buck, P.d.C.ás.; Salemi, V.M.C.; Ianni, B.M.; Nastari, L.; Dias, R.R. 2008: Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies. Arquivos Brasileiros de Cardiologia 91(1): 46-54

Zhang, Q.; Cheng, X.-R.; Sheng, G.-Y. 2010: Serum NT-proBNP levels in neonates with severe asphyxia and the effects of nalmefene on the NT-proBNP levels. Zhongguo Dang Dai Er Ke Za Zhi 12(11): 922-923

Koch, A.; Zimmermann, H.W.; Baeck, C.; Schneider, C.; Yagmur, E.; Trautwein, C.; Tacke, F. 2012: Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosis. Clinical Biochemistry 45(6): 429-435

Aggerholm-Pedersen, N.; Rasmussen, P.; Dybdahl, H.; Rossen, P.; Nielsen, O.Steen.; Safwat, A. 2011: Serum Natrium Determines Outcome of Treatment of Advanced GIST with Imatinib: A Retrospective Study of 80 Patients from a Single Institution. Isrn Oncology 2011: 523915

Moondra, V.; Sarma, S.; Buxton, T.; Safa, R.; Cote, G.; Storer, T.; Lebrasseur, N.K.; Sawyer, D.B. 2009: Serum Neuregulin-1beta as a Biomarker of Cardiovascular Fitness. Open Biomarkers Journal 2: 1-5

Schroeter, M.L.; Mueller, K.; Arelin, K.; Sacher, J.; Holiga, Št.; Kratzsch, J.ür.; Luck, T.; Riedel-Heller, S.; Villringer, A. 2015: Serum Neuron-Specific Enolase Is Related to Cerebellar Connectivity: a Resting-State Functional Magnetic Resonance Imaging Pilot Study. Journal of Neurotrauma 32(17): 1380-1384

Khosravi, M.B.; Milani, S.; Kakaei, F. 2013: Serum Neutrophil Gelatinase-Associated Lipocalin versus Serum Creatinine for the Prediction of Acute Kidney Injury after Liver Transplantation. International Journal of Organ Transplantation Medicine 4(3): 102-109

Harel, N.Y.; Cudkowicz, M.E.; Brown, R.H.; Strittmatter, S.M. 2009: Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 14(6): 414-417

Ezzat, M.H.M.; Imam, S.S.; Shaheen, K.Y.A.; Elbrhami, E.M. 2011: Serum OX40 ligand levels in asthmatic children: a potential biomarker of severity and persistence. Allergy and Asthma Proceedings 32(4): 313-318

Elter, K.; Ozay, T.A.; Ergin, E.; Ozörnek, M.H. 2013: Serum Oestradiol Pattern during Coasting is Different in Antagonist Cycles Compared with Long Agonist Cycles in in Vitro Fertilisation. Balkan Medical Journal 30(4): 406-409

Miki, D.; Ohishi, W.; Ochi, H.; Hayes, C.N.; Abe, H.; Tsuge, M.; Imamura, M.; Kamatani, N.; Nakamura, Y.; Chayama, K. 2012: Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection. Journal of Viral Hepatitis 19(2): E126-E133

Chen, A.; Chung, E.; DeFranco, E.A.; Pinney, S.M.; Dietrich, K.N. 2011: Serum PBDEs and age at menarche in adolescent girls: analysis of the National Health and Nutrition Examination Survey 2003-2004. Environmental research 111(6): 831-837

Stapleton, H.M.; Eagle, S.; Sjödin, A.; Webster, T.F. 2012: Serum PBDEs in a North Carolina toddler cohort: associations with handwipes, house dust, and socioeconomic variables. Environmental Health Perspectives 120(7): 1049-1054

Trnovec, T.ás.; Sovcíková, E.; Pavlovcinová, G.; Jakubíková, J.; Jusko, T.A.; Husták, M.; Jurecková, D.; Palkovicová, L.'u.; Kocan, A.; Drobná, B.; Lancz, K.; Wimmerová, S. 2010: Serum PCB concentrations and cochlear function in 12-year-old children. Environmental Science and Technology 44(8): 2884-2889

Wong, L-Yang.; Uddin, M.S.; Turner, W.; Ragin, A.D.; Dearwent, S. 2015: Serum PCB concentrations in residents of Calcasieu and Lafayette Parishes, Louisiana with comparison to the U.S. population. Chemosphere 118: 156-162

Herrick, R.F.; Meeker, J.D.; Hauser, R.; Altshul, L.; Weymouth, G.A. 2007: Serum PCB levels and congener profiles among US construction workers. Environmental Health: a Global Access Science Source 6: 25

Huetos, O.; Bartolomé, M.; Aragonés, N.; Cervantes-Amat, M.; Esteban, M.; Ruiz-Moraga, M.; Pérez-Gómez, B.; Calvo, E.; Vila, M.; Castaño, A. 2014: Serum PCB levels in a representative sample of the Spanish adult population: the BIOAMBIENT.ES project. Science of the Total Environment 493: 834-844

Taylor, B.A.; Panza, G.; Pescatello, L.S.; Chipkin, S.; Gipe, D.; Shao, W.; White, C.M.; Thompson, P.D. 2014: Serum PCSK9 Levels Distinguish Individuals who do not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C. Journal of Lipids 2014: 140723

Cui, Q.; Ju, X.; Yang, T.; Zhang, M.; Tang, W.; Chen, Q.; Hu, Y.; Haas, J.V.; Troutt, J.S.; Pickard, R.T.; Darling, R.; Konrad, R.J.; Zhou, H.; Cao, G. 2010: Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population. Atherosclerosis 213(2): 632-636

Karstadt, M.L. 2007: Serum PFOA levels in residents of communities near a Teflon-production facility. Environmental health perspectives 115(10): A486-A487

Snyderman, C. 2008: Serum PGE2 levels are inversely correlated with T classification in patients with squamous cell carcinoma of the head and neck. Head and Neck 30(1): 132-3; Author Reply 133

Bayrak, A.; Bayrak, T.ül.; Tokgözoglu, S.L.; Volkan-Salanci, B.; Deniz, A.; Yavuz, B.ün.; Alikasifoglu, M.; Demirpençe, E. 2012: Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis. Journal of Atherosclerosis and Thrombosis 19(4): 376-384

Kobayashi, M.; Nukui, A.; Morita, T. 2008: Serum PSA and percent free PSA value changes after antibiotic treatment. a diagnostic method in prostate cancer suspects with asymptomatic prostatitis. Urologia Internationalis 80(2): 186-192

Rastrelli, G.; Corona, G.; Vignozzi, L.; Maseroli, E.; Silverii, A.; Monami, M.; Mannucci, E.; Forti, G.; Maggi, M. 2013: Serum PSA as a predictor of testosterone deficiency. Journal of Sexual Medicine 10(10): 2518-2528

Zuberi, K.A.; Urquhart, A.C. 2010: Serum PTH and ionized calcium levels as predictors of symptomatic hypocalcemia after parathyroidectomy. Laryngoscope 120(Suppl 4): S192

Miguel Perelló, J.; Flores Pastor, B.; del Pozo, P.; Andrés, C. 2009: Serum PTH levels as a predictive factor of hypocalcaemia after total thyroidectomy. Cirugia Espanola 86(6): 390; Author Reply 392-3

Cantor, M.M.; Tuba, J.; Capsey, P.A. 1947: Serum Phosphatases and Alloxan Diabetes. Science 105(2731): 476-477

Shojaei Nik, M.H.; Darabi, M.; Ziaee, A.; Hajmanoochehri, F. 2014: Serum Phospholipase A2-IIA, hs-CRP, and Lipids in Women with Subclinical Hypothyroidism. International Journal of Endocrinology and Metabolism 12(3): E16967

Soeholm, H.; Kirkegaard, H. 2012: Serum Potassium Changes During Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest-Should It Be Treated?. Therapeutic Hypothermia and Temperature Management 2(1): 30-36

Lustgarten, M.S.; Price, L.L.; Phillips, E.M.; Kirn, D.R.; Mills, J.; Fielding, R.A. 2016: Serum Predictors of Percent Lean Mass in Young Adults. Journal of Strength and Conditioning Research 30(8): 2194-2201

Marshall, M.S. 1934: Serum Preservatives. California and Western Medicine 41(2): 94-98

Bohr, J.; Jones, I.; Tysk, C.; Järnerot, G. 1995: Serum Procollagen IIi Propeptide Is not of Diagnostic Predictive Value in Collagenous Colitis. Inflammatory Bowel Diseases 1(4): 276-279

Jobling, J.W.; Eggstein, A.A.; Petersen, W. 1915: Serum Proteases and the Mechanism of the Abderhalden Reaction : Studies on Ferment Action. Xx. Journal of Experimental Medicine 21(3): 239-249

Liangpunsakul, S.; Lai, X.; Ringham, H.N.; Crabb, D.W.; Witzmann, F.A. 2009: Serum Proteomic Profiles in Subjects with Heavy Alcohol Abuse. Journal of Proteomics and Bioinformatics 2: 236-243

Wasilewska, A.; Rybi-Szuminska, A.; Zoch-Zwierz, W. 2010: Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatric Nephrology 25(10): 2067-2075

Komase, K.; Maekawa, S.; Miura, M.; Sueki, R.; Kadokura, M.; Shindo, H.; Shindo, K.; Amemiya, F.; Nakayama, Y.; Inoue, T.; Sakamoto, M.; Yamashita, A.; Moriishi, K.; Enomoto, N. 2013: Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis C. Hepatology Research: the Official Journal of the Japan Society of Hepatology 43(8): 865-875

Eguchi, H.; Ishikawa, O.; Ohigashi, H.; Takahashi, H.; Yano, M.; Nishiyama, K.; Tomita, Y.; Uehara, R.; Takehara, A.; Nakamura, Y.; Nakagawa, H. 2009: Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer. Pancreas 38(7): 791-798

Row, R. 1902: Serum Reaction of "Bacillus Pestis" in Plague: A Preliminary Communication. British Medical Journal 2(2190): 1895-1896

Stejskal, D.; Karpisek, M.; Horakova, D.; Cizek, L.; Janoutova, G.; Janout, V. 2007: Serum Reg-Ialpha is not suitable marker of metabolic syndrome. Bratislavske Lekarske Listy 108(3): 138-140

Beck, H.; Flynn, K.; Lindenberg, K.S.; Schwarz, H.; Bradke, F.; Di Giovanni, S.; Knöll, B. 2012: Serum Response Factor (SRF)-cofilin-actin signaling axis modulates mitochondrial dynamics. Proceedings of the National Academy of Sciences of the United States of America 109(38): E2523-E2532

Blondin, S.A.; Yeung, E.H.; Mumford, S.L.; Zhang, C.; Browne, R.W.; Wactawski-Wende, J.; Schisterman, E.F. 2013: Serum Retinol and Carotenoids in Association with Biomarkers of Insulin Resistance among Premenopausal Women. Isrn Nutrition 2013: 619516

Zytko, J.; Cantero, A. 1962: Serum Ribonuclease in Patients with Malignant Disease. Canadian Medical Association Journal 86(11): 482-485

Prakash, J.; Velpandian, T.; Pande, J.N.; Gupta, S.K. 2003: Serum Rifampicin Levels in Patients with Tuberculosis : Effect of P-Glycoprotein and CYP3A4 Blockers on its Absorption. Clinical Drug Investigation 23(7): 463-472

Shinozaki, K.; Oda, S.; Sadahiro, T.; Nakamura, M.; Abe, R.; Nakada, T-Aki.; Nomura, F.; Nakanishi, K.; Kitamura, N.; Hirasawa, H. 2009: Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. Resuscitation 80(8): 870-875

Ishibashi, H.; Funakoshi, Y. 2008: Serum S-100B protein levels in left- and right-hemisphere strokes. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 15(5): 520-525

Studahl, M.; Günther, G.ör.; Rosengren, L. 2009: Serum S-100B protein levels in patients with herpes simplex encephalitis and tick-borne encephalitis--a marker of CNS damage during the initial stage of disease. Journal of Neurology 256(4): 586-590

Cheuvront, S.N.; Chinevere, T.D.; Ely, B.R.; Kenefick, R.W.; Goodman, D.A.; McClung, J.P.; Sawka, M.N. 2008: Serum S-100beta response to exercise-heat strain before and after acclimation. Medicine and Science in Sports and Exercise 40(8): 1477-1482

Zakiyanov, O.; Kalousová, M.; Kříha, V.ít.ěz.; Zima, T.áš; Tesař, V.ír. 2011: Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease. Kidney and Blood Pressure Research 34(6): 457-464

Abdul-Aziez, O.A.; Saber, N.Z.; El-Bakry, S.A.; Mohammad, A.A.; Abdel-Maksud, S.S.; Ali, Y. 2010: Serum S100A12 and temporomandibular joint magnetic resonance imaging in juvenile idiopathic arthritis Egyptian patients: a case control study. Pakistan Journal of Biological Sciences: Pjbs 13(3): 101-113

Brinar, M.; Cleynen, I.; Coopmans, T.; Van Assche, G.; Rutgeerts, P.; Vermeire, S. 2010: Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity. Gut 59(12): 1728-9; author reply 1729-30

Liu, J.; Ren, Y.-G.; Zhang, L.-H.; Tong, Y.-W.; Kang, L. 2014: Serum S100A12 concentrations are correlated with angiographic coronary lesion complexity in patients with coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation 74(2): 149-154

Zhao, P.; Wu, M.; Yu, H.; Huang, Y.; Wang, Y.; Wang, W.; Yin, W. 2013: Serum S100A12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 61(5): 861-866

Bae, C-Bum.; Suh, C-Hee.; An, J-Mi.; Jung, J-Yang.; Jeon, J-Young.; Nam, J-Young.; Kim, H-Ah. 2014: Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. Journal of Rheumatology 41(12): 2403-2408

Wei, B.-R.; Hoover, S.B.; Ross, M.M.; Zhou, W.; Meani, F.; Edwards, J.B.; Spehalski, E.I.; Risinger, J.I.; Alvord, W.G.; Quiñones, O.A.; Belluco, C.; Martella, L.; Campagnutta, E.; Ravaggi, A.; Dai, R.-M.; Goldsmith, P.K.; Woolard, K.D.; Pecorelli, S.; Liotta, L.A.; Petricoin, E.F.; Simpson, R.M. 2009: Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients. Plos one 4(10): E7670

Kim, H-Ah.; An, J-Mi.; Nam, J-Young.; Jeon, J-Young.; Suh, C-Hee. 2012: Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease. Journal of Rheumatology 39(7): 1399-1406

Jang, B-Su.; Kim, H.; Lim, S-Won.; Jang, K-Won.; Kim, D-Kwan. 2008: Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response. Psychiatry Investigation 5(3): 193-198

Egberts, F.; Momkvist, A.; Egberts, J.-H.; Kaehler, K.C.; Hauschild, A. 2010: Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patients. Anticancer Research 30(5): 1799-1805

Roka, A.; Kelen, D.; Halasz, J.; Beko, G.; Azzopardi, D.; Szabo, M. 2012: Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatrica 101(3): 319-323

Da Silva, L.G.; Mottin, C.áu.C.á; Souza, D.O.; Portela, L.V.; Braga, C.W.; Vargas, C.B.; Padoin, A.V.; Martinez, D.; Dias, R.D. 2008: Serum S100B but not NSE levels are increased in morbidly obese individuals affected by obstructive sleep apnea-hypopnea syndrome. Obesity Surgery 18(8): 993-999

Bouvier, D.; Fournier, M.; Dauphin, J-Benoît.; Amat, F.; Ughetto, S.; Labbé, Aé.; Sapin, V. 2012: Serum S100B determination in the management of pediatric mild traumatic brain injury. Clinical Chemistry 58(7): 1116-1122

Van Munster, B.C.; Korevaar, J.C.; Korse, C.M.; Bonfrer, J.M.; Zwinderman, A.H.; de Rooij, S.E. 2010: Serum S100B in elderly patients with and without delirium. International Journal of Geriatric Psychiatry 25(3): 234-239

Stocchero, C.M.A.; Oses, J.P.; Cunha, G.S.; Martins, J.B.; Brum, L.M.; Zimmer, E.R.; Souza, D.O.; Portela, L.V.; Reischak-Oliveira, A. 2014: Serum S100B level increases after running but not cycling exercise. Applied Physiology Nutrition and Metabolism 39(3): 340-344

Einav, S.; Itshayek, E.; Kark, J.D.; Ovadia, H.; Weiniger, C.F.; Shoshan, Y. 2008: Serum S100B levels after meningioma surgery: a comparison of two laboratory assays. Bmc Clinical Pathology 8: 9

Loquai, C.; Müller-Brenne, T.; Schadmand-Fischer, S.; Grabbe, S. 2013: Serum S100B levels correlate with clinical benefit in a metastatic melanoma patient treated by CTLA-4 blockade: a case report. Onkologie 36(10): 578-581

Atici, Y.; Alehan, Füsun.; Sezer, T.; Tuygun, N.; Haberal, Aşegül.; Yazici, Aşe.Can.; Karacan, C.Demir. 2012: Serum S100B levels in children with simple febrile seizures. Seizure 21(3): 175-177

Morochovic, R.; Rácz, O.; Kitka, M.; Pingorová, S.; Cibur, P.; Tomková, D.; Lenártová, R. 2009: Serum S100B protein in early management of patients after mild traumatic brain injury. European Journal of Neurology 16(10): 1112-1117

Kim, J.-K.; Kim, S.G.; Kim, H.J.; Song, Y.R. 2012: Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease. Clinical Biochemistry 45(18): 1573-1577

Stamataki, E.; Stathopoulos, A.; Garini, E.; Kokkoris, S.; Glynos, C.; Psachoulia, C.; Pantziou, H.; Nanas, S.; Routsi, C. 2013: Serum S100B protein is increased and correlates with interleukin 6, hypoperfusion indices, and outcome in patients admitted for surgical control of hemorrhage. Shock 40(4): 274-280

Duru, S.; Hikmet Fırat, I.; Colak, N.; Giniş, Z.; Delibaşı, T.; Ardıç, S.ık. 2012: Serum S100B protein: a useful marker in obstructive sleep apnea syndrome. Neurologia i Neurochirurgia Polska 46(5): 450-455

Schroeter, M.L.; Sacher, J.; Steiner, J.; Schoenknecht, P.; Mueller, K. 2013: Serum S100B represents a new biomarker for mood disorders. Current Drug Targets 14(11): 1237-1248

Tanaka, Y.; Marumo, T.; Shibuta, H.; Omura, T.; Yoshida, S. 2009: Serum S100B, brain edema, and hematoma formation in a rat model of collagenase-induced hemorrhagic stroke. Brain Research Bulletin 78(4-5): 158-163

Weide, B.; Richter, S.; Büttner, P.; Leiter, U.; Forschner, A.; Bauer, J.ür.; Held, L.; Eigentler, T.K.; Meier, F.; Garbe, C. 2013: Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy. Plos one 8(11): E81624

Falcone, T.; Fazio, V.; Lee, C.; Simon, B.; Franco, K.; Marchi, N.; Janigro, D. 2010: Serum S100B: a potential biomarker for suicidality in adolescents?. Plos one 5(6): E11089

Yao, B.; Zhang, L.-N.; Ai, Y.-H.; Liu, Z.-Y.; Huang, L. 2014: Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochemical Research 39(7): 1263-1269

Han, S.-x.; Wang, J.-l.; Guo, X.-j.; He, C.-c.; Ying, X.; Ma, J.-l.; Zhang, Y.-y.; Zhao, Q.; Zhu, Q. 2014: Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma. Journal of Immunology Research 2014: 262385

Feng, X.-y.; Li, J.-h.; Li, J.-z.; Han, Z.-x.; Xing, R.-d. 2010: Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma. International Journal of Biological Markers 25(2): 93-98

Siman, R.; Shahim, P.; Tegner, Y.; Blennow, K.; Zetterberg, H.; Smith, D.H. 2015: Serum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Postconcussion Symptoms. Journal of Neurotrauma 32(17): 1294-1300

Mosbah, A.A.A.E.-r.; Abdellatif, N.A.B.; Sorour, E.I.; Awadallah, M.F.M. 2012: Serum SP-D levels as a biomarker of lung injury in children suffering of bronchopneumonia. Journal of the Egyptian Society of Parasitology 42(1): 25-32

Kawasaki, Y.; Endo, K.; Suyama, K.; Sato, M.; Ito, M.; Hashimoto, K.; Hosoya, M. 2011: Serum SP-D levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Pediatric Pulmonology 46(1): 18-22

Lee, Y.J.; Heo, Y.-S.; Park, H.S.; Lee, S.H.; Lee, S.K.; Jang, Y.J. 2014: Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults. Obesity Surgery 24(4): 604-610

Liu, D-mei.; Lu, N.; Zhao, L.; Zhang, M-jia.; Tao, B.; Xuan, Y.; Sun, L-hao.; Zhao, H-yan.; Wang, W-qing.; Liu, J-min.; Ning, G. 2014: Serum Sema3A is in a weak positive association with bone formation marker osteocalcin but not related to bone mineral densities in postmenopausal women. Journal of clinical endocrinology and metabolism 99(12): E2504-E2509

Loftis, J.M.; Morasco, B.J.; Menasco, D.; Fuchs, D.; Strater, M.; Hauser, P. 2010: Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C. Open Infectious Diseases Journal 4: 132-141

Mizuguchi, S.; Nishiyama, N.; Iwata, T.; Nishida, T.; Izumi, N.; Tsukioka, T.; Inoue, K.; Uenishi, T.; Wakasa, K.; Suehiro, S. 2007: Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage i non-small cell lung cancer. Lung Cancer 58(3): 369-375

Fleisher, M.S.; Jones, L. 1931: Serum Sickness in Rabbits : I. Manifestations of Serum Sickness. Journal of Experimental Medicine 54(4): 597-613

Farahmand, F.; Choobi Anzali, B.; Heshmat, R.; Ghafouri, H.-B.; Hamedanchi, S. 2013: Serum Sodium and Potassium Levels in Cerebro-vascular Accident Patients. Malaysian Journal of Medical Sciences: Mjms 20(3): 39-43

Nielsen, M.K.; Vidyashankar, A.N.; Bellaw, J.; Gravatte, H.S.; Cao, X.; Rubinson, E.F.; Reinemeyer, C.R. 2015: Serum Strongylus vulgaris-specific antibody responses to anthelmintic treatment in naturally infected horses. Parasitology Research 114(2): 445-451

Yahya, R.S.; Fouda, M.I.; El-Baz, H.A.; Mosa, T.E.; Elmaksoud, M.D.A. 2012: Serum Survivin and TP53 Gene Expression in Children with Acute Lymphoblastic Leukemia. Iranian Journal of Public Health 41(1): 37-44

Barahmani, N.; Lopez, A.; Babu, D.; Hernandez, M.; Donley, S.E.; Duvic, M. 2010: Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clinical and Experimental Dermatology 35(4): 409-416

Yang, J.Won.; Han, S.Tae.; Song, S.Han.; Kim, M.Keun.; Kim, J.Seok.; Choi, S.Ok.; Han, B-Geun. 2012: Serum T3 level can predict cardiovascular events and all-cause mortality rates in CKD patients with proteinuria. Renal Failure 34(3): 364-372

Mashek, D.G.; Greenberg, A.S. 2014: Serum TAG analysis differentiates between genetic and obesity-associated NAFLD. Diabetes 63(1): 42-44

Teraki, Y.; Taguchi, R. 2014: Serum TARC levels correlate with disease activity in patients with non-episodic angioedema with eosinophilia. Journal of Dermatology 41(9): 858-860

Kawashima, T.; Tada, Y.; Asano, Y.; Yazawa, N.; Tomita, M.; Tamaki, Z.; Kubo, M.; Ihn, H.; Sugaya, M.; Kadono, T.; Tamaki, K.; Sato, S. 2010: Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease. Journal of Dermatological Science 60(1): 52-54

Xiao, L.; Liu, Y-Peng.; Xiao, C-Xing.; Ren, J-Lin.; Guleng, B. 2014: Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers. Bmc Clinical Pathology 14: 26

Schonewille, M.; Brufau, G.; Shiri-Sverdlov, R.; Groen, A.K.; Plat, J. 2014: Serum TG-lowering properties of plant sterols and stanols are associated with decreased hepatic VLDL secretion. Journal of Lipid Research 55(12): 2554-2561

Manuyakorn, W.; Kamchaisatian, W.; Atamasirikul, K.; Sasisakulporn, C.; Direkwattanachai, C.; Benjaponpitak, S. 2008: Serum TGF-beta1 in atopic asthma. Asian Pacific Journal of Allergy and Immunology 26(4): 185-189

Kapetanakis, S.; Drygiannakis, I.; Kazakos, K.; Papanas, N.; Kolios, G.; Kouroumalis, E.; Verettas, D.-A. 2010: Serum TGF-beta2 and TGF-beta3 are increased and positively correlated to pain, functionality, and radiographic staging in osteoarthritis. Orthopedics 33(8)

Mahmoud, A.A.; Bakir, A.S.; Shabana, S.S. 2012: Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 18(5): 327-333

Chen, C.; Lei, W.; Chen, W.; Zhong, J.; Gao, X.; Li, B.; Wang, H.; Huang, C. 2014: Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease. Bmc Cardiovascular Disorders 14: 18

Liu, Y.; Zhang, D.-F.; Zhou, X.; Xu, L.; Zhang, L.; Shi, X. 2017: Comprehensive Analysis Reveals two Distinct Evolution Patterns of Salmonella Flagellin Gene Clusters. Frontiers in Microbiology 8: 2604

Lee, J.-H.; Choi, J.-W.; Kim, Y.-S. 2011: Serum TIMP-1 predicts survival outcomes of invasive breast carcinoma patients: a meta-analysis. Archives of Medical Research 42(6): 463-468

Kinra, P.; Dutta, V. 2013: Serum TNF alpha levels: a prognostic marker for assessment of severity of malaria. Tropical Biomedicine 30(4): 645-653

Gonzalez-Quintela, A.; Campos, J.; Loidi, L.; Quinteiro, C.; Perez, L.-F.; Gude, F. 2008: Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol 42(6): 513-518

Dominika Kaminiarczyk-Pyzalka; Adamczak, K.; Mikos, H.; Klimecka, I.; Moczko, J.; Niedziela, M. 2014: Serum TNF-α levels and Indicators of Disease Activity in Children with Oligoarticular Juvenile Idiopathic Arthritis (oJIA) in the First Year of the Disease. Clinical Laboratory 2014(5): 10.7754/Clin.Lab.2013.130452

Jalali, A.; Pipelzadeh, M.H.; Taraz, M.; Khodadadi, A.; Makvandi, M.; Rowan, E.G. 2011: Serum TNF-α levels reflect the clinical severity of envenomation following a Hemiscorpius lepturus sting. European Cytokine Network 22(1): 5-10

Hofmann, M.A.; Kiecker, F.; Küchler, I.; Kors, C.; Trefzer, U. 2011: Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma. Journal of Cancer Research and Clinical Oncology 137(3): 455-462

Ajami, A.; Abedian, F.; Hamzeh Hosseini, S.; Akbarian, E.; Alizadeh-Navaei, R.; Taghipour, M. 2014: Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine. Iranian Journal of Immunology: Iji 11(3): 200-209

Kyriakidis, I.; Samara, P.; Papa, A. 2011: Serum TNF-α, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil's syndrome. Cytokine 54(2): 117-120

Drugova, E.D. 2007: Serum TNFalpha and its receptors in professionals after prolonged exposure to radiation in remote period. Radiatsionnaia Biologiia Radioecologiia 47(6): 696-700

Gasowska-Bodnar, A.; Bodnar, L.; Synowiec, A.; Jerzak, M.; Wcislo, G.; Smoter, M.; Szczylik, C.; Baranowski, W. 2011: Serum TRAIL levels in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. a pilot study. European Journal of Gynaecological Oncology 32(6): 642-646

Xiong, W.-H.; Duvoisin, R.M.; Adamus, G.; Jeffrey, B.G.; Gellman, C.; Morgans, C.W. 2013: Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice. Plos one 8(8): E69506

Karmisholt, J.; Laurberg, P. 2008: Serum TSH and serum thyroid peroxidase antibody fluctuate in parallel and high urinary iodine excretion predicts subsequent thyroid failure in a 1-year study of patients with untreated subclinical hypothyroidism. European Journal of Endocrinology 158(2): 209-215

Aoki, Y.; Belin, R.M.; Clickner, R.; Jeffries, R.; Phillips, L.; Mahaffey, K.R. 2007: Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid: official journal of the American Thyroid Association 17(12): 1211-1223

Lee, Y.Kyung.; Kim, J.Eun.; Oh, H.Ju.; Park, K.Sun.; Kim, S.Kyung.; Park, S.Won.; Kim, M.Jong.; Cho, Y.Wook. 2011: Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean Journal of Internal Medicine 26(4): 432-439

Schalin-Jäntti, C.; Tanner, P.; Välimäki, M.J.; Hämäläinen, E. 2011: Serum TSH reference interval in healthy Finnish adults using the Abbott Architect 2000i Analyzer. Scandinavian Journal of Clinical and Laboratory Investigation 71(4): 344-349

Svare, A.; Nilsen, T.I.L.; Bjøro, T.; Asvold, B.ør.O.; Langhammer, A. 2011: Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clinical Endocrinology 74(6): 769-775

Mazziotti, G.; Porcelli, T.; Patelli, I.; Vescovi, P.P.; Giustina, A. 2010: Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone 46(3): 747-751

Åsvold, Børn.O.; Vatten, L.J.; Midthjell, K.; Bjøro, T. 2012: Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT Study in Norway. Journal of Clinical Endocrinology and Metabolism 97(1): 93-99

Anonymous 1952: Serum Tests for Syphilis in Extremis. British journal of venereal diseases 28(1): 1-2

Antonelli, A.; Fallahi, P.; Ferrari, S.M.; Pupilli, C.; d'Annunzio, G.; Lorini, R.; Vanelli, M.; Ferrannini, E. 2008: Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study. Diabetic Medicine: a Journal of the British Diabetic Association 25(11): 1349-1353

Agarwal, A.; Agrawal, U.; Verma, S.; Mohanty, N.K.; Saxena, S. 2010: Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy. Immunopharmacology and Immunotoxicology 32(2): 348-356

Ozyurt, K.; Celik, A.; Sayarlıoglu, M.; Colgecen, E.; Incı, R.; Karakas, T.; Kelles, M.; Cetin, G.Y. 2014: Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 43(9): 691-695

Abdallah, M.; Attia, E.A.S.; Saad, A.A.; El-Khateeb, E.A.; Lotfi, R.A.; Abdallah, M.; El-Shennawy, D. 2014: Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells. Experimental Dermatology 23(10): 742-747

Attia, E.A.S.; Abdallah, M.; El-Khateeb, E.; Saad, A.A.; Lotfi, R.A.; Abdallah, M.; El-Shennawy, D. 2014: Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines. Archives of Dermatological Research 306(9): 793-801

Park, W.H. 1931: Serum Therapy. Bulletin of the new York Academy of Medicine 7(6): 401-411

Macnamara, J. 1933: Serum Therapy in Poliomyelitis. British Medical Journal 1(3768): 526-528

Young, I.W. 1915: Serum Therapy: a Discourse: Some Clinical Observations in the use of Neiser Bacterin and Mixed Infection Phylacogen. Journal of the National Medical Association 7(3): 179-182

Vianello, F.; Vettore, S.; Tezza, F.; Toni, L.D.; Scandellari, R.; Sambado, L.; Treleani, M.; Fabris, F. 2014: Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different Etiologies. Hematology Reports 6(1): 4996

Noda, S.; Asano, Y.; Aozasa, N.; Akamata, K.; Yamada, D.; Masui, Y.; Tamaki, Z.; Kadono, T.; Sato, S. 2011: Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosis. Journal of the European Academy of Dermatology and Venereology: JEADV 25(12): 1476-1479

Bocanegra, M.; Hinostroza, F.; Kefalides, N.A. 1963: Serum Transaminase Changes in Severe Burns. Annals of Surgery 157(3): 438-445

Anonymous 1927: Serum Treatment for Mushroom Poisoning. Science 66(1716): Xii

Flexner, S.; Jobling, J.W. 1908: Serum Treatment of Epidemic Cerebro-Spinal Meningitis. Journal of Experimental Medicine 10(1): 141-203

Wollstein, M. 1911: Serum Treatment of Influenzal Meningitis. Journal of Experimental Medicine 14(1): 73-82

Anonymous 1938: Serum Treatment of Pneumonia. British medical journal 1(4018): 76-77

Anonymous 1933: Serum Treatment of Poliomyelitis: Supplies for the London Area. British medical journal 2(3783): 71

Bullowa, J.G. 1929: Serum Treatment of the Pneumococcus Pneumonias. British Medical Journal 1(3568): 943-946

Bell, G. 1923: Serum Treatment of Glanders. Canadian Medical Association Journal 13(3): 200-201

Chase, I.C. 1930: The Host City for 1930. American Journal of Public Health and the Nation's Health 20(5): 522-524

Wylie, M.E. 1930: Serum Treatment of Scarlatine. Journal of Hygiene 30(3): 331-336

McSweeney, C.J. 1937: Serum Treatment of Typhoid. British Medical Journal 2(4013): 1118-1119

Haas, P.; Steindl, K.; Aggermann, T.; Schmid-Kubista, K.; Krugluger, W.; Hageman, G.S.; Binder, S. 2011: Serum VEGF and CFH in exudative age-related macular degeneration. Current Eye Research 36(2): 143-148

Kopanakis, N.; Saiti, A.; D'Avgerinos, E.; Masselou, K.; Simiri, M.; Mandaraka, A.; Vasiliadis, G.; Katergiannakis, V. 2014: Serum VEGF and bFGF in patients with inflammatory bowel diseases. Annali Italiani di Chirurgia 85(3): 203-206

Mukozu, T.; Nagai, H.; Matsui, D.; Kanekawa, T.; Sumino, Y. 2013: Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma. Anticancer Research 33(3): 1013-1021

Deguchi, T.; Hashiguchi, T.; Horinouchi, S.; Uto, T.; Oku, H.; Kimura, K.; Makisumi, K.; Arimura, K. 2009: Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Diabetic Medicine: a Journal of the British Diabetic Association 26(3): 247-252

Zhan, P.; Qian, Q.; Yu, L.-K. 2013: Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surgery and Nutrition 2(4): 209-215

Koukourakis, M.I.; Limberis, V.; Tentes, I.; Kontomanolis, E.; Kortsaris, A.; Sivridis, E.; Giatromanolaki, A. 2011: Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer. Cytokine 53(3): 370-375

Papaioannou, A.I.; Zakynthinos, E.; Kostikas, K.; Kiropoulos, T.; Koutsokera, A.; Ziogas, A.; Koutroumpas, A.; Sakkas, L.; Gourgoulianis, K.I.; Daniil, Z.D. 2009: Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. Bmc Pulmonary Medicine 9: 18

Vincenzi, B.; Napolitano, A.; Zoccoli, A.; Iuliani, M.; Pantano, F.; Papapietro, N.; Denaro, V.; Santini, D.; Tonini, G. 2012: Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw. Journal of Hematology and Oncology 5: 56

Nobile-Orazio, E.; Terenghi, F.; Giannotta, C.; Gallia, F.; Nozza, A. 2009: Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies. Neurology 72(11): 1024-1026

Lee, S.-C.; Lee, K.-Y.; Kim, Y.-J.; Kim, S.H.; Koh, S.-H.; Lee, Y.J. 2010: Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis. European Journal of Neurology 17(1): 45-51

Nash, G.F. 2008: Serum VEGF, blood transfusion, and wound orientation : Letter re: Belizon et al. Surg Endosc. 2008 Jan 18. Surgical Endoscopy 22(10): 2328

Young, L.; Lee, H-Seung.; Inoue, Y.; Moss, J.; Singer, L.G.; Strange, C.; Nakata, K.; Barker, A.F.; Chapman, J.T.; Brantly, M.L.; Stocks, J.M.; Brown, K.K.; Lynch, J.P.; Goldberg, H.J.; Downey, G.P.; Swigris, J.J.; Taveira-DaSilva, A.M.; Krischer, J.P.; Trapnell, B.C.; McCormack, F.X. 2013: Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet. Respiratory Medicine 1(6): 445-452

Ni, X.-F.; Wu, C.-P.; Jiang, J.-T. 2010: Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX. World Journal of Gastroenterology 16(17): 2163-2169

Grobin, W. 1959: Serum Vitamin B(12) Content as an Index of Hepatic Damage. Canadian Medical Association Journal 81(11): 935-936

Itik, V.; Kemik, O.; Kemik, A.; Dulger, A.C.; Sümer, A.; Soyoral, Y.U.; Begenik, H.; Purisa, S.; Kotan, C. 2011: Serum YKL-40 Levels in Patients with Gastric Cancer. Biomarkers in Cancer 3: 25-30

Mylin, A.K.; Andersen, N.F.; Johansen, J.S.; Abildgaard, N.; Heickendorff, L.; Standal, T.; Gimsing, P.; Knudsen, L.M. 2009: Serum YKL-40 and bone marrow angiogenesis in multiple myeloma. International Journal of Cancer 124(6): 1492-1494

Biggar, R.J.; Johansen, J.S.; Smedby, K.E.öm.; Rostgaard, K.; Chang, E.T.; Adami, H.-O.; Glimelius, B.; Molin, D.; Hamilton-Dutoit, S.; Melbye, M.; Hjalgrim, H. 2008: Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(21): 6974-6978

Gybel-Brask, D.; Høgdall, E.; Johansen, J.; Christensen, I.J.; Skibsted, L. 2014: Serum YKL-40 and uterine artery Doppler -- a prospective cohort study, with focus on preeclampsia and small-for-gestational-age. Acta Obstetricia et Gynecologica Scandinavica 93(8): 817-824

Mitsuhashi, A.; Matsui, H.; Usui, H.; Nagai, Y.; Tate, S.; Unno, Y.; Hirashiki, K.; Seki, K.; Shozu, M. 2009: Serum YKL-40 as a marker for cervical adenocarcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 20(1): 71-77

Wang, X.; Xing, G.-H. 2014: Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome. Scandinavian Journal of Clinical and Laboratory Investigation 74(1): 74-78

Bernardi, D.; Padoan, A.; Ballin, A.; Sartori, M.; Manara, R.; Scienza, R.; Plebani, M.; Della Puppa, A. 2012: Serum YKL-40 following resection for cerebral glioblastoma. Journal of Neuro-Oncology 107(2): 299-305

Harutyunyan, M.; Johansen, J.S.; Mygind, N.D.; Reuter, S.B.; Kastrup, J. 2014: Serum YKL-40 for monitoring myocardial ischemia after revascularization in patients with stable coronary artery disease. Biomarkers in Medicine 8(8): 977-987

Ahmed, S.F.; Attia, E.A.S.; Saad, A.A.; Sharara, M.; Fawzy, H.; El Nahrery, E.M.A. 2015: Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings. Journal of the European Academy of Dermatology and Venereology: Jeadv 29(4): 682-688

Zhu, C.-B.; Wang, C.; Chen, L.-L.; Ma, G.-L.; Zhang, S.-C.; Su, L.; Tian, J.-J.; Gai, Z.-T. 2012: Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma. Plos one 7(9): E44648

Iwamoto, F.M.; Hottinger, A.F.; Karimi, S.; Riedel, E.; Dantis, J.; Jahdi, M.; Panageas, K.S.; Lassman, A.B.; Abrey, L.E.; Fleisher, M.; DeAngelis, L.M.; Holland, E.C.; Hormigo, A.íl. 2011: Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Neuro-Oncology 13(11): 1244-1251

Xu, Y.; Meng, H.-L.; Su, Y.-M.; Chen, C.; Huang, Y.-H.; Li, X.-F.; Fan, M.-K.; Yan, Y.-J.; Wu, J.; Jiang, M.-H.; Pan, M. 2015: Serum YKL-40 is increased in patients with slow coronary flow. Coronary Artery Disease 26(2): 121-125

Xu, C.-H.; Yu, L.-K.; Hao, K.-K. 2014: Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer. Plos one 9(5): E96384

Kucur, M.; Isman, F.K.; Balci, C.; Onal, B.; Hacibekiroglu, M.; Ozkan, F.; Ozkan, A. 2008: Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urologic Oncology 26(1): 47-52

Musumeci, M.; Caruso, V.; Medulla, E.; Torrisi, V.; Migale, R.; Angeletti, S.; Musumeci, S. 2014: Serum YKL-40 levels and chitotriosidase activity in patients with beta-thalassemia major. Disease Markers 2014: 965971

Tuten, A.; Kucur, M.; Imamoglu, M.; Oncul, M.; Acikgoz, A.S.; Sofiyeva, N.; Ozturk, Z.; Kaya, B.; Oral, E. 2014: Serum YKL-40 levels are altered in endometriosis. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(5): 381-384

Kwon, J.-W.; Kim, T.-W.; Cho, S.-H.; Min, K.-U.; Park, H.-W. 2011: Serum YKL-40 levels are correlated with symptom severity in patients with allergic rhinitis. Allergy 66(9): 1252-1253

Jiang, Y.-X.; Zhang, G.-H.; Wang, Z.-M.; Yang, H. 2014: Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage. Clinical Biochemistry 47(18): 302-306

Yamac, D.; Ozturk, B.; Coskun, U.; Tekin, E.; Sancak, B.; Yildiz, R.; Atalay, C. 2008: Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Advances in Therapy 25(8): 801-809

Park, H.Y.; Jun, C.-D.; Jeon, S.-J.; Choi, S.-S.; Kim, H.-R.; Choi, D.-B.; Kwak, S.; Lee, H.-S.; Cheong, J.S.; So, H.-S.; Lee, Y.-J.; Park, D.-S. 2012: Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients. Plos one 7(12): E51722

Koc, M.; Zulfikaroglu, B.; Kemal Isman, F.; Ozalp, N.; Acar, A.; Kucur, M. 2010: Serum YKL-40 levels in acute appendicitis. Bratislavske Lekarske Listy 111(12): 656-658

Chudecka-Głaz, A.; Górski, B.; Zielińska, D.; Błogowski, W.; Wojciechowska, I.; Bedner, R.; Rzepka-Górska, I. 2009: Serum YKL-40 levels in patients with ovarian cancer and women with BRCA1 gene mutation--comparison to CA 125 antigen. European Journal of Gynaecological Oncology 30(6): 668-671

Bilim, O.; Takeishi, Y.; Kitahara, T.; Ishino, M.; Sasaki, T.; Suzuki, S.; Shishido, T.; Kubota, I. 2010: Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure. Journal of Cardiac Failure 16(11): 873-879

Erfan, G.; Guzel, S.; Alpsoy, S.; Rifaioglu, E.N.; Kaya, S.; Kucukyalcın, V.; Topcu, B.; Kulac, M. 2015: Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?. Molecular and Cellular Biochemistry 400(1-2): 207-212

Waqar Rabbani, M.; Ali, I.; Zahid Latif, H.; Basit, A.; Rabbani, M.A. 2013: Serum Zinc Level in Children Presenting with Febrile Seizures. Pakistan Journal of Medical Sciences 29(4): 1008-1011

Reina de la Torre, M.L.; Navarro-Alarcón, M.; del Moral, L.M.í; López-G de la Serrana, H.; Palomares-Bayo, M.; Oliveras López, M.ía.J.ús.; Blanca Herrera, R.M.ía.; Agil, A. 2014: Serum Zn levels and Cu/Zn ratios worsen in hemodialysis patients, implying increased cardiovascular risk: a 2-year longitudinal study. Biological Trace Element Research 158(2): 129-135

Santos, C.A.; Fonseca, J.; Brito, J.é; Fernandes, T.ân.; Gonçalves, L.ís.; Sousa Guerreiro, A.ón. 2014: Serum Zn levels in dysphagic patients who underwent endoscopic gastrostomy for long term enteral nutrition. Nutricion Hospitalaria 29(2): 359-364

Zhang, X.; Zhang, Y.; Nie, Y.; Wang, S.; Chen, Y.; Sun, D. 2014: Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(7): 6879-6886

Bird, M.-L.; Hill, K.D.; Robertson, I.K.; Ball, M.J.; Pittaway, J.; Williams, A.D. 2013: Serum [25(OH)D] status, ankle strength and activity show seasonal variation in older adults: relevance for winter falls in higher latitudes. Age and Ageing 42(2): 181-185

Chen, X.; Li, Z.-Y.; Maleewong, W.; Maleewong, P.; Liang, J.; Zeng, X.; Zheng, H.; Wu, Z.-D.; Sun, X. 2014: Serum aca-mir-146a is a potential biomarker for early diagnosis of Angiostrongylus cantonensis infection. Parasitology Research 113(9): 3221-3227

Ware, A.G.; Seegers, W.H. 1948: Serum accelerator globulin; quantitative determination, purification and properties. Federation Proceedings 7(1 Part 1): 131

Hasegawa, G.; Nakano, K.; Ienaga, K. 2011: Serum accumulation of a creatinine oxidative metabolite (NZ-419: 5-hydroxy-1- methylhydatoin) as an intrinsic antioxidant in diabetic patients with or without chronic kidney disease. Clinical Nephrology 76(4): 284-289

Waring, W.S.; Benhalim, S. 2008: Serum acetaminophen concentrations after acute overdose are not altered by opioid co-ingestion. Journal of Toxicological Sciences 33(5): 549-553

Tiwari, S.C.; Siddiqui, J.S.; Tuteja, N.; Lal, N.; Trivedi, J.K.; Bahuguna, L.M. 1982: Serum acetylcholinesterase activity in psychiatric patients. Indian Journal of Psychiatry 24(3): 291-294

Shah, N.; Dave, K. 1992: Serum acetylcholinesterase level in the patients of opioid (brown sugar) dependence. Indian Journal of Psychiatry 34(4): 373-375

Goto, T.; Kawano, H.; Akiyama, T.; Shinoda, Y.; Okuma, T.; Kobayashi, H.; Nemoto, T.; Funata, N. 2009: Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone. Archives of Orthopaedic and Trauma Surgery 129(12): 1641-1644

Grammatikos, G.; Mühle, C.; Ferreiros, N.; Schroeter, S.; Bogdanou, D.; Schwalm, S.; Hintereder, G.; Kornhuber, J.; Zeuzem, S.; Sarrazin, C.; Pfeilschifter, J. 2014: Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. Biochimica et Biophysica Acta 1841(7): 1012-1020

Yasuda, K.; Nagakawa, O.; Akashi, T.; Fujiuchi, Y.; Koizumi, K.; Komiya, A.; Saiki, I.; Fuse, H. 2009: Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer. Prostate 69(4): 346-351

De Kretser, D.M.; Bensley, J.G.; Pettilä, V.; Linko, R.; Hedger, M.P.; Hayward, S.; Allan, C.A.; McLachlan, R.I.; Ludlow, H.; Phillips, D.J. 2013: Serum activin a and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study. Critical Care 17(5): R263

Linko, R.; Hedger, M.P.; Pettilä, V.; Ruokonen, E.; Ala-Kokko, T.; Ludlow, H.; de Kretser, D.M. 2014: Serum activin a and B, and follistatin in critically ill patients with influenza A(H1N1) infection. Bmc Infectious Diseases 14: 253

Näf, S.; Escote, X.; Ballesteros, Mónica.; Yañez, R.Elena.; Simón-Muela, I.; Gil, P.; Albaiges, G.; Vendrell, J.; Megia, A. 2014: Serum activin A and follistatin levels in gestational diabetes and the association of the Activin A-Follistatin system with anthropometric parameters in offspring. Plos one 9(4): E92175

Elito Júnior, J.; Gustavo Oliveira, L.; Octávio Fernandes Silva, M.; Araujo Júnior, E.; Camano, L. 2014: Serum activin a levels and tubal ectopic pregnancy. Iranian Journal of Reproductive Medicine 12(3): 227-228

Florio, P.; Reis, F.M.; Battista, R.; Luisi, S.; Moncini, I.; Bocchi, C.; Severi, F.M.; Petraglia, F. 2011: Serum activin a levels are lower in tubal than intrauterine spontaneously conceived pregnancies. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(6): 391-395

Kim, W.R.; Flamm, S.L.; Di Bisceglie, A.M.; Bodenheimer, H.C.; Di Bisceglie, A.M.; Bodenheimer, H.C.; Lindsay, K.L.; Yee, H.; Goss, J.; Kaplan, L.M.; Gish, R.G.; Kim, W.R.; Sanyal, A. 2008: Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47(4): 1363-1370

Gołab, K.; Passowicz-Muszyńska, E.; Jankowska, R.; Warwas, M. 2009: Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report). Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 26(153): 194-197

Yang, J.; Zhang, Y.; Xu, J.; Geng, Y.; Chen, X.; Yang, H.; Wang, S.; Wang, H.; Jiang, X.; Guo, X.; Zhao, G. 2009: Serum activity of platelet-activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage. Plos one 4(1): E4181

Masi, A.T.; Rehman, A.A.; Elmore, K.B.; Aldag, J.C. 2013: Serum acute phase protein and inflammatory cytokine network correlations: comparison of a pre-rheumatoid arthritis and non-rheumatoid arthritis community cohort. Journal of Innate Immunity 5(2): 100-113

Mitchell, K.D.; Kruth, S.A.; Wood, R.D.; Jefferson, B. 2009: Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia. Journal of Veterinary Internal Medicine 23(3): 585-591

Caldin, M.; Tasca, S.; Carli, E.; Bianchini, S.; Furlanello, T.; Martinez-Subiela, S.; Cerón, J.J. 2009: Serum acute phase protein concentrations in dogs with hyperadrenocorticism with and without concurrent inflammatory conditions. Veterinary Clinical Pathology 38(1): 63-68

Nivy, R.; Caldin, M.; Lavy, E.; Shaabon, K.; Segev, G.; Aroch, I. 2014: Serum acute phase protein concentrations in dogs with spirocercosis and their association with esophageal neoplasia - a prospective cohort study. Veterinary Parasitology 203(1-2): 153-159

Tecles, F.; Caldín, M.; Zanella, A.; Membiela, F.; Tvarijonaviciute, A.; Subiela, S.M.ín.; Cerón, J.é J.ín. 2009: Serum acute phase protein concentrations in female dogs with mammary tumors. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 21(2): 214-219

Saco, Y.; Fraile, L.; Giménez, M.è; Alegre, A.; López-Jimenez, R.; Cortey, M.í; Segalés, J.; Bassols, A. 2011: Serum acute phase proteins as biomarkers of pleuritis and cranio-ventral pulmonary consolidation in slaughter-aged pigs. Research in Veterinary Science 91(1): 52-57

Tvarijonaviciute, A.; Martinez, S.; Gutierrez, A.; Ceron, J.J.; Tecles, F. 2011: Serum acute phase proteins concentrations in dogs during experimentally short-term induced overweight. a preliminary study. Research in Veterinary Science 90(1): 31-34

Borlak, J.ür.; Chatterji, B.; Londhe, K.B.; Watkins, P.B. 2013: Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury. Genome Medicine 5(9): 86

Wadden, D.; Cahill, F.; Amini, P.; Randell, E.; Vasdev, S.; Yi, Y.; Zhang, W.; Sun, G. 2012: Serum acylated ghrelin concentrations in response to short-term overfeeding in normal weight, overweight, and obese men. Plos one 7(9): E45748

Amini, P.; Wadden, D.; Cahill, F.; Randell, E.; Vasdev, S.; Chen, X.; Gulliver, W.; Zhang, W.; Zhang, H.; Yi, Y.; Sun, G. 2012: Serum acylated ghrelin is negatively correlated with the insulin resistance in the CODING study. Plos one 7(9): E45657

Chiu, Y.-L.; Rubin, D.T.; Vermeire, S.; Louis, E.; Robinson, A.M.; Lomax, K.G.; Pollack, P.F.; Paulson, S.K. 2013: Serum adalimumab concentration and clinical remission in patients with Crohn's disease. Inflammatory Bowel Diseases 19(6): 1112-1122

Kisacik, B.; Akdogan, A.; Yilmaz, G.; Karadag, O.; Yilmaz, F.M.; Koklu, S.; Yuksel, O.; Ertenli, A.I.; Kiraz, S. 2009: Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever. European Journal of Internal Medicine 20(1): 44-47

Beyazit, Y.; Koklu, S.; Tas, A.; Purnak, T.; Sayilir, A.; Kurt, M.; Turhan, T.; Celik, T.; Suvak, B.; Torun, S.; Akbal, E. 2012: Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis. Journal of Crohn's and Colitis 6(1): 102-107

Sunnetcioglu, M.; Karadas, S.; Aslan, M.; Ceylan, M.R.; Demir, H.; Oncu, M.R.; Karahocagil, M.K.ım.; Sunnetcioglu, A.; Aypak, C. 2014: Serum adenosine deaminase activity in cutaneous anthrax. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 20: 1151-1154

Mokhtari, M.; Hashemi, M.; Yaghmaei, M.; Molashahi, F.; Shikhzadeh, A.; Niazi, A.; Ghavami, S. 2010: Serum adenosine deaminase activity in gestational diabetes mellitus and normal pregnancy. Archives of Gynecology and Obstetrics 281(4): 623-626

Saghiri, R.; Ghashghai, N.; Movaseghi, S.; Poursharifi, P.; Jalilfar, S.; Bidhendi, M.A.; Ghazizadeh, L.; Ebrahimi-Rad, M. 2012: Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern. Rheumatology International 32(6): 1633-1638

Bahadır, G.ök.; Döventaş, Y.E.ğa.; Turkal, R.; Koldaş, M.; Basınoğlu, F.; Dane, B.; Altunkaynak, E. 2011: Serum adenosine deaminase and its isoenzyme activities in pregnancy. Journal of the Turkish German Gynecological Association 12(4): 209-213

Salesi, M.; Ghazvini, R.A.; Farajzadegan, Z.; Karimifar, M.; Karimzadeh, H.; Masoumi, M.; Ebrahimi, B. 2012: Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate. Journal of Research in Pharmacy Practice 1(2): 72-76

Mishra, R.; Agarwal, M.K.; Chansuria, J.P. 2000: Serum adenosine deaminase levels as an index of tumor growth in head and neck malignancy. Indian journal of otolaryngology and head and neck surgery: official publication of the Association of Otolaryngologists of India 52(4): 360-363

Oztürk, Z.A.; Köklü, S.; Erol, M.F.; Yilmaz, F.M.; Basar, O.; Yüksel, O.; Yilmaz, G.; Kisacik, B.; Yüksel, I. 2008: Serum adenosine deaminase levels in diagnosis of acute appendicitis. Emergency Medicine Journal: Emj 25(9): 583-585

Ibiş, M.; Köklü, S.; Yilmaz, F.M.ç; Başar, O.; Yilmaz, G.ül.; Yüksel, O.; Yildirim, E.; Oztürk, Z.A. 2007: Serum adenosine deaminase levels in pancreatic diseases. Pancreatology: Official Journal of the International Association of Pancreatology . 7(5-6): 526-530

Zamani, B.; Jamali, R.; Jamali, A. 2012: Serum adenosine deaminase may predict disease activity in rheumatoid arthritis. Rheumatology International 32(7): 1967-1975

Pratibha, K.; Anand, U.; Agarwal, R. 2004: Serum adenosine deaminase, 5' nucleotidase and malondialdehyde in acute infective hepatitis. Indian Journal of Clinical Biochemistry: Ijcb 19(2): 128-131

Pirinççi, N.; Geçit, I.; Güneş, M.; Yüksel, M.B.; Kaba, M.; Tanık, S.; Demir, H.; Aslan, M. 2012: Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer. Clinics 67(12): 1443-1446

Hasegawa, M.; Asano, Y.; Endo, H.; Fujimoto, M.; Goto, D.; Ihn, H.; Inoue, K.; Ishikawa, O.; Kawaguchi, Y.; Kuwana, M.; Ogawa, F.; Takahashi, H.; Tanaka, S.; Sato, S.; Takehara, K. 2014: Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. Plos one 9(2): E88150

Alwi, I. 2008: Serum adhesion molecule levels in acute coronary syndrome among Indonesian patients. Acta Medica Indonesiana 40(3): 135-138

Janan, M.; Proungvitaya, S.; Limpaiboon, T.; Proungvitaya, T.; Roytrakul, S.; Wongkham, C.; Jearanaikoon, P.; Chur-in, S.; Wongkham, S. 2012: Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients. Asian Pacific Journal of Cancer Prevention: Apjcp 13 Suppl: 107-114

Kung, C-Te.; Su, C-Min.; Chang, H-Wen.; Cheng, H-Hung.; Hsiao, S-Yuan.; Tsai, T-Cheng.; Chang, W-Neng.; Tsai, N-Wen.; Wang, H-Chen.; Su, Y-Jih.; Huang, C-Cheng.; Lin, W-Che.; Cheng, B-Chung.; Chang, Y-Ting.; Chiang, Y-Fang.; Lu, C-Hsien. 2014: Serum adhesion molecules as outcome predictors in adult severe sepsis patients requiring mechanical ventilation in the emergency department. Clinical Biochemistry 47(15): 38-43

Tso, A.W.K.; Xu, A.; Sham, P.C.; Wat, N.M.S.; Wang, Y.; Fong, C.H.Y.; Cheung, B.M.Y.; Janus, E.D.; Lam, K.S.L. 2007: Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30(10): 2667-2672

Schmilovitz-Weiss, H.; Laish, I.; Levi, Z.; Monsselise, Y.; Harif, Y.; Braun, M.; Boaz, M.; Ben-Ari, Z. 2012: Serum adipocyte fatty acid binding protein in liver transplant recipients and the metabolic syndrome. Annals of Hepatology 11(3): 343-349

Hao, Y.; Ma, X.; Luo, Y.; Shen, Y.; Dou, J.; Pan, X.; Bao, Y.; Jia, W. 2014: Serum adipocyte fatty acid binding protein levels are positively associated with subclinical atherosclerosis in Chinese pre- and postmenopausal women with normal glucose tolerance. Journal of Clinical Endocrinology and Metabolism 99(11): 4321-4327

Haluzík, M.M.; Anderlová, K.; Doležalová, R.; Adamíková, A.; Haluzíková, D.; Housová, J.; Svacina, S.; Haluzík, M. 2009: Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment. Physiological Research 58(1): 93-99

Jin, J.; Peng, D.-q.; Yuan, S.-g.; Zhao, S.-p.; Ning, X.-h.; Wang, S.-h.; Li, S.-l. 2010: Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clinica Chimica Acta; International Journal of Clinical Chemistry 411(21-22): 1761-1765

Tso, A.W.K.; Lam, T.K.Y.; Xu, A.; Yiu, K.H.; Tse, H.F.; Li, L.S.W.; Law, L.S.C.; Cheung, B.M.Y.; Cheung, R.T.F.; Lam, K.S.L. 2011: Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology 76(23): 1968-1975

Yoo, H.J.; Kim, S.; Park, M.S.; Choi, H.Y.; Yang, S.J.; Seo, J.A.; Kim, S.G.; Kim, N.H.; Baik, S.H.; Choi, D.S.; Choi, K.M. 2011: Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. Journal of Clinical Endocrinology and Metabolism 96(3): E488-E492

Miyoshi, T.; Onoue, G.; Hirohata, A.; Hirohata, S.; Usui, S.; Hina, K.; Kawamura, H.; Doi, M.; Kusano, K.F.; Kusachi, S.; Ninomiya, Y. 2010: Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 211(1): 164-169

Koh, J.H.; Shin, Y.G.; Nam, S.M.; Lee, M.Y.; Chung, C.H.; Shin, J.Y. 2009: Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 32(1): 147-152

Huang, C.-L.; Wu, Y.-W.; Hsieh, A.-R.; Hung, Y.-H.; Chen, W.-J.; Yang, W.-S. 2013: Serum adipocyte fatty acid-binding protein levels in patients with critical illness are associated with insulin resistance and predict mortality. Critical Care 17(1): R22

Choi, K.M.; Yannakoulia, M.; Park, M.S.; Cho, G.J.; Kim, J.H.; Lee, S.H.; Hwang, T.G.; Yang, S.J.; Kim, T.N.; Yoo, H.J.; Baik, S.H.; Kim, S.M.; Mantzoros, C.S. 2011: Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study. American Journal of Clinical Nutrition 93(1): 19-26

Lam, D.C.-L.; Xu, A.; Lam, K.S.-L.; Lam, B.; Lam, J.C.-M.; Lui, M.M.-S.; Ip, M.S.-M. 2009: Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. European Respiratory Journal 33(2): 346-351

Kim, Y.-C.; Cho, Y.-K.; Lee, W.-Y.; Kim, H.-J.; Park, J.-H.; Park, D.-I.; Sohn, C.-I.; Jeon, W.-K.; Kim, B.-I.; Park, S.-E.; Rhee, E.-J.; Park, C.-Y.; Oh, K.-W.; Park, S.-W.; Kim, S.-W.; Ryu, S.-H. 2011: Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. Journal of Nutritional Biochemistry 22(3): 289-292

Chaliasos, N.; Challa, A.; Hatzimichael, E.; Koutsouka, F.; Bourantas, D.K.; Vlahos, A.P.; Siamopoulou, A.; Bourantas, K.L.; Makis, A. 2010: Serum adipocytokine and vascular inflammation marker levels in Beta-thalassaemia major patients. Acta Haematologica 124(4): 191-196

Arisan, E.D.; Arisan, S.; Atis, G.; Palavan-Unsal, N.; Ergenekon, E. 2009: Serum adipocytokine levels in prostate cancer patients. Urologia Internationalis 82(2): 203-208

Watt, K.D.; Fan, C.; Therneau, T.; Heimbach, J.K.; Seaberg, E.C.; Charlton, M.R. 2014: Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20(7): 791-797

Paek, J.; Kang, J.-H.; Kim, H.-S.; Lee, I.; Seo, K.W.; Yang, M.-P. 2014: Serum adipokine concentrations in dogs with acute pancreatitis. Journal of Veterinary Internal Medicine 28(6): 1760-1769

Cho, K.-D.; Paek, J.; Kang, J.-H.; Chang, D.; Na, K.-J.; Yang, M.-P. 2014: Serum adipokine concentrations in dogs with naturally occurring pituitary-dependent hyperadrenocorticism. Journal of Veterinary Internal Medicine 28(2): 429-436

Tsochatzis, E.; Papatheodoridis, G.V.; Hadziyannis, E.; Georgiou, A.; Kafiri, G.; Tiniakos, D.G.; Manesis, E.K.; Archimandritis, A.J. 2008: Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scandinavian Journal of Gastroenterology 43(9): 1128-1136

Abenavoli, L.; Luigiano, C.; Guzzi, P.H.; Milic, N.; Morace, C.; Stelitano, L.; Consolo, P.; Miraglia, S.; Fagoonee, S.; Virgilio, C.; Luzza, F.; De Lorenzo, A.; Pellicano, R. 2014: Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. Panminerva Medica 56(2): 189-193

Syrbe, U.; Callhoff, J.; Conrad, K.; Poddubnyy, D.; Haibel, H.; Junker, S.; Frommer, K.W.; Müller-Ladner, U.; Neumann, E.; Sieper, J. 2015: Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression. Arthritis and Rheumatology 67(3): 678-685

De Sanctis, J.B.; Zabaleta, M.; Bianco, Nás.E.; Garmendia, J.V.; Rivas, L. 2009: Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42(4): 272-274

Shu, K.-H.; Wu, M.-J.; Chen, C.-H.; Cheng, C.-H.; Yu, T.-M.; Chuang, Y.-W.; Huang, S.-T.; Tsai, S.-F.; Lo, Y.-C.; Weng, S.-C.; Wen, M.-C.; Ho, H.-C. 2014: Serum adipokine levels in renal transplant recipients. Transplantation Proceedings 46(2): 381-384

Kim, K.S.; Choi, H.-M.; Ji, H.-I.; Song, R.; Yang, H.-I.; Lee, S.-K.; Yoo, M.C.; Park, Y.-B. 2014: Serum adipokine levels in rheumatoid arthritis patients and their contributions to the resistance to treatment. Molecular Medicine Reports 9(1): 255-260

Tasci, I.; Dogru, T.; Erdem, G.; Tapan, S.; Ercin, C.N.; Sonmez, A. 2009: Serum adipokine levels in the obese people. International Journal of Biological Sciences 5(3): 286

Yazıcı, D.; Yavuz, D.; Öğünç, A.Velioğlu.; Sirikçi, Önder.; Toprak, A.; Deyneli, Oğuzhan.; Akalın, S. 2012: Serum adipokine levels in type 1 diabetic patients: association with carotid intima media thickness. Metabolic Syndrome and Related Disorders 10(1): 26-31

Pákáski, M.; Fehér, A.; Juhász, A.; Drótos, G.; Fazekas, O.C.; Kovács, J.án.; Janka, Z.án.; Kálmán, J.án. 2014: Serum adipokine levels modified by donepezil treatment in Alzheimer's disease. Journal of Alzheimer's Disease: Jad 38(2): 371-377

Lemoine, M.; Ratziu, V.; Kim, M.; Maachi, M.; Wendum, D.; Paye, F.ço.; Bastard, J.P.; Poupon, R.; Housset, C.; Capeau, J.; Serfaty, L. 2009: Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Liver International: Official Journal of the International Association for the Study of the Liver 29(9): 1431-1438

Martins, S.V.; Lopes, P.A.; Alfaia, C.M.; Rodrigues, P.O.; Alves, S.P.; Pinto, R.M.A.; Castro, M.F.; Bessa, R.J.B.; Prates, J.é A.M. 2010: Serum adipokine profile and fatty acid composition of adipose tissues are affected by conjugated linoleic acid and saturated fat diets in obese Zucker rats. British Journal of Nutrition 103(6): 869-878

Aramă, V.; Tilişcan, C.ăt.ăl.; Ion, D.A.; Mihăilescu, R.; Munteanu, D.; Streinu-Cercel, A.; Tudor, A.M.; Hristea, A.; Leoveanu, V.; Olaru, I.; Aramă, S.S. 2012: Serum adipokines and HIV viral replication in patients undergoing antiretroviral therapy. Germs 2(1): 12-17

Toussirot, E.; Grandclément, E.; Gaugler, B.éa.; Michel, F.; Wendling, D.; Saas, P.; Dumoulin, G. 2013: Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. a comparative study. Frontiers in Immunology 4: 453

Waluga, M.; Hartleb, M.; Boryczka, G.; Kukla, M.ł; Zwirska-Korczala, K. 2014: Serum adipokines in inflammatory bowel disease. World Journal of Gastroenterology 20(22): 6912-6917

De Boer, T.N.; van Spil, W.E.; Huisman, A.M.; Polak, A.A.; Bijlsma, J.W.J.; Lafeber, F.P.J.G.; Mastbergen, S.C. 2012: Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis and Cartilage 20(8): 846-853

Eder, L.; Jayakar, J.; Pollock, R.; Pellett, F.; Thavaneswaran, A.; Chandran, V.; Rosen, C.F.; Gladman, D.D. 2013: Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Annals of the Rheumatic Diseases 72(12): 1956-1961

Marousi, S.; Theodorou, G.; Karakantza, M.; Papathanasopoulos, P.; Ellul, J. 2010: Serum adiponectin acutely after an ischemic stroke: implications for a long-lasting, suppressed anti-inflammatory role. Acta Neurologica Scandinavica 121(4): 277-284

Takeuchi, S.; Otani, N.; Nawashiro, H. 2011: Serum adiponectin after ischemic stroke. Acta Neurologica Scandinavica 124(2): 149; Author Reply 150

Oliveira, G.B.d.F.; França, J.ão.Ít.D.; Piegas, L.S. 2013: Serum adiponectin and cardiometabolic risk in patients with acute coronary syndromes. Arquivos Brasileiros de Cardiologia 101(5): 399-409

Chitalia, N.; Raja, R.B.; Bhandara, T.; Agrawal, P.; Kaski, J.C.; Jha, V.; Banerjee, D. 2010: Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation. Journal of Nephrology 23(1): 77-84

Li, J.-Q.; Li, M.-Y.; Dai, Y.-X.; Liu, Y.-M.; Zheng, J.; Liu, W.-B. 2008: Serum adiponectin and free fatty acid profile in essential hypertensive patients with or without metabolic syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 36(3): 232-235

Gökşen, D.; Levent, E.ür.; Kar, S.; Ozen, S.; Darcan, S.ük. 2013: Serum adiponectin and hsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus. Journal of Clinical Research in Pediatric Endocrinology 5(3): 174-181

Hasan-Ali, H.; Abd El-Mottaleb, N.A.; Hamed, H.B.; Abd-Elsayed, A. 2011: Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis. Coronary Artery Disease 22(4): 264-269

Yang, L.-F.; Xie, H.; Yuan, L.-Q. 2008: Serum adiponectin and leptin levels and bone mineral density in 232 men. Zhong Nan da Xue Xue Bao. Yi Xue Ban 33(6): 523-526

Nishimura, K.; Soda, T.; Nakazawa, S.; Yamanaka, K.; Hirai, T.; Kishikawa, H.; Ichikawa, Y. 2012: Serum adiponectin and leptin levels are useful markers for prostate cancer screening after adjustments for age, obesity-related factors, and prostate volume. Minerva Urologica e Nefrologica 64(3): 199-208

Baran, A.; Flisiak, I.; Jaroszewicz, J.; Świderska, M. 2015: Serum adiponectin and leptin levels in psoriatic patients according to topical treatment. Journal of Dermatological Treatment 26(2): 134-138

Lisowska, A.; Lisowski, P.; Knapp, M.; Tycinska, A.; Sawicki, R.; Malyszko, J.; Hirnle, T.; Musial, W.J. 2014: Serum adiponectin and markers of endothelial dysfunction in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG). Advances in Medical Sciences 59(2): 245-249

Saito, O.; Saito, T.; Okuda, K.; Okuda, K.; Kotoda, A.; Akimoto, T.; Ando, Y.; Muto, S.; Ishikawa, S.-E.; Kusano, E. 2008: Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans. Clinical and Experimental Nephrology 12(1): 58-64

Breitfeld, J.; Sandvoss, R.; Schleinitz, D.; Böttcher, Y.; Fasshauer, M.; Blüher, M.; Stumvoll, M.; Kovacs, P.; Wittenburg, H.; Tönjes, A. 2014: Serum adiponectin and progranulin levels are associated with gallstone disease. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 122(10): 559-563

Saraheimo, M.; Forsblom, C.; Thorn, L.; Wadén, J.; Rosengård-Bärlund, M.; Heikkilä, O.; Hietala, K.; Gordin, D.; Frystyk, J.; Flyvbjerg, A.; Groop, P.-H.; Mathiassen, K.; Petersen, H.; Megel, A.; Sandelin, A.; Lindh, S.; Halonen, A.; Koistinen, A.; Koskiaho, P.; Laukkanen, M.; Saltevo, J.; Tiihonen, M.; Kinnunen, P.; Orvola, A.; Salonen, T.; Vähänen, A.; Paldanius, R.; Riihelä, M.; Ryysy, L.; Nyländen, P.; Sademies, A.; Anderson, S.; Asplund, B.; Byskata, U.; Virkkala, T.; Eerola, R.M.; Jatkola, E.; Lönnblad, T.R.; Mäkelä, J.; Malm, A.; Rautamo, E.; Rosvall, H.; Rosengård-Bärlund, M.; Rönnback, M.; Wadén, J.; Toivanen, E.; Jokelainen, S.; Kemppainen, P.; Mankinen, A.-M.; Sankari, M.; Stuckey, H.; Suominen, P.; Koskinen, E.; S 2008: Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 31(6): 1165-1169

Pangaribuan, B.; Yusuf, I.; Mansyur, M.; Wijaya, A. 2011: Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism 2(6): 235-245

Medyńska, A.; Kiliś-Pstrusińska, K.; Galar, A.; Zwolińska, D. 2009: Serum adiponectin and resistin level in children with idiopathic nephrotic syndrome. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 26(154): 298-300

El-Baz, H.A.; Mosa, T.E.; Elabd, E.M.; Ramadan, A.; Elharoun, A.S.; Elmorsy, E.A.; Fouda, M.I. 2013: Serum adiponectin and resistin levels in de novo and relapsed acute lymphoblastic leukemia children patients. Iranian Journal of Public Health 42(5): 504-510

Lehto, S.M.; Huotari, A.; Niskanen, L.; Tolmunen, T.; Koivumaa-Honkanen, H.; Honkalampi, K.; Ruotsalainen, H.; Herzig, K.-H.; Viinamäki, H.; Hintikka, J. 2010: Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatrica Scandinavica 121(3): 209-215

Ari, M.; Ozturk, O.H.; Bez, Y.; Arica, S.; Can, Y.; Erduran, D. 2012: Serum adiponectin and resistin levels in patients with obsessive compulsive disorder. Journal of Affective Disorders 136(3): 979-982

Wang, Y.; Xie, X.; Zhu, W. 2010: Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications. Journal of Huazhong University of Science and Technology. Medical Sciences 30(5): 638-642

Honsawek, S.; Chayanupatkul, M.; Chongsrisawat, V.; Theamboonlers, A.; Praianantathavorn, K.; Udomsinprasert, W.; Vejchapipat, P.; Poovorawan, Y. 2011: Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia. Bmc Gastroenterology 11: 16

Rajalingham, S.; Das, S. 2012: Serum adiponectin and type 1 diabetes: the real myth. Journal of Internal Medicine 271(3): 315

Jee, S.H.; Ahn, C.W.; Park, J.S.; Park, C.G.; Kim, H.-S.; Lee, S.-H.; Park, S.; Lee, M.; Lee, C.B.; Park, H.S.; Kimm, H.; Choi, S.H.; Sung, J.; Oh, S.; Joung, H.; Kim, S.R.; Youn, H.-J.; Kim, S.M.; Lee, H.S.; Mok, Y.; Choi, E.; Yun, Y.D.; Baek, S.-J.; Jo, J.; Huh, K.B. 2013: Serum adiponectin and type 2 diabetes: a 6-year follow-up cohort study. Diabetes and Metabolism Journal 37(4): 252-261

Ozgen, M.; Koca, S.S.; Dagli, N.; Balin, M.; Ustundag, B.; Isik, A. 2010: Serum adiponectin and vaspin levels in rheumatoid arthritis. Archives of Medical Research 41(6): 457-463

Petridou, E.T.; Sergentanis, T.N.; Dessypris, N.; Vlachantoni, I.T.; Tseleni-Balafouta, S.; Pourtsidis, A.; Moschovi, M.; Polychronopoulou, S.; Athanasiadou-Piperopoulou, F.; Kalmanti, M.; Mantzoros, C.S. 2009: Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(30): 5049-5055

Yun, J.E.; Sull, J.W.; Lee, H.Y.; Park, E.; Kim, S.; Jo, J.; Lee, S.J.; Kim, S.Y.; Choi, Y.J.; Jee, S.H.; Huh, K.B. 2009: Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes/Metabolism Research and Reviews 25(3): 259-265

Lee, S.-A.; Sung, H.; Han, W.; Noh, D.-Y.; Ahn, S.-H.; Kang, D. 2014: Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival. Asian Pacific Journal of Cancer Prevention: Apjcp 15(15): 6137-6143

Tvarijonaviciute, A.; Cerón, J.é J.ín.; Tecles, F. 2012: Serum adiponectin concentration in dogs - absence of diurnal variation and lack of effect of feeding and methylprednisolone administration. Acta Veterinaria Hungarica 60(4): 489-500

Murakami, K.; Sasaki, S.; Uenishi, K.; Yamasaki, M.; Hisatomi, Y.; Soezima, J.; Takedomi, K.; Kohri, T.; Kaba, N.; Uneoka, E.; Hayabuchi, H.; Umeki, Y.; Baba, K.; Suzuki, M.; Watanabe, R.; Muramatsu, K.; Ohki, K.; Shiga, S.; Ebisawa, H.; Fuwa, M.; Suzuki, A.; Kudo, F.; Shibata, K.; Hirose, J.; Takahashi, T.; Kato, M.; Goda, T.; Ichikawa, Y.; Suzuki, J.; Niida, Y.; Morohashi, S.; Shimizu, C.; Takeuchi, N.; Oka, J.; Ide, T.; Sugiyama, Y.; Furuki, M.; Watanabe, T. 2013: Serum adiponectin concentration in relation to macronutrient and food intake in young Japanese women. Nutrition 29(11-12): 1315-1320

Owecki, M.; Miczke, A.; Pupek-Musialik, D.; Bryll, W.ła.; Cymerys, M.; Nikisch, E.; Sowiński, J. 2007: Serum adiponectin concentrations and their relationship with plasma lipids in obese diabetic and non-diabetic Caucasians. Neuro Endocrinology Letters 28(6): 901-907

Ebina, K.; Fukuhara, A.; Ando, W.; Hirao, M.; Koga, T.; Oshima, K.; Matsuda, M.; Maeda, K.; Nakamura, T.; Ochi, T.; Shimomura, I.; Yoshikawa, H.; Hashimoto, J. 2009: Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clinical Rheumatology 28(4): 445-451

Vitoratos, N.; Deliveliotou, A.; Vlahos, N.F.; Mastorakos, G.; Papadias, K.; Botsis, D.; Creatsas, G.K. 2008: Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 24(11): 614-619

Gokulakrishnan, K.; Aravindhan, V.; Amutha, A.; Abhijit, S.; Ranjani, H.; Anjana, R.M.; Unnikrishnan, R.; Miranda, P.; Narayan, K.M.V.; Mohan, V. 2013: Serum adiponectin helps to differentiate type 1 and type 2 diabetes among young Asian Indians. Diabetes Technology and Therapeutics 15(8): 696-702

Siagris, D.; Vafiadis, G.; Michalaki, M.; Lekkou, A.; Starakis, I.; Makri, M.; Margaritis, V.; Christofidou, M.; Tsamandas, A.C.; Labropoulou-Karatza, C. 2007: Serum adiponectin in chronic hepatitis C and B. Journal of Viral Hepatitis 14(8): 577-583

Michaëlsson, K.; Lind, L.; Frystyk, J.; Flyvbjerg, A.; Gedeborg, R.; Berne, C.; Zethelius, B.ör.; Mallmin, H.; Söderberg, S.; Melhus, H.åk. 2008: Serum adiponectin in elderly men does not correlate with fracture risk. Journal of Clinical Endocrinology and Metabolism 93(10): 4041-4047

Doruk, M.; Uğur, M.; Oruç, A.S.; Demirel, N.; Yildiz, Y. 2014: Serum adiponectin in gestational diabetes and its relation to pregnancy outcome. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 34(6): 471-475

Daniels, K.M.; Zavin, A.; Allsup, K.; Joseph, J.; Arena, R.; Lazzari, A.A.; Schulze, P.C.; Lecker, S.H.; Brown, J.; Forman, D.E. 2013: Serum adiponectin in non-cachectic heart failure patients. International Journal of Cardiology 168(4): 4363-4364

Parul, S.S.; Mazumder, M.; Debnath, B.C.; Haque, M.E. 2011: Serum adiponectin in patients with coronary heart disease. Mymensingh Medical Journal: Mmj 20(1): 78-82

Cohen, S.S.; Gammon, M.D.; Signorello, L.B.; North, K.E.; Lange, E.M.; Fowke, J.H.; Hargreaves, M.K.; Cai, Q.; Zheng, W.; Blot, W.J.; Matthews, C.E. 2011: Serum adiponectin in relation to body mass index and other correlates in black and white women. Annals of Epidemiology 21(2): 86-94

Rzepka-Górska, I.; Bedner, R.; Cymbaluk-Płoska, A.; Chudecka-Głaz, A. 2008: Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women. European Journal of Gynaecological Oncology 29(6): 594-597

Gardener, H.; Crisby, M.; Sjoberg, C.; Hudson, B.; Goldberg, R.; Mendez, A.J.; Wright, C.B.; Rundek, T.; Elkind, M.S.V.; Sacco, R.L. 2013: Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study. Metabolic Syndrome and Related Disorders 11(1): 46-55

Sull, J.W.; Kim, H.J.; Yun, J.E.; Kim, G.; Park, E.J.; Kim, S.; Lee, H.Y.; Jee, S.H. 2009: Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women. European Journal of Endocrinology 160(1): 39-43

Dankner, R.; Chetrit, A.; Murad, H.; Sela, B-Ami.; Frystyk, J.; Raz, I.; Flyvbjerg, A. 2010: Serum adiponectin is associated with homocysteine in elderly men and women, and with 5,10-methylenetetrahydrofolate reductase (MTHFR) in a sex-dependent manner. Metabolism, Clinical and Experimental 59(12): 1767-1774

Sull, J.W.; Kim, H.J.; Yun, J.E.; Park, E.J.; Kim, G.; Jee, S.H. 2009: Serum adiponectin is associated with smoking status in healthy Korean men. Endocrine Journal 56(1): 73-78

Siegel, A.B.; Goyal, A.; Salomao, M.; Wang, S.; Lee, V.; Hsu, C.; Rodriguez, R.; Hershman, D.L.; Brown, R.S.; Neugut, A.I.; Emond, J.; Kato, T.; Samstein, B.; Faleck, D.; Karagozian, R. 2015: Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients. Oncology 88(1): 57-68

Arca, M.; Cambuli, V.M.; Montali, A.; Sentinelli, F.; Filippi, E.; Campagna, F.; Quagliarini, F.; Antonini, R.; Romeo, S.; Baroni, M.G. 2009: Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 19(9): 660-666

Thyagarajan, B.; Jacobs, D.R.; Smith, L.J.; Kalhan, R.; Gross, M.D.; Sood, A. 2010: Serum adiponectin is positively associated with lung function in young adults, independent of obesity: the CARDIA study. Respiratory Research 11: 176

Yildiz, Y.; Ozaksit, G.ül.; Serdar Unlu, B.; Ozgu, E.; Energin, H.; Kaba, M.; Ugur, M. 2014: Serum adiponectin level and clinical, metabolic, and hormonal markers in patients with polycystic ovary syndrome. International Journal of Fertility and Sterility 7(4): 331-336

Jover, E.; Hernández-Romero, D.; Hurtado, J.é A.; Romero-Aniorte, A.I.; Casas, T.; Valdés, M. 2012: Serum adiponectin level as a biomarker of coronary artery calcification and severe coronary lesions. Revista Espanola de Cardiologia 65(11): 1060-1061

Vafaeimanesh, J.; Heidari, A.; Effatpanah, M.; Parham, M. 2014: Serum adiponectin level in diabetic patients with and without Helicobacter pylori infection: is there any difference?. Thescientificworldjournal 2014: 402685

Shi, H.-f.; Ding, Y.-p.; He, H.-w. 2008: Serum adiponectin level in patients of chronic pulmonary heart disease with cardiac failure. Zhonghua Yi Xue Za Zhi 88(36): 2544-2546

Sethna, C.B.; Leonard, M.B.; Gallagher, P.R.; Meyers, K.E.C. 2009: Serum adiponectin levels and ambulatory blood pressure monitoring in pediatric renal transplant recipients. Transplantation 88(8): 1030-1037

Alam, A.; Molnar, M.Z.; Czira, M.E.; Rudas, A.; Ujszaszi, A.; Kalantar-Zadeh, K.; Rosivall, L.; Mucsi, I. 2013: Serum adiponectin levels and mortality after kidney transplantation. Clinical Journal of the American Society of Nephrology: Cjasn 8(3): 460-467

Gialamas, S.P.; Petridou, E.Th.; Tseleni-Balafouta, S.; Spyridopoulos, T.N.; Matsoukis, I.L.; Kondi-Pafiti, A.; Zografos, G.; Mantzoros, C.S. 2011: Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism, Clinical and Experimental 60(11): 1530-1538

Yanai, H.; Hirowatari, Y. 2013: Serum adiponectin levels are significantly associated with favorable metabolic parameters and elevation of atherosclerotic markers. International Journal of Cardiology 167(6): 3065-3066

Elshoreya, H.; Steinberg, F.; Perry, R.; Hansen, C.; Milcareck, B.; Elkouachi, S.; Check, J.H. 2011: Serum adiponectin levels are significantly reduced during the second half of normal pregnancy. Clinical and Experimental Obstetrics and Gynecology 38(3): 211-213

Cassani, E.; Cancello, R.; Cavanna, F.; Maestrini, S.; Di Blasio, A.M.; Liuzzi, A.; Pezzoli, G.; Barichella, M. 2011: Serum adiponectin levels in advanced-stage Parkinson's disease patients. Parkinson's Disease 2011: 624764

Arvaniti, V.A.; Thomopoulos, K.C.; Tsamandas, A.; Makri, M.; Psyrogiannis, A.; Vafiadis, G.; Assimakopoulos, S.F.; Asimakopoulos, S.; Labropoulou-Karatza, C. 2008: Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis. Acta Gastro-Enterologica Belgica 71(4): 355-360

Yasar, L.; Ekin, M.; Gedikbasi, A.; Erturk, A.D.; Savan, K.; Ozdemir, A.; Temur, M. 2011: Serum adiponectin levels in high school girls with polycystic ovary syndrome and hyperandrogenism. Journal of Pediatric and Adolescent Gynecology 24(2): 90-93

Fayyaz, I.; Ahmed, M.Z.; Shah, S.I.; Mehmood, S.; Akram, S.; Ghani, M. 2009: Serum adiponectin levels in patients with coronary artery disease. Journal of Ayub Medical College Abbottabad: Jamc 21(4): 90-92

Yildirim, A.; Bilici, M.; Cayir, K.; Yanmaz, V.; Yildirim, S.; Tekin, S.B. 2009: Serum adiponectin levels in patients with esophageal cancer. Japanese Journal of Clinical Oncology 39(2): 92-96

Ciprandi, G.; De Amici, M.; Tosca, M.; Marseglia, G. 2010: Serum adiponectin levels in patients with seasonal allergic rhinitis. International Immunopharmacology 10(5): 635-638

Avci, I.; Ozerkan, K.; Uncu, G.ür. 2010: Serum adiponectin levels increase in lean preeclamptic women. Prenatal Diagnosis 30(1): 91-92

Masui, Y.; Asano, Y.; Shibata, S.; Noda, S.; Aozasa, N.; Akamata, K.; Yamada, D.; Tamaki, Z.; Tada, Y.; Sugaya, M.; Sato, S.; Kadono, T. 2012: Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis. Journal of the European Academy of Dermatology and Venereology: Jeadv 26(3): 354-360

Kotani, K.; Wakai, K.; Shibata, A.; Fujita, Y.; Ogimoto, I.; Naito, M.; Kurozawa, Y.; Suzuki, H.; Yoshimura, T.; Tamakoshi, A.; Tamakoshi, A.; Mori, M.; Sakauchi, F.; Motohashi, Y.; Tsuji, I.; Nakamura, Y.; Iso, H.; Mikami, H.; Kurosawa, M.; Hoshiyama, Y.; Tanabe, N.; Tamakoshi, K.; Wakai, K.; Tokudome, S.; Suzuki, K.; Hashimoto, S.; Kikuchi, S.; Wada, Y.; Kawamura, T.; Watanabe, Y.; Ozasa, K.; Miki, T.; Date, C.; Sakata, K.; Kurozawa, Y.; Yoshimura, T.; Fujino, Y.; Shibata, A.; Okamoto, N.; Shio, H. 2009: Serum adiponectin multimer complexes and liver cancer risk in a large cohort study in Japan. Asian Pacific Journal of Cancer Prevention: Apjcp 10 Suppl: 87-90

Zemanová, M.; Staňková, B.; Ušiakova, Z.; Tvrzická, E.; Pazdro, A.; Petruželka, L.š; Zeman, M. 2014: Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 20: 2351-2357

Koch, A.; Sanson, E.; Voigt, S.; Helm, A.; Trautwein, C.; Tacke, F. 2011: Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. Journal of Critical Care 26(2): 166-174

Schenk, J.M.; Kristal, A.R.; Neuhouser, M.L.; Tangen, C.M.; White, E.; Lin, D.W.; Thompson, I.M. 2009: Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate 69(12): 1303-1311

Musabak, U.; Demirkaya, S.; Genç, G.; Ilikci, R.S.; Odabasi, Z. 2011: Serum adiponectin, TNF-α, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens. Neuroimmunomodulation 18(1): 57-66

Bozcali, E.; Polat, V.; Akbulut, H.; Ferzeyn Yavuzkir, M.; Karaca, I. 2013: Serum adiponectin, anemia and left ventricular dimensions in patients with cardiac cachexia. Cardiology 126(4): 207-213

Miazgowski, T.; Noworyta-Ziętara, M.; Safranow, K.; Ziemak, J.; Widecka, K. 2012: Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed Type 2 diabetes: a 12-month follow-up. Diabetic Medicine: a Journal of the British Diabetic Association 29(1): 62-69

Lei, X.; Peng, X.; Wu, N.; Hu, M.; Sun, Z. 2009: Serum adiponectin, leptin level, and bone mineral density in postmenopausal women. Zhong Nan da Xue Xue Bao. Yi Xue Ban 34(6): 559-562

Bobe, G.; Murphy, G.; Rogers, C.J.; Hance, K.W.; Albert, P.S.; Laiyemo, A.O.; Sansbury, L.B.; Lanza, E.; Schatzkin, A.; Cross, A.J. 2010: Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 19(6): 1441-1452

Boyraz, M.; Cekmez, F.; Karaoglu, A.; Cinaz, P.; Durak, M.; Bideci, A. 2013: Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease. Biomarkers in Medicine 7(5): 737-745

Asgeirsson, T.; Zhang, S.; Khoo, S.K.; Resau, J.H.; Dujovny, N.; Senagore, A.J. 2011: Serum adiponectin, resistin, and circulating soluble receptor for advanced glycation end products in colectomy patients. Mediators of Inflammation 2011: 916807

Mokrowiecka, A.; Daniel, P.; Jasinska, A.; Pietruczuk, M.; Pawlowski, M.; Szczesniak, P.; Orszulak-Michalak, D.; Malecka-Panas, E. 2012: Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD. Hepato-Gastroenterology 59(120): 2395-2399

Redondo, M.J.; Rodriguez, L.M.; Haymond, M.W.; Hampe, C.S.; Smith, E.O.; Balasubramanyam, A.; Devaraj, S. 2014: Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatric Diabetes 15(8): 543-549

Ciprandi, G.; De Amici, M.; Marseglia, G. 2009: Serum adipsin levels in patients with seasonal allergic rhinitis: preliminary data. International Immunopharmacology 9(12): 1460-1463

Macnamara, J. 1948: Serum administration in infantile paralysis. Journal of Bone and Joint Surgery. British Volume 30b (1): 222

Yu, H.-y.; Zhao, P.; Wu, M.-c.; Liu, J.; Yin, W. 2014: Serum adropin levels are decreased in patients with acute myocardial infarction. Regulatory Peptides 190-191: 46-49

Tan, K.C.B.; Shiu, S.W.M.; Wong, Y.; Tam, X. 2011: Serum advanced glycation end products (AGEs) are associated with insulin resistance. Diabetes/Metabolism Research and Reviews 27(5): 488-492

Aydin, S.; Sabuncuoglu, S.; Erkekoglu, P.; Sahin, G.ön.ül.; Giray, B.K. 2014: Serum aflatoxin levels of the healthy adult population living in the north and south regions of Turkey. Public Health Nutrition 17(11): 2496-2504

Walenda, T.; Bokermann, G.; Jost, E.; Galm, O.; Schellenberg, A.; Koch, C.M.; Piroth, D.M.; Drescher, W.; Brümmendorf, T.H.; Wagner, W. 2011: Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells. Plos one 6(3): E18012

Cadosch, D.; Toffoli, A.M.; Gautschi, O.P.; Frey, S.ön.P.; Zellweger, R.é; Skirving, A.P.; Filgueira, L. 2010: Serum after traumatic brain injury increases proliferation and supports expression of osteoblast markers in muscle cells. Journal of Bone and Joint Surgery. American Volume 92(3): 645-653

Patel, D.A.; Srinivasan, S.R.; Chen, W.; Berenson, G.S. 2011: Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study. Metabolic Syndrome and Related Disorders 9(3): 211-216

Loomba, R. 2014: Serum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 12(10): 1731-1732

Omagari, K.; Takamura, R.; Matsutake, S.; Ichimura, M.; Kato, S.; Morikawa, S.-I.; Nagaoka, S.; Osabe, M. 2011: Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver. Journal of Clinical Biochemistry and Nutrition 49(3): 200-206

Heard, K.J.; Green, J.L.; Dart, R.C. 2010: Serum alanine aminotransferase elevation during 10 days of acetaminophen use in nondrinkers. PharmacoTherapy 30(8): 818-822